<!DOCTYPE html SYSTEM "about:legacy-compat"><html lang="en" class="win-std-desktop-val"><head>
<META http-equiv="Content-Type" content="text/html">
<title>Source View: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/</title><meta name="robots" content="noindex,nofollow"><meta name="SortSite-IgnoreRule-Page" content="AccHtmlLinkTextReused,AccAdvancedReadingLevel,Section508-m-3,BugHtmlColgroup,BugIeCssMinMaxWidthHeight,ErrSpellingError,SeoBingTitleLength,SeoPage150k,UseGov5.1,UseGov9.2.3,UseGov10.11,UseGov11.7,UseGov14.3,UseGov17.4,UseGunningFog,W3cTitleTooLong"><link rel="icon" href="https://www-powermapper-com.azureedge.net/favicon.ico"><link rel="stylesheet" href="../Report/report-min-20200618.css"><script type="text/javascript" src="../Report/report-min-20210409.js"></script><!--[if lte IE 8]>
            <script>
                document.createElement('header');
                document.createElement('aside');
            </script>
            <![endif]--></head><body class="source"><a class="accessible" href="#content">Skip to Content</a><header><h1>
                        HTML Document
                    </h1><table><tr><th>
                        URL:
                    </th><td><a rel="nofollow" target="_top" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/</a></td></tr><tr><th>
                        HTTP Status:
                    </th><td>200 OK</td></tr><tr><th>
                        MIME Type:
                    </th><td>text/html </td></tr><tr><th>
                        Last Modified:
                    </th><td>Mon, 01 Jan 1601 00:00:00 GMT</td></tr><tr><th>
                        Download Time:
                    </th><td>2 seconds
                            </td></tr><tr><th>
                        Cookies:
                    </th><td> ncbi_sid=8A1AED4817306781_045  WebEnv=1rSAgV%408A1AED4817306  pmc.article.report= </td></tr><tr><th>
                        Size:
                    </th><td>269 KB
                        </td></tr><tr><th>
                                Depth:
                            </th><td>3 clicks from home page
                            </td></tr><tr><th>
                                Charset:
                            </th><td>utf-8</td></tr><tr><th>
                                Forms:
                            </th><td>1 forms containing 2 controls
                            </td></tr><tr><th>
                        HTTP Headers:
                    </th><td><button class="chevron toggleChevron" data-toggleid="HttpHeaders"><img width="20" height="20" alt="View Headers" id="chevHttpHeaders" src="../Report/chevron-down.svg"></button>&nbsp;<span>14&nbsp;headers</span><div class="links" id="expand-HttpHeaders">Cache-Control: private<br>Connection: Keep-Alive<br>Content-Security-Policy: upgrade-insecure-requests<br>Date: Tue, 26 Oct 2021 18:06:02 GMT<br>Keep-Alive: timeout=1, max=10<br>NCBI-PHID: 8A1AC59A17840EA10000000001100110.m_9<br>NCBI-SID: 8A1AED4817306781_0453SID<br>Referrer-Policy: origin-when-cross-origin<br>Server: Apache<br>Set-Cookie: pmc.article.report=; domain=.nih.gov; path=/; Max-Age=31536000<br>Strict-Transport-Security: max-age=31536000; includeSubDomains; preload<br>Transfer-Encoding: chunked<br>X-UA-Compatible: IE=Edge<br>X-XSS-Protection: 1; mode=block<br></div></td></tr><tr><th>
                        Links In:
                    </th><td><button class="chevron toggleChevron" data-toggleid="LinksIn"><img width="20" height="20" alt="View Links" id="chevLinksIn" src="../Report/chevron-down.svg"></button>&nbsp;<span>2&nbsp;pages</span><div class="links" id="expand-LinksIn"><a class="viewsource" rel="nofollow" target="_top" href="https://prod-www.papaandbarkleycbd.com/learn/hemp-oil-vs-cbd-oil-what-you-should-know" data-pageid="156" data-line="0" data-col="0">https://prod-www.papaandbarkleycbd.com/learn/hemp-oil-vs-cbd-oil-what-you-should-know</a><br><a class="viewsource" rel="nofollow" target="_top" href="https://prod-www.papaandbarkleycbd.com/learn/cbd-for-pets-a-natural-way-to-relieve-pain-and-anxiety" data-pageid="355" data-line="0" data-col="0">https://prod-www.papaandbarkleycbd.com/learn/cbd-for-pets-a-natural-way-to-relieve-pain-and-anxiety</a><br></div></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td></tr><tr class="middle"><th><img alt="OK" width="20" height="20" src="../Report/bench-better.svg">
                                Issues:
                            </th><td>
                                No issues found
                            </td></tr></table></header><main id="content" class="pre"><p><code>1</code><code>&lt;?xml version="1.0" encoding="utf-8"?&gt;</code></p><p><code>2</code><code>          </code></p><p><code>3</code><code>&lt;!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"&gt;</code></p><p><code>4</code><code>          </code></p><p><code>5</code><code>&lt;html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"&gt;</code></p><p><code>6</code><code>          </code></p><p><code>7</code><code>    </code></p><p><code>8</code><code>    &lt;head&gt;</code></p><p><code>9</code><code>&lt;meta http-equiv="Content-Type" content="text/html; charset=utf-8" /&gt;</code></p><p><code>10</code><code>          </code></p><p><code>11</code><code>        &lt;!-- AppResources meta begin --&gt;</code></p><p><code>12</code><code>          </code></p><p><code>13</code><code>        &lt;script type="text/javascript"&gt;</code></p><p><code>14</code><code>var ncbi_startTime = new Date();&lt;/script&gt;</code></p><p><code>15</code><code>          </code></p><p><code>16</code><code>        &lt;!-- AppResources meta end --&gt;</code></p><p><code>17</code><code>          </code></p><p><code>18</code><code>        </code></p><p><code>19</code><code>        &lt;!-- TemplateResources meta begin --&gt;</code></p><p><code>20</code><code>          </code></p><p><code>21</code><code>        &lt;meta name="paf_template" content="" /&gt;</code></p><p><code>22</code><code>          </code></p><p><code>23</code><code>          </code></p><p><code>24</code><code>        &lt;!-- TemplateResources meta end --&gt;</code></p><p><code>25</code><code>          </code></p><p><code>26</code><code>        </code></p><p><code>27</code><code>        &lt;!-- Logger begin --&gt;</code></p><p><code>28</code><code>          </code></p><p><code>29</code><code>        &lt;meta name="ncbi_db" content="pmc" /&gt;</code></p><p><code>30</code><code>&lt;meta name="ncbi_pdid" content="article" /&gt;</code></p><p><code>31</code><code>&lt;meta name="ncbi_acc" content="" /&gt;</code></p><p><code>32</code><code>&lt;meta name="ncbi_domain" content="nihpa" /&gt;</code></p><p><code>33</code><code>&lt;meta name="ncbi_report" content="record" /&gt;</code></p><p><code>34</code><code>&lt;meta name="ncbi_type" content="fulltext" /&gt;</code></p><p><code>35</code><code>&lt;meta name="ncbi_objectid" content="" /&gt;</code></p><p><code>36</code><code>&lt;meta name="ncbi_pcid" content="/articles/PMC2828614/" /&gt;</code></p><p><code>37</code><code>&lt;meta name="ncbi_app" content="pmc" /&gt;</code></p><p><code>38</code><code>          </code></p><p><code>39</code><code>        &lt;!-- Logger end --&gt;</code></p><p><code>40</code><code>          </code></p><p><code>41</code><code>        </code></p><p><code>42</code><code>        &lt;title&gt;</code></p><p><code>43</code><code>Cannabinoids as novel anti-inflammatory drugs&lt;/title&gt;</code></p><p><code>44</code><code>          </code></p><p><code>45</code><code>        </code></p><p><code>46</code><code>        &lt;!-- AppResources external_resources begin --&gt;</code></p><p><code>47</code><code>          </code></p><p><code>48</code><code>        &lt;link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /&gt;</code></p><p><code>49</code><code>&lt;script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"&gt;</code></p><p><code>50</code><code>&lt;/script&gt;</code></p><p><code>51</code><code>          </code></p><p><code>52</code><code>          </code></p><p><code>53</code><code>        &lt;!-- AppResources external_resources end --&gt;</code></p><p><code>54</code><code>          </code></p><p><code>55</code><code>        </code></p><p><code>56</code><code>        &lt;!-- Page meta begin --&gt;</code></p><p><code>57</code><code>          </code></p><p><code>58</code><code>        &lt;meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /&gt;</code></p><p><code>59</code><code>&lt;link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/" /&gt;</code></p><p><code>60</code><code>&lt;link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /&gt;</code></p><p><code>61</code><code>&lt;meta name="citation_journal_title" content="Future medicinal chemistry" /&gt;</code></p><p><code>62</code><code>&lt;meta name="citation_title" content="Cannabinoids as novel anti-inflammatory drugs" /&gt;</code></p><p><code>63</code><code>&lt;meta name="citation_authors" content="Prakash Nagarkatti, Rupal Pandey, Sadiye Amcaoglu Rieder, Venkatesh L Hegde, Mitzi Nagarkatti" /&gt;</code></p><p><code>64</code><code>&lt;meta name="citation_date" content="October 2009" /&gt;</code></p><p><code>65</code><code>&lt;meta name="citation_issue" content="7" /&gt;</code></p><p><code>66</code><code>&lt;meta name="citation_volume" content="1" /&gt;</code></p><p><code>67</code><code>&lt;meta name="citation_firstpage" content="1333" /&gt;</code></p><p><code>68</code><code>&lt;meta name="citation_doi" content="10.4155/fmc.09.93" /&gt;</code></p><p><code>69</code><code>&lt;meta name="citation_abstract_html_url" content="/pmc/articles/PMC2828614/?report=abstract" /&gt;</code></p><p><code>70</code><code>&lt;meta name="citation_fulltext_html_url" content="/pmc/articles/PMC2828614/" /&gt;</code></p><p><code>71</code><code>&lt;meta name="citation_pmid" content="20191092" /&gt;</code></p><p><code>72</code><code>&lt;meta name="DC.Title" content="Cannabinoids as novel anti-inflammatory drugs" /&gt;</code></p><p><code>73</code><code>&lt;meta name="DC.Type" content="Text" /&gt;</code></p><p><code>74</code><code>&lt;meta name="DC.Publisher" content="NIH Public Access" /&gt;</code></p><p><code>75</code><code>&lt;meta name="DC.Contributor" content="Prakash Nagarkatti" /&gt;</code></p><p><code>76</code><code>&lt;meta name="DC.Contributor" content="Rupal Pandey" /&gt;</code></p><p><code>77</code><code>&lt;meta name="DC.Contributor" content="Sadiye Amcaoglu Rieder" /&gt;</code></p><p><code>78</code><code>&lt;meta name="DC.Contributor" content="Venkatesh L Hegde" /&gt;</code></p><p><code>79</code><code>&lt;meta name="DC.Contributor" content="Mitzi Nagarkatti" /&gt;</code></p><p><code>80</code><code>&lt;meta name="DC.Date" content="2009 Oct" /&gt;</code></p><p><code>81</code><code>&lt;meta name="DC.Identifier" content="10.4155/fmc.09.93" /&gt;</code></p><p><code>82</code><code>&lt;meta name="DC.Language" content="en" /&gt;</code></p><p><code>83</code><code>&lt;meta property="og:title" content="Cannabinoids as novel anti-inflammatory drugs" /&gt;</code></p><p><code>84</code><code>&lt;meta property="og:type" content="article" /&gt;</code></p><p><code>85</code><code>&lt;meta property="og:description" content="Cannabinoids are a group of compounds that mediate their effects through cannabinoid receptors. The discovery of Δ[9] -tetrahydrocannabinol (THC) as the major psychoactive principle in marijuana, as well as the identification of cannabinoid receptors ..." /&gt;</code></p><p><code>86</code><code>&lt;meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/" /&gt;</code></p><p><code>87</code><code>&lt;meta property="og:site_name" content="PubMed Central (PMC)" /&gt;</code></p><p><code>88</code><code>&lt;meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png?_=0" /&gt;</code></p><p><code>89</code><code>&lt;meta name="twitter:card" content="summary" /&gt;</code></p><p><code>90</code><code>&lt;meta name="twitter:site" content="@ncbi" /&gt;</code></p><p><code>91</code><code>&lt;link rel="stylesheet" href="/corehtml/pmc/css/3.15.12/ncbi.min.css" type="text/css" data-apply="standalone" /&gt;</code></p><p><code>92</code><code>&lt;link rel="stylesheet" href="/corehtml/pmc/css/3.15.12/pmc.min.css" type="text/css" /&gt;</code></p><p><code>93</code><code>&lt;link rel="stylesheet" href="/corehtml/pmc/css/3.15.12/pmcrefs1.min.css" type="text/css" /&gt;</code></p><p><code>94</code><code>&lt;link rel="stylesheet" href="/corehtml/pmc/css/3.15.12/pmc_extras_prnt.min.css" type="text/css" media="print" /&gt;</code></p><p><code>95</code><code>&lt;style type="text/css"&gt;</code></p><p><code>96</code><code>.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}&lt;/style&gt;</code></p><p><code>97</code><code>&lt;style type="text/css"&gt;</code></p><p><code>98</code><code>.print-view{display:block}&lt;/style&gt;</code></p><p><code>99</code><code>&lt;script&gt;</code></p><p><code>100</code><code>          </code></p><p><code>101</code><code>				var isjq= typeof jQuery === "function"</code></p><p><code>102</code><code>			&lt;/script&gt;</code></p><p><code>103</code><code>&lt;script type="text/javascript"&gt;</code></p><p><code>104</code><code>if (!isjq){document.write('\x3Cscript type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"\x3E\x3C/script\x3E')}{document.write('\x3Cscript type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js"\x3E\x3C/script\x3E')}&lt;/script&gt;</code></p><p><code>105</code><code>&lt;script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.15.12"&gt;</code></p><p><code>106</code><code>//&lt;/script&gt;</code></p><p><code>107</code><code>&lt;script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.15.12"&gt;</code></p><p><code>108</code><code>//&lt;/script&gt;</code></p><p><code>109</code><code>&lt;script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.15.12"&gt;</code></p><p><code>110</code><code>//&lt;/script&gt;</code></p><p><code>111</code><code>&lt;meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'" /&gt;</code></p><p><code>112</code><code>&lt;script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js"&gt;</code></p><p><code>113</code><code>//&lt;/script&gt;</code></p><p><code>114</code><code>&lt;link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /&gt;</code></p><p><code>115</code><code>&lt;script type="text/javascript"&gt;</code></p><p><code>116</code><code>window.name="mainwindow";&lt;/script&gt;</code></p><p><code>117</code><code>&lt;style type="text/css"&gt;</code></p><p><code>118</code><code>          </code></p><p><code>119</code><code>        div.pmc_para_cit li.highlight,</code></p><p><code>120</code><code>        div.pmc_para_cit li.highlight .one_line_source</code></p><p><code>121</code><code>        { background: #E0E0E0; }</code></p><p><code>122</code><code>        a.bibr.highlight { background: #E0E0E0; } </code></p><p><code>123</code><code>      &lt;/style&gt;</code></p><p><code>124</code><code>&lt;meta name="cited_in_systematic_reviews" content="" /&gt;</code></p><p><code>125</code><code>&lt;link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2828614/pdf/nihms155268.pdf" /&gt;</code></p><p><code>126</code><code>          </code></p><p><code>127</code><code>          </code></p><p><code>128</code><code>        &lt;!-- Page meta end --&gt;</code></p><p><code>129</code><code>          </code></p><p><code>130</code><code>    &lt;link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /&gt;</code></p><p><code>131</code><code>&lt;meta name="ncbi_phid" content="8A1AC59A17840EA10000000001100110.m_8" /&gt;</code></p><p><code>132</code><code>          </code></p><p><code>133</code><code>&lt;meta name='referrer' content='origin-when-cross-origin'/&gt;</code></p><p><code>134</code><code>&lt;link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4201310/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4200827/4200829/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /&gt;</code></p><p><code>135</code><code>&lt;link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4201310/css/3411343/3882866/4157116.css" media="print" /&gt;</code></p><p><code>136</code><code>&lt;/head&gt;</code></p><p><code>137</code><code>          </code></p><p><code>138</code><code>    &lt;body class="article"&gt;</code></p><p><code>139</code><code>          </code></p><p><code>140</code><code>        &lt;div class="grid"&gt;</code></p><p><code>141</code><code>          </code></p><p><code>142</code><code>            &lt;div class="col twelve_col nomargin shadow"&gt;</code></p><p><code>143</code><code>          </code></p><p><code>144</code><code>                &lt;!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet --&gt;</code></p><p><code>145</code><code>          </code></p><p><code>146</code><code>                &lt;div class="sysmessages"&gt;</code></p><p><code>147</code><code>          </code></p><p><code>148</code><code>                    &lt;noscript&gt;</code></p><p><code>149</code><code>          </code></p><p><code>150</code><code>	&lt;p class="nojs"&gt;</code></p><p><code>151</code><code>          </code></p><p><code>152</code><code>	&lt;strong&gt;</code></p><p><code>153</code><code>Warning:&lt;/strong&gt;</code></p><p><code>154</code><code>          </code></p><p><code>155</code><code>	The NCBI web site requires JavaScript to function. </code></p><p><code>156</code><code>	&lt;a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank"&gt;</code></p><p><code>157</code><code>more...&lt;/a&gt;</code></p><p><code>158</code><code>          </code></p><p><code>159</code><code>	&lt;/p&gt;</code></p><p><code>160</code><code>          </code></p><p><code>161</code><code>	&lt;/noscript&gt;</code></p><p><code>162</code><code>          </code></p><p><code>163</code><code>                &lt;/div&gt;</code></p><p><code>164</code><code>          </code></p><p><code>165</code><code>                &lt;!--/.sysmessage--&gt;</code></p><p><code>166</code><code>          </code></p><p><code>167</code><code>                &lt;div class="wrap"&gt;</code></p><p><code>168</code><code>          </code></p><p><code>169</code><code>                    &lt;div class="page"&gt;</code></p><p><code>170</code><code>          </code></p><p><code>171</code><code>                        &lt;div class="top"&gt;</code></p><p><code>172</code><code>          </code></p><p><code>173</code><code>                            &lt;div class="universal_header" id="universal_header"&gt;</code></p><p><code>174</code><code>&lt;ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"&gt;</code></p><p><code>175</code><code>&lt;li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"&gt;</code></p><p><code>176</code><code>&lt;a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"&gt;</code></p><p><code>177</code><code>&lt;span class="offscreen_noflow"&gt;</code></p><p><code>178</code><code>NCBI&lt;/span&gt;</code></p><p><code>179</code><code>&lt;img src="//static.pubmed.gov/portal/portal3rc.fcgi/4201310/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /&gt;</code></p><p><code>180</code><code>&lt;/a&gt;</code></p><p><code>181</code><code>&lt;/li&gt;</code></p><p><code>182</code><code>&lt;li class="offscreen_noflow ui-ncbimenu-item-skip access"&gt;</code></p><p><code>183</code><code>&lt;a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3"&gt;</code></p><p><code>184</code><code>Skip to main</code></p><p><code>185</code><code>                        content&lt;/a&gt;</code></p><p><code>186</code><code>&lt;/li&gt;</code></p><p><code>187</code><code>&lt;li class="offscreen_noflow ui-ncbimenu-item-skip access"&gt;</code></p><p><code>188</code><code>&lt;a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4"&gt;</code></p><p><code>189</code><code>Skip to</code></p><p><code>190</code><code>                        navigation&lt;/a&gt;</code></p><p><code>191</code><code>&lt;/li&gt;</code></p><p><code>192</code><code>&lt;li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"&gt;</code></p><p><code>193</code><code>&lt;a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources"&gt;</code></p><p><code>194</code><code>Resources&lt;/a&gt;</code></p><p><code>195</code><code>&lt;/li&gt;</code></p><p><code>196</code><code>&lt;li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"&gt;</code></p><p><code>197</code><code>&lt;a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto"&gt;</code></p><p><code>198</code><code>How To&lt;/a&gt;</code></p><p><code>199</code><code>&lt;/li&gt;</code></p><p><code>200</code><code>&lt;li class="offscreen_noflow ui-ncbimenu-item-skip access"&gt;</code></p><p><code>201</code><code>&lt;a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0"&gt;</code></p><p><code>202</code><code>About NCBI Accesskeys&lt;/a&gt;</code></p><p><code>203</code><code>&lt;/li&gt;</code></p><p><code>204</code><code>&lt;/ul&gt;</code></p><p><code>205</code><code>&lt;div class="myncbi"&gt;</code></p><p><code>206</code><code>&lt;span id="myncbiusername" style="display:none"&gt;</code></p><p><code>207</code><code>&lt;a href="/account/settings/" id="mnu" title="Edit account settings"&gt;</code></p><p><code>208</code><code>&lt;/a&gt;</code></p><p><code>209</code><code>&lt;/span&gt;</code></p><p><code>210</code><code>&lt;a accesskey="2" href="/myncbi/" id="myncbi" style="display:none"&gt;</code></p><p><code>211</code><code>My NCBI&lt;/a&gt;</code></p><p><code>212</code><code>&lt;a href="/account/" id="sign_in"&gt;</code></p><p><code>213</code><code>Sign in to NCBI&lt;/a&gt;</code></p><p><code>214</code><code>&lt;a href="/account/signout/" id="sign_out" style="display:none"&gt;</code></p><p><code>215</code><code>Sign Out&lt;/a&gt;</code></p><p><code>216</code><code>&lt;/div&gt;</code></p><p><code>217</code><code>&lt;/div&gt;</code></p><p><code>218</code><code>          </code></p><p><code>219</code><code>                            &lt;div class="header"&gt;</code></p><p><code>220</code><code>          </code></p><p><code>221</code><code>    &lt;div class="res_logo"&gt;</code></p><p><code>222</code><code>          </code></p><p><code>223</code><code>  &lt;h1 class="img_logo"&gt;</code></p><p><code>224</code><code>&lt;a href="/pmc/" class="pmc_logo offscreen"&gt;</code></p><p><code>225</code><code>PMC&lt;/a&gt;</code></p><p><code>226</code><code>&lt;/h1&gt;</code></p><p><code>227</code><code>          </code></p><p><code>228</code><code>  &lt;div class="NLMLogo"&gt;</code></p><p><code>229</code><code>          </code></p><p><code>230</code><code>    &lt;a href="https://www.nlm.nih.gov/" title="US National Library of Medicine"&gt;</code></p><p><code>231</code><code>US National Library of Medicine&lt;/a&gt;</code></p><p><code>232</code><code>          </code></p><p><code>233</code><code>    &lt;br /&gt;</code></p><p><code>234</code><code>          </code></p><p><code>235</code><code>    &lt;a href="https://www.nih.gov/" title="National Institutes of Health"&gt;</code></p><p><code>236</code><code>National Institutes of Health&lt;/a&gt;</code></p><p><code>237</code><code>          </code></p><p><code>238</code><code>  &lt;/div&gt;</code></p><p><code>239</code><code>          </code></p><p><code>240</code><code>&lt;/div&gt;</code></p><p><code>241</code><code>          </code></p><p><code>242</code><code>    &lt;div class="search"&gt;</code></p><p><code>243</code><code>&lt;form method="get" action="/pmc/"&gt;</code></p><p><code>244</code><code>&lt;div class="search_form"&gt;</code></p><p><code>245</code><code>&lt;label for="database" class="offscreen_noflow"&gt;</code></p><p><code>246</code><code>Search database&lt;/label&gt;</code></p><p><code>247</code><code>&lt;select id="database"&gt;</code></p><p><code>248</code><code>&lt;optgroup label="Recent"&gt;</code></p><p><code>249</code><code>&lt;option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete"&gt;</code></p><p><code>250</code><code>PMC&lt;/option&gt;</code></p><p><code>251</code><code>&lt;/optgroup&gt;</code></p><p><code>252</code><code>&lt;optgroup label="All"&gt;</code></p><p><code>253</code><code>&lt;option value="gquery"&gt;</code></p><p><code>254</code><code>All Databases&lt;/option&gt;</code></p><p><code>255</code><code>&lt;option value="assembly"&gt;</code></p><p><code>256</code><code>Assembly&lt;/option&gt;</code></p><p><code>257</code><code>&lt;option value="biocollections"&gt;</code></p><p><code>258</code><code>Biocollections&lt;/option&gt;</code></p><p><code>259</code><code>&lt;option value="bioproject"&gt;</code></p><p><code>260</code><code>BioProject&lt;/option&gt;</code></p><p><code>261</code><code>&lt;option value="biosample"&gt;</code></p><p><code>262</code><code>BioSample&lt;/option&gt;</code></p><p><code>263</code><code>&lt;option value="biosystems"&gt;</code></p><p><code>264</code><code>BioSystems&lt;/option&gt;</code></p><p><code>265</code><code>&lt;option value="books"&gt;</code></p><p><code>266</code><code>Books&lt;/option&gt;</code></p><p><code>267</code><code>&lt;option value="clinvar"&gt;</code></p><p><code>268</code><code>ClinVar&lt;/option&gt;</code></p><p><code>269</code><code>&lt;option value="cdd"&gt;</code></p><p><code>270</code><code>Conserved Domains&lt;/option&gt;</code></p><p><code>271</code><code>&lt;option value="gap"&gt;</code></p><p><code>272</code><code>dbGaP&lt;/option&gt;</code></p><p><code>273</code><code>&lt;option value="dbvar"&gt;</code></p><p><code>274</code><code>dbVar&lt;/option&gt;</code></p><p><code>275</code><code>&lt;option value="gene"&gt;</code></p><p><code>276</code><code>Gene&lt;/option&gt;</code></p><p><code>277</code><code>&lt;option value="genome"&gt;</code></p><p><code>278</code><code>Genome&lt;/option&gt;</code></p><p><code>279</code><code>&lt;option value="gds"&gt;</code></p><p><code>280</code><code>GEO DataSets&lt;/option&gt;</code></p><p><code>281</code><code>&lt;option value="geoprofiles"&gt;</code></p><p><code>282</code><code>GEO Profiles&lt;/option&gt;</code></p><p><code>283</code><code>&lt;option value="gtr"&gt;</code></p><p><code>284</code><code>GTR&lt;/option&gt;</code></p><p><code>285</code><code>&lt;option value="homologene"&gt;</code></p><p><code>286</code><code>HomoloGene&lt;/option&gt;</code></p><p><code>287</code><code>&lt;option value="ipg"&gt;</code></p><p><code>288</code><code>Identical Protein Groups&lt;/option&gt;</code></p><p><code>289</code><code>&lt;option value="medgen"&gt;</code></p><p><code>290</code><code>MedGen&lt;/option&gt;</code></p><p><code>291</code><code>&lt;option value="mesh"&gt;</code></p><p><code>292</code><code>MeSH&lt;/option&gt;</code></p><p><code>293</code><code>&lt;option value="ncbisearch"&gt;</code></p><p><code>294</code><code>NCBI Web Site&lt;/option&gt;</code></p><p><code>295</code><code>&lt;option value="nlmcatalog"&gt;</code></p><p><code>296</code><code>NLM Catalog&lt;/option&gt;</code></p><p><code>297</code><code>&lt;option value="nuccore"&gt;</code></p><p><code>298</code><code>Nucleotide&lt;/option&gt;</code></p><p><code>299</code><code>&lt;option value="omim"&gt;</code></p><p><code>300</code><code>OMIM&lt;/option&gt;</code></p><p><code>301</code><code>&lt;option value="pmc" data-ac_dict="pmc-search-autocomplete"&gt;</code></p><p><code>302</code><code>PMC&lt;/option&gt;</code></p><p><code>303</code><code>&lt;option value="popset"&gt;</code></p><p><code>304</code><code>PopSet&lt;/option&gt;</code></p><p><code>305</code><code>&lt;option value="protein"&gt;</code></p><p><code>306</code><code>Protein&lt;/option&gt;</code></p><p><code>307</code><code>&lt;option value="proteinclusters"&gt;</code></p><p><code>308</code><code>Protein Clusters&lt;/option&gt;</code></p><p><code>309</code><code>&lt;option value="protfam"&gt;</code></p><p><code>310</code><code>Protein Family Models&lt;/option&gt;</code></p><p><code>311</code><code>&lt;option value="pcassay"&gt;</code></p><p><code>312</code><code>PubChem BioAssay&lt;/option&gt;</code></p><p><code>313</code><code>&lt;option value="pccompound"&gt;</code></p><p><code>314</code><code>PubChem Compound&lt;/option&gt;</code></p><p><code>315</code><code>&lt;option value="pcsubstance"&gt;</code></p><p><code>316</code><code>PubChem Substance&lt;/option&gt;</code></p><p><code>317</code><code>&lt;option value="pubmed"&gt;</code></p><p><code>318</code><code>PubMed&lt;/option&gt;</code></p><p><code>319</code><code>&lt;option value="snp"&gt;</code></p><p><code>320</code><code>SNP&lt;/option&gt;</code></p><p><code>321</code><code>&lt;option value="sra"&gt;</code></p><p><code>322</code><code>SRA&lt;/option&gt;</code></p><p><code>323</code><code>&lt;option value="structure"&gt;</code></p><p><code>324</code><code>Structure&lt;/option&gt;</code></p><p><code>325</code><code>&lt;option value="taxonomy"&gt;</code></p><p><code>326</code><code>Taxonomy&lt;/option&gt;</code></p><p><code>327</code><code>&lt;option value="toolkit"&gt;</code></p><p><code>328</code><code>ToolKit&lt;/option&gt;</code></p><p><code>329</code><code>&lt;option value="toolkitall"&gt;</code></p><p><code>330</code><code>ToolKitAll&lt;/option&gt;</code></p><p><code>331</code><code>&lt;option value="toolkitbookgh"&gt;</code></p><p><code>332</code><code>ToolKitBookgh&lt;/option&gt;</code></p><p><code>333</code><code>&lt;/optgroup&gt;</code></p><p><code>334</code><code>&lt;/select&gt;</code></p><p><code>335</code><code>&lt;div class="nowrap"&gt;</code></p><p><code>336</code><code>&lt;label for="term" class="offscreen_noflow" accesskey="/"&gt;</code></p><p><code>337</code><code>Search term&lt;/label&gt;</code></p><p><code>338</code><code>&lt;div class="nowrap"&gt;</code></p><p><code>339</code><code>&lt;input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" /&gt;</code></p><p><code>340</code><code>&lt;/div&gt;</code></p><p><code>341</code><code>&lt;button id="search" type="submit" class="button_search nowrap" cmd="go"&gt;</code></p><p><code>342</code><code>Search&lt;/button&gt;</code></p><p><code>343</code><code>&lt;/div&gt;</code></p><p><code>344</code><code>&lt;/div&gt;</code></p><p><code>345</code><code>&lt;/form&gt;</code></p><p><code>346</code><code>&lt;ul class="searchlinks inline_list"&gt;</code></p><p><code>347</code><code>&lt;li&gt;</code></p><p><code>348</code><code>          </code></p><p><code>349</code><code>                        &lt;a href="/pmc/advanced/"&gt;</code></p><p><code>350</code><code>Advanced&lt;/a&gt;</code></p><p><code>351</code><code>          </code></p><p><code>352</code><code>                    &lt;/li&gt;</code></p><p><code>353</code><code>&lt;li&gt;</code></p><p><code>354</code><code>          </code></p><p><code>355</code><code>                        &lt;a href="/pmc/journals/"&gt;</code></p><p><code>356</code><code>Journal list&lt;/a&gt;</code></p><p><code>357</code><code>          </code></p><p><code>358</code><code>                    &lt;/li&gt;</code></p><p><code>359</code><code>&lt;li class="help"&gt;</code></p><p><code>360</code><code>          </code></p><p><code>361</code><code>                        &lt;a target="_blank" href="/books/NBK3825/"&gt;</code></p><p><code>362</code><code>Help&lt;/a&gt;</code></p><p><code>363</code><code>          </code></p><p><code>364</code><code>                    &lt;/li&gt;</code></p><p><code>365</code><code>&lt;/ul&gt;</code></p><p><code>366</code><code>&lt;/div&gt;</code></p><p><code>367</code><code>          </code></p><p><code>368</code><code>&lt;/div&gt;</code></p><p><code>369</code><code>          </code></p><p><code>370</code><code>          </code></p><p><code>371</code><code>                            </code></p><p><code>372</code><code>                            </code></p><p><code>373</code><code>                        &lt;!--&lt;component id="Page" label="headcontent"/&gt;</code></p><p><code>374</code><code>--&gt;</code></p><p><code>375</code><code>          </code></p><p><code>376</code><code>                            </code></p><p><code>377</code><code>                        &lt;/div&gt;</code></p><p><code>378</code><code>          </code></p><p><code>379</code><code>                        &lt;div class="content"&gt;</code></p><p><code>380</code><code>          </code></p><p><code>381</code><code>                            &lt;!-- site messages --&gt;</code></p><p><code>382</code><code>          </code></p><p><code>383</code><code>                            &lt;div class="ncbi-alerts pmc-labs-ad" id="pmc-labs-ad" role="region" aria-label="Alert" style="margin-bottom: 16px;"&gt;</code></p><p><code>384</code><code>&lt;div class="pmc-labs-ad-outer"&gt;</code></p><p><code>385</code><code>&lt;div class="pmc-labs-ad-inner"&gt;</code></p><p><code>386</code><code>&lt;p&gt;</code></p><p><code>387</code><code>Try out &lt;a href="https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC2828614/"&gt;</code></p><p><code>388</code><code>PMC Labs&lt;/a&gt;</code></p><p><code>389</code><code> and tell us what you think. &lt;a href="https://ncbiinsights.ncbi.nlm.nih.gov/2021/06/02/pmc-labs/" target="_blank"&gt;</code></p><p><code>390</code><code>Learn More&lt;/a&gt;</code></p><p><code>391</code><code>.&lt;/p&gt;</code></p><p><code>392</code><code>&lt;/div&gt;</code></p><p><code>393</code><code>&lt;/div&gt;</code></p><p><code>394</code><code>&lt;button type="button" class="close pmc-labs-ad-close" aria-controls="pmc-labs-ad" aria-label="Close Alert"&gt;</code></p><p><code>395</code><code>&lt;/button&gt;</code></p><p><code>396</code><code>&lt;/div&gt;</code></p><p><code>397</code><code>          </code></p><p><code>398</code><code>&lt;div class="container"&gt;</code></p><p><code>399</code><code>          </code></p><p><code>400</code><code>    &lt;div id="maincontent" class="content eight_col col"&gt;</code></p><p><code>401</code><code>          </code></p><p><code>402</code><code>          </code></p><p><code>403</code><code>        &lt;div class="navlink-box"&gt;</code></p><p><code>404</code><code>          </code></p><p><code>405</code><code>            &lt;ul class="page-breadcrumbs inline_list small"&gt;</code></p><p><code>406</code><code>&lt;li class="journal-list"&gt;</code></p><p><code>407</code><code>&lt;a href="/pmc/journals/" class="navlink"&gt;</code></p><p><code>408</code><code>Journal List&lt;/a&gt;</code></p><p><code>409</code><code>&lt;/li&gt;</code></p><p><code>410</code><code>&lt;li class="article-entrez-filter"&gt;</code></p><p><code>411</code><code>&lt;a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink"&gt;</code></p><p><code>412</code><code>HHS Author Manuscripts&lt;/a&gt;</code></p><p><code>413</code><code>&lt;/li&gt;</code></p><p><code>414</code><code>&lt;li class="accid"&gt;</code></p><p><code>415</code><code>PMC2828614&lt;/li&gt;</code></p><p><code>416</code><code>&lt;/ul&gt;</code></p><p><code>417</code><code>          </code></p><p><code>418</code><code>        &lt;/div&gt;</code></p><p><code>419</code><code>          </code></p><p><code>420</code><code>          </code></p><p><code>421</code><code>        &lt;!-- Journal banner --&gt;</code></p><p><code>422</code><code>          </code></p><p><code>423</code><code>        &lt;div class="pmc-page-banner whole_rhythm"&gt;</code></p><p><code>424</code><code>&lt;div&gt;</code></p><p><code>425</code><code>&lt;img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap" /&gt;</code></p><p><code>426</code><code>&lt;map id="logo-imagemap" name="logo-imagemap"&gt;</code></p><p><code>427</code><code>&lt;area target="_blank" rel="noopener noreferrer" shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" /&gt;</code></p><p><code>428</code><code>&lt;area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CBanner&amp;amp;TO=Publisher%7COther%7CN/A" /&gt;</code></p><p><code>429</code><code>&lt;area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CBanner&amp;amp;TO=Publisher%7COther%7CN/A" /&gt;</code></p><p><code>430</code><code>&lt;/map&gt;</code></p><p><code>431</code><code>&lt;/div&gt;</code></p><p><code>432</code><code> &lt;/div&gt;</code></p><p><code>433</code><code>          </code></p><p><code>434</code><code>        </code></p><p><code>435</code><code>        &lt;!--component id='MainPortlet' label='search-reference'/--&gt;</code></p><p><code>436</code><code>          </code></p><p><code>437</code><code>        </code></p><p><code>438</code><code>        &lt;!-- Book content --&gt;</code></p><p><code>439</code><code>          </code></p><p><code>440</code><code>        &lt;div class=""&gt;</code></p><p><code>441</code><code>          </code></p><p><code>442</code><code>            </code></p><p><code>443</code><code>        </code></p><p><code>444</code><code>            </code></p><p><code>445</code><code>            &lt;div id="mc" class=" article lit-style content pmc-wm slang-all page-box"&gt;</code></p><p><code>446</code><code>&lt;!--main-content--&gt;</code></p><p><code>447</code><code>&lt;div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"&gt;</code></p><p><code>448</code><code>&lt;div class="fm-sec half_rhythm no_top_margin"&gt;</code></p><p><code>449</code><code>&lt;div class="fm-flexbox"&gt;</code></p><p><code>450</code><code>&lt;div class="fm-citation"&gt;</code></p><p><code>451</code><code>&lt;div&gt;</code></p><p><code>452</code><code>&lt;span id="pmcmata"&gt;</code></p><p><code>453</code><code>Future Med Chem.&lt;/span&gt;</code></p><p><code>454</code><code> Author manuscript; available in PMC 2010 Aug 1.&lt;/div&gt;</code></p><p><code>455</code><code>&lt;div&gt;</code></p><p><code>456</code><code>&lt;/div&gt;</code></p><p><code>457</code><code>&lt;div class="final-form"&gt;</code></p><p><code>458</code><code>&lt;em&gt;</code></p><p><code>459</code><code>Published in final edited form as:&lt;/em&gt;</code></p><p><code>460</code><code>&lt;/div&gt;</code></p><p><code>461</code><code>&lt;div class="final-citation"&gt;</code></p><p><code>462</code><code>&lt;div class="fm-vol-iss-date"&gt;</code></p><p><code>463</code><code>&lt;a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=20191092" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CFront%20Matter&amp;amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"&gt;</code></p><p><code>464</code><code>Future Med Chem. 2009 Oct; 1(7): 1333–1349. &lt;/a&gt;</code></p><p><code>465</code><code>&lt;/div&gt;</code></p><p><code>466</code><code> &lt;span class="doi"&gt;</code></p><p><code>467</code><code>&lt;span&gt;</code></p><p><code>468</code><code>doi: &lt;/span&gt;</code></p><p><code>469</code><code>&lt;a href="//dx.doi.org/10.4155%2Ffmc.09.93" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CFront%20Matter&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI"&gt;</code></p><p><code>470</code><code>10.4155/fmc.09.93&lt;/a&gt;</code></p><p><code>471</code><code>&lt;/span&gt;</code></p><p><code>472</code><code>&lt;/div&gt;</code></p><p><code>473</code><code>&lt;/div&gt;</code></p><p><code>474</code><code>&lt;div class="fm-ids"&gt;</code></p><p><code>475</code><code>&lt;div class="fm-citation-pmcid"&gt;</code></p><p><code>476</code><code>&lt;span class="fm-citation-ids-label"&gt;</code></p><p><code>477</code><code>PMCID: &lt;/span&gt;</code></p><p><code>478</code><code>&lt;span&gt;</code></p><p><code>479</code><code>PMC2828614&lt;/span&gt;</code></p><p><code>480</code><code>&lt;/div&gt;</code></p><p><code>481</code><code>&lt;div class="fm-citation-manuscriptid"&gt;</code></p><p><code>482</code><code>&lt;span class="fm-citation-ids-label"&gt;</code></p><p><code>483</code><code>NIHMSID: &lt;/span&gt;</code></p><p><code>484</code><code>&lt;span&gt;</code></p><p><code>485</code><code>NIHMS155268&lt;/span&gt;</code></p><p><code>486</code><code>&lt;/div&gt;</code></p><p><code>487</code><code>&lt;div class="fm-citation-pmid"&gt;</code></p><p><code>488</code><code>PMID: &lt;a href="/pubmed/20191092"&gt;</code></p><p><code>489</code><code>20191092&lt;/a&gt;</code></p><p><code>490</code><code>&lt;/div&gt;</code></p><p><code>491</code><code>&lt;/div&gt;</code></p><p><code>492</code><code>&lt;/div&gt;</code></p><p><code>493</code><code>&lt;h1 class="content-title"&gt;</code></p><p><code>494</code><code>Cannabinoids as novel anti-inflammatory drugs&lt;/h1&gt;</code></p><p><code>495</code><code>&lt;div class="half_rhythm"&gt;</code></p><p><code>496</code><code>&lt;div class="contrib-group fm-author"&gt;</code></p><p><code>497</code><code>&lt;a href="/pubmed/?term=Nagarkatti%20P%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=20191092"&gt;</code></p><p><code>498</code><code>Prakash Nagarkatti&lt;/a&gt;</code></p><p><code>499</code><code>,&lt;sup&gt;</code></p><p><code>500</code><code>&amp;#x02020;&lt;/sup&gt;</code></p><p><code>501</code><code> &lt;a href="/pubmed/?term=Pandey%20R%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=20191092"&gt;</code></p><p><code>502</code><code>Rupal Pandey&lt;/a&gt;</code></p><p><code>503</code><code>,&lt;sup&gt;</code></p><p><code>504</code><code>*&lt;/sup&gt;</code></p><p><code>505</code><code> &lt;a href="/pubmed/?term=Rieder%20SA%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=20191092"&gt;</code></p><p><code>506</code><code>Sadiye Amcaoglu Rieder&lt;/a&gt;</code></p><p><code>507</code><code>,&lt;sup&gt;</code></p><p><code>508</code><code>*&lt;/sup&gt;</code></p><p><code>509</code><code> &lt;a href="/pubmed/?term=Hegde%20VL%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=20191092"&gt;</code></p><p><code>510</code><code>Venkatesh L Hegde&lt;/a&gt;</code></p><p><code>511</code><code>, and  &lt;a href="/pubmed/?term=Nagarkatti%20M%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=20191092"&gt;</code></p><p><code>512</code><code>Mitzi Nagarkatti&lt;/a&gt;</code></p><p><code>513</code><code>&lt;/div&gt;</code></p><p><code>514</code><code>&lt;div style="display:none" class="contrib-group aff-tip"&gt;</code></p><p><code>515</code><code>&lt;/div&gt;</code></p><p><code>516</code><code>&lt;/div&gt;</code></p><p><code>517</code><code>&lt;div class="fm-panel half_rhythm"&gt;</code></p><p><code>518</code><code>&lt;div class="togglers fm-copyright-license"&gt;</code></p><p><code>519</code><code>&lt;a href="#" class="pmctoggle" rid="idm139818007633824_ai"&gt;</code></p><p><code>520</code><code>Author information&lt;/a&gt;</code></p><p><code>521</code><code> &lt;a href="#" class="pmctoggle" rid="idm139818007633824_cpl"&gt;</code></p><p><code>522</code><code>Copyright and License information&lt;/a&gt;</code></p><p><code>523</code><code> &lt;a href="/pmc/about/disclaimer/" style="margin-left: 1em"&gt;</code></p><p><code>524</code><code>Disclaimer&lt;/a&gt;</code></p><p><code>525</code><code>&lt;/div&gt;</code></p><p><code>526</code><code>&lt;div class="fm-authors-info fm-panel hide half_rhythm" id="idm139818007633824_ai" style="display:none"&gt;</code></p><p><code>527</code><code>&lt;div id="FN1"&gt;</code></p><p><code>528</code><code>&lt;sup&gt;</code></p><p><code>529</code><code>&amp;#x02020;&lt;/sup&gt;</code></p><p><code>530</code><code>          </code></p><p><code>531</code><code>Author for correspondence: Department of Pathology, Microbiology and Immunology, University of South Carolina, School of Medicine, Columbia, SC 29208, USA, &lt;a href="mailto:dev@null" data-email="ude.cs.demcsu@kraganp" class="oemail"&gt;</code></p><p><code>532</code><code>ude.cs.demcsu@kraganp&lt;/a&gt;</code></p><p><code>533</code><code>&lt;/div&gt;</code></p><p><code>534</code><code>&lt;div id="FN2"&gt;</code></p><p><code>535</code><code>&lt;sup&gt;</code></p><p><code>536</code><code>*&lt;/sup&gt;</code></p><p><code>537</code><code>Both authors contributed equally to this review&lt;/div&gt;</code></p><p><code>538</code><code>&lt;/div&gt;</code></p><p><code>539</code><code>&lt;div class="fm-article-notes fm-panel half_rhythm"&gt;</code></p><p><code>540</code><code>&lt;/div&gt;</code></p><p><code>541</code><code>&lt;div class="permissions fm-panel half_rhythm hide" id="idm139818007633824_cpl" style="display:none"&gt;</code></p><p><code>542</code><code>&lt;div class="fm-copyright half_rhythm"&gt;</code></p><p><code>543</code><code>&lt;a href="/pmc/about/copyright/"&gt;</code></p><p><code>544</code><code>Copyright notice&lt;/a&gt;</code></p><p><code>545</code><code> &lt;/div&gt;</code></p><p><code>546</code><code>&lt;/div&gt;</code></p><p><code>547</code><code>&lt;/div&gt;</code></p><p><code>548</code><code>&lt;div id="pmclinksbox" class="links-box whole_rhythm"&gt;</code></p><p><code>549</code><code>&lt;div class="fm-panel"&gt;</code></p><p><code>550</code><code>&lt;div&gt;</code></p><p><code>551</code><code>The publisher's final edited version of this article is available  at &lt;a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=20191092" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CFront%20Matter&amp;amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"&gt;</code></p><p><code>552</code><code>Future Med Chem&lt;/a&gt;</code></p><p><code>553</code><code>&lt;/div&gt;</code></p><p><code>554</code><code>&lt;div&gt;</code></p><p><code>555</code><code>See other articles in PMC that &lt;a href="/pmc/articles/PMC2828614/citedby/"&gt;</code></p><p><code>556</code><code>cite&lt;/a&gt;</code></p><p><code>557</code><code> the published article.&lt;/div&gt;</code></p><p><code>558</code><code>&lt;/div&gt;</code></p><p><code>559</code><code>&lt;/div&gt;</code></p><p><code>560</code><code>&lt;/div&gt;</code></p><p><code>561</code><code>&lt;div class="sec"&gt;</code></p><p><code>562</code><code>&lt;/div&gt;</code></p><p><code>563</code><code>&lt;div id="idm139818004390304" lang="en" class="tsec sec"&gt;</code></p><p><code>564</code><code>&lt;h2 class="head no_bottom_margin" id="idm139818004390304title"&gt;</code></p><p><code>565</code><code>Abstract&lt;/h2&gt;</code></p><p><code>566</code><code>&lt;!--article-meta--&gt;</code></p><p><code>567</code><code>&lt;div&gt;</code></p><p><code>568</code><code>&lt;p id="P1" class="p p-first-last"&gt;</code></p><p><code>569</code><code>Cannabinoids are a group of compounds that mediate their effects through cannabinoid receptors. The discovery of &amp;#x00394;&lt;sup&gt;</code></p><p><code>570</code><code>9&lt;/sup&gt;</code></p><p><code>571</code><code>-tetrahydrocannabinol (THC) as the major psychoactive principle in marijuana, as well as the identification of cannabinoid receptors and their endogenous ligands, has led to a significant growth in research aimed at understanding the physiological functions of cannabinoids. Cannabinoid receptors include CB1, which is predominantly expressed in the brain, and CB2, which is primarily found on the cells of the immune system. The fact that both CB1 and CB2 receptors have been found on immune cells suggests that cannabinoids play an important role in the regulation of the immune system. Recent studies demonstrated that administration of THC into mice triggered marked apoptosis in T cells and dendritic cells, resulting in immunosuppression. In addition, several studies showed that cannabinoids downregulate cytokine and chemokine production and, in some models, upregulate T-regulatory cells (Tregs) as a mechanism to suppress inflammatory responses. The endocannabinoid system is also involved in immunoregulation. For example, administration of endocannabinoids or use of inhibitors of enzymes that break down the endocannabinoids, led to immunosuppression and recovery from immune-mediated injury to organs such as the liver. Manipulation of endocannabinoids and/or use of exogenous cannabinoids &lt;em&gt;</code></p><p><code>572</code><code>in vivo&lt;/em&gt;</code></p><p><code>573</code><code> can constitute a potent treatment modality against inflammatory disorders. This review will focus on the potential use of cannabinoids as a new class of anti-inflammatory agents against a number of inflammatory and autoimmune diseases that are primarily triggered by activated T cells or other cellular immune components.&lt;/p&gt;</code></p><p><code>574</code><code>&lt;/div&gt;</code></p><p><code>575</code><code>&lt;/div&gt;</code></p><p><code>576</code><code>&lt;div id="idm139818008088368" class="tsec sec"&gt;</code></p><p><code>577</code><code>&lt;h2 class="headless nomenu"&gt;</code></p><p><code>578</code><code>&lt;/h2&gt;</code></p><p><code>579</code><code>&lt;p id="P2" class="p p-first"&gt;</code></p><p><code>580</code><code>Cannabis, commonly known as marijuana, is a product of the &lt;em&gt;</code></p><p><code>581</code><code>Cannabis sativa&lt;/em&gt;</code></p><p><code>582</code><code> plant and the active compounds from this plant are collectively referred to as &lt;strong&gt;</code></p><p><code>583</code><code>cannabinoids&lt;/strong&gt;</code></p><p><code>584</code><code>. For several centuries, marijuana has been used as an alternative medicine in many cultures and, recently, its beneficial effects have been shown in: the treatment of nausea and vomiting associated with cancer chemotherapy; anorexia and cachexia seen in HIV/AIDS patients; and in neuropathic pain and spasticity in multiple sclerosis [&lt;a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461365"&gt;</code></p><p><code>585</code><code>1&lt;/a&gt;</code></p><p><code>586</code><code>&amp;#x02013;&lt;a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461461"&gt;</code></p><p><code>587</code><code>4&lt;/a&gt;</code></p><p><code>588</code><code>]. Cannabinoid pharmacology has made important advances in recent years after the discovery of the &lt;strong&gt;</code></p><p><code>589</code><code>cannabinoid receptors&lt;/strong&gt;</code></p><p><code>590</code><code> (CB1 and CB2). Cannabinoid receptors and their endogenous ligands have provided an excellent platform for the investigation of the therapeutic effects of cannabinoids. It is well known that CB1 and CB2 are heterotrimeric G&lt;sub&gt;</code></p><p><code>591</code><code>i/o&lt;/sub&gt;</code></p><p><code>592</code><code>-protein-coupled receptors and that they are both expressed in the periphery and the CNS. However, CB1 expression is predominant in the CNS, especially on presynaptic nerves, and CB2 is primarily expressed on immune cells [&lt;a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461508"&gt;</code></p><p><code>593</code><code>5&lt;/a&gt;</code></p><p><code>594</code><code>,&lt;a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461444"&gt;</code></p><p><code>595</code><code>6&lt;/a&gt;</code></p><p><code>596</code><code>].&lt;/p&gt;</code></p><p><code>597</code><code>&lt;p id="P3"&gt;</code></p><p><code>598</code><code>Arachidonic acid metabolites have been shown to exhibit properties similar to compounds found in &lt;em&gt;</code></p><p><code>599</code><code>Cannabis sativa&lt;/em&gt;</code></p><p><code>600</code><code>. These metabolites are hence referred to as endocannabinoids. These ubiquitous endogenous cannabinoids act as natural ligands for the cannabinoid receptors expressed in mammalian tissue, thus constituting an important lipid-signaling system termed the endocannabinoid system. The endocannabinoid system is an important biological regulatory system that has been shown to be highly conserved from lower invertebrates to higher mammals [&lt;a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461436"&gt;</code></p><p><code>601</code><code>7&lt;/a&gt;</code></p><p><code>602</code><code>]. Other than the lipid transmitters that serve as ligands for the cannabinoid receptors, the endocannabinoid family also comprises the enzymes for biosynthesis and degradation of the ligands. The endocannabinoids include &lt;em&gt;</code></p><p><code>603</code><code>N&lt;/em&gt;</code></p><p><code>604</code><code>-arachidonoylethanolamine, anandamide (AEA), 2-arachidonoyl glycerol (2-AG), &lt;em&gt;</code></p><p><code>605</code><code>N&lt;/em&gt;</code></p><p><code>606</code><code>-arachydonoyldopamine, noladin ether and virodhamine. AEA was discovered by Devane &lt;em&gt;</code></p><p><code>607</code><code>et al&lt;/em&gt;</code></p><p><code>608</code><code>. and is an amide formed from arachidonic acid and ethanolamine [&lt;a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461388"&gt;</code></p><p><code>609</code><code>8&lt;/a&gt;</code></p><p><code>610</code><code>]. AEA binds to brain CB1 with high affinity and mimics the behavioral actions of exogenous cannabinoid &amp;#x00394;&lt;sup&gt;</code></p><p><code>611</code><code>9&lt;/sup&gt;</code></p><p><code>612</code><code>-tetrahydrocannabinol (THC) when injected into rodents. 2-AG was discovered independently 3 years later by Mechoulam &lt;em&gt;</code></p><p><code>613</code><code>et al&lt;/em&gt;</code></p><p><code>614</code><code>. [&lt;a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461448"&gt;</code></p><p><code>615</code><code>9&lt;/a&gt;</code></p><p><code>616</code><code>] and Sugiura &lt;em&gt;</code></p><p><code>617</code><code>et al&lt;/em&gt;</code></p><p><code>618</code><code>. [&lt;a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461494"&gt;</code></p><p><code>619</code><code>10&lt;/a&gt;</code></p><p><code>620</code><code>]. It was found to exist in much higher concentration in serum and brain than AEA. 2-AG has similar affinities for both CB1 and CB2 receptors, as does AEA, but it exhibits higher efficacy. Endocannabinoids are derivatives of arachidonic acid conjugated with either ethanolamine or glycerol. They are synthesized on demand from phospholipid precursors residing in the cell membrane in response to a rise in intracellular calcium levels. Inside cells, endocannabinoids are catalytically hydrolyzed by the aminohydrolase fatty acid amide hydrolase (FAAH), which degrades AEA into arachidonic acid and ethanolamine [&lt;a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461429"&gt;</code></p><p><code>621</code><code>11&lt;/a&gt;</code></p><p><code>622</code><code>]. 2-AG is hydrolyzed into AEA and glycerol by either FAAH or by monoacyl glycerol lipase (MAGL). Fatty acid-binding proteins (FABPs) have been reported to play an important role as intracellular carriers in the transport of AEA from the plasma membrane to FAAH for their subsequent inactivation [&lt;a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461366"&gt;</code></p><p><code>623</code><code>12&lt;/a&gt;</code></p><p><code>624</code><code>]. Studies to date indicate that the main pharmacological function of the endocannabinoid system is in neuromodulation: controlling motor functions, cognition, emotional responses, homeostasis and motivation. However, in the periphery, this system is an important modulator of the ANS, immune system and microcirculation [&lt;a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_327953579"&gt;</code></p><p><code>625</code><code>13&lt;/a&gt;</code></p><p><code>626</code><code>]. Some well-known natural and synthetic cannabinoids and endocannabinoids are depicted in &lt;a href="/pmc/articles/PMC2828614/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""&gt;</code></p><p><code>627</code><code>&lt;span&gt;</code></p><p><code>628</code><code>Table 1&lt;/span&gt;</code></p><p><code>629</code><code>&lt;/a&gt;</code></p><p><code>630</code><code>.&lt;/p&gt;</code></p><p><code>631</code><code>&lt;!--table ft1--&gt;</code></p><p><code>632</code><code>&lt;!--table-wrap mode="anchored" t5--&gt;</code></p><p><code>633</code><code>&lt;div class="table-wrap anchored whole_rhythm" id="T1"&gt;</code></p><p><code>634</code><code>&lt;h3&gt;</code></p><p><code>635</code><code>Table 1&lt;/h3&gt;</code></p><p><code>636</code><code>&lt;!--caption a7--&gt;</code></p><p><code>637</code><code>&lt;div class="caption"&gt;</code></p><p><code>638</code><code>&lt;p id="__p5"&gt;</code></p><p><code>639</code><code>Selected cannabinoid molecules.&lt;/p&gt;</code></p><p><code>640</code><code>&lt;/div&gt;</code></p><p><code>641</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139818001510048" class="xtable"&gt;</code></p><p><code>642</code><code>&lt;table frame="box" rules="groups" class="rendered small default_table"&gt;</code></p><p><code>643</code><code>&lt;thead&gt;</code></p><p><code>644</code><code>&lt;tr&gt;</code></p><p><code>645</code><code>&lt;th valign="bottom" align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>646</code><code>Endocannabinoids&lt;/th&gt;</code></p><p><code>647</code><code>&lt;th valign="bottom" align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>648</code><code>Natural cannabinoids&lt;/th&gt;</code></p><p><code>649</code><code>&lt;th valign="bottom" align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>650</code><code>Synthetic cannabinoids&lt;/th&gt;</code></p><p><code>651</code><code>&lt;/tr&gt;</code></p><p><code>652</code><code>&lt;/thead&gt;</code></p><p><code>653</code><code>&lt;tbody&gt;</code></p><p><code>654</code><code>&lt;tr&gt;</code></p><p><code>655</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>656</code><code>Arachidonylethanolamide&lt;/td&gt;</code></p><p><code>657</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>658</code><code>&amp;#x00394;&lt;sup&gt;</code></p><p><code>659</code><code>9&lt;/sup&gt;</code></p><p><code>660</code><code>-tetrahydrobannbinol&lt;/td&gt;</code></p><p><code>661</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>662</code><code>JWH-133&lt;/td&gt;</code></p><p><code>663</code><code>&lt;/tr&gt;</code></p><p><code>664</code><code>&lt;tr&gt;</code></p><p><code>665</code><code>&lt;td align="left" valign="bottom" rowspan="1" colspan="1"&gt;</code></p><p><code>666</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139818008551200" class="figure"&gt;</code></p><p><code>667</code><code>&lt;img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms155268t1.jpg" title="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms155268t1.jpg" src="/pmc/articles/PMC2828614/bin/nihms155268t1.jpg" /&gt;</code></p><p><code>668</code><code>&lt;/div&gt;</code></p><p><code>669</code><code>&lt;div id="largeobj_idm139818008551200" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>670</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2828614/table/T1/?report=objectonly"&gt;</code></p><p><code>671</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>672</code><code>&lt;/div&gt;</code></p><p><code>673</code><code>&lt;hr /&gt;</code></p><p><code>674</code><code>&lt;/td&gt;</code></p><p><code>675</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>676</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139818077329072" class="figure"&gt;</code></p><p><code>677</code><code>&lt;img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms155268t2.jpg" title="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms155268t2.jpg" src="/pmc/articles/PMC2828614/bin/nihms155268t2.jpg" /&gt;</code></p><p><code>678</code><code>&lt;/div&gt;</code></p><p><code>679</code><code>&lt;div id="largeobj_idm139818077329072" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>680</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2828614/table/T1/?report=objectonly"&gt;</code></p><p><code>681</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>682</code><code>&lt;/div&gt;</code></p><p><code>683</code><code>&lt;/td&gt;</code></p><p><code>684</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>685</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139818077326704" class="figure"&gt;</code></p><p><code>686</code><code>&lt;img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms155268t3.jpg" title="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms155268t3.jpg" src="/pmc/articles/PMC2828614/bin/nihms155268t3.jpg" /&gt;</code></p><p><code>687</code><code>&lt;/div&gt;</code></p><p><code>688</code><code>&lt;div id="largeobj_idm139818077326704" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>689</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2828614/table/T1/?report=objectonly"&gt;</code></p><p><code>690</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>691</code><code>&lt;/div&gt;</code></p><p><code>692</code><code>&lt;/td&gt;</code></p><p><code>693</code><code>&lt;/tr&gt;</code></p><p><code>694</code><code>&lt;tr&gt;</code></p><p><code>695</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>696</code><code>2-arachidonoylglycerol&lt;/td&gt;</code></p><p><code>697</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>698</code><code>Cannabidiol&lt;/td&gt;</code></p><p><code>699</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>700</code><code>WIN55,212-2&lt;/td&gt;</code></p><p><code>701</code><code>&lt;/tr&gt;</code></p><p><code>702</code><code>&lt;tr&gt;</code></p><p><code>703</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>704</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139818007824912" class="figure"&gt;</code></p><p><code>705</code><code>&lt;img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms155268t4.jpg" title="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms155268t4.jpg" src="/pmc/articles/PMC2828614/bin/nihms155268t4.jpg" /&gt;</code></p><p><code>706</code><code>&lt;/div&gt;</code></p><p><code>707</code><code>&lt;div id="largeobj_idm139818007824912" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>708</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2828614/table/T1/?report=objectonly"&gt;</code></p><p><code>709</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>710</code><code>&lt;/div&gt;</code></p><p><code>711</code><code>&lt;/td&gt;</code></p><p><code>712</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>713</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139818007822512" class="figure"&gt;</code></p><p><code>714</code><code>&lt;img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms155268t5.jpg" title="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms155268t5.jpg" src="/pmc/articles/PMC2828614/bin/nihms155268t5.jpg" /&gt;</code></p><p><code>715</code><code>&lt;/div&gt;</code></p><p><code>716</code><code>&lt;div id="largeobj_idm139818007822512" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>717</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2828614/table/T1/?report=objectonly"&gt;</code></p><p><code>718</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>719</code><code>&lt;/div&gt;</code></p><p><code>720</code><code>&lt;/td&gt;</code></p><p><code>721</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>722</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139818000296272" class="figure"&gt;</code></p><p><code>723</code><code>&lt;img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms155268t6.jpg" title="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms155268t6.jpg" src="/pmc/articles/PMC2828614/bin/nihms155268t6.jpg" /&gt;</code></p><p><code>724</code><code>&lt;/div&gt;</code></p><p><code>725</code><code>&lt;div id="largeobj_idm139818000296272" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>726</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2828614/table/T1/?report=objectonly"&gt;</code></p><p><code>727</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>728</code><code>&lt;/div&gt;</code></p><p><code>729</code><code>&lt;/td&gt;</code></p><p><code>730</code><code>&lt;/tr&gt;</code></p><p><code>731</code><code>&lt;/tbody&gt;</code></p><p><code>732</code><code>&lt;/table&gt;</code></p><p><code>733</code><code>&lt;/div&gt;</code></p><p><code>734</code><code>&lt;div id="largeobj_idm139818001510048" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>735</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2828614/table/T1/?report=objectonly"&gt;</code></p><p><code>736</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>737</code><code>&lt;/div&gt;</code></p><p><code>738</code><code>&lt;/div&gt;</code></p><p><code>739</code><code>&lt;p id="P4" class="p"&gt;</code></p><p><code>740</code><code>Cannabinoids are potent anti-inflammatory agents and they exert their effects through induction of apoptosis, inhibition of cell proliferation, suppression of &lt;strong&gt;</code></p><p><code>741</code><code>cytokine&lt;/strong&gt;</code></p><p><code>742</code><code> production and induction of T-regulatory cells (Tregs). In this review, we provide an in-depth description of all four different mechanisms and we further discuss the immunosuppressive properties of cannabinoids in the context of inflammatory and &lt;strong&gt;</code></p><p><code>743</code><code>autoimmune disease&lt;/strong&gt;</code></p><p><code>744</code><code> states, triggered by cellular rather than humoral components of the immune system.&lt;/p&gt;</code></p><p><code>745</code><code>&lt;/div&gt;</code></p><p><code>746</code><code>&lt;div id="S1" class="tsec sec"&gt;</code></p><p><code>747</code><code>&lt;h2 class="head no_bottom_margin" id="S1title"&gt;</code></p><p><code>748</code><code>Apoptotic effects of cannabinoids on immune cell populations&lt;/h2&gt;</code></p><p><code>749</code><code>&lt;p id="P5" class="p p-first"&gt;</code></p><p><code>750</code><code>One major mechanism of immunosupression by cannabinoids is the induction of cell death or apoptosis in immune cell populations. Under normal conditions, apoptosis is required in order to maintain homeostasis and it involves morphological changes (i.e., cell shrinkage, nuclear fragmentation and membrane blebbing) as well as molecular changes (i.e., induction of caspases and cytochrome c leakage) [&lt;a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461373"&gt;</code></p><p><code>751</code><code>14&lt;/a&gt;</code></p><p><code>752</code><code>]. The extrinsic pathway of apoptosis is initiated with the ligation of death receptors (i.e., CD95) on the cell surface, leading to activation of major caspases, such as caspase 3, 8 and 10. The intrinsic pathway of apoptosis is initiated via mitochondria and caspase 9; cytochrome c and caspase 3 are the major players in the induction of cell death [&lt;a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461395"&gt;</code></p><p><code>753</code><code>14&lt;/a&gt;</code></p><p><code>754</code><code>,&lt;a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461432"&gt;</code></p><p><code>755</code><code>15&lt;/a&gt;</code></p><p><code>756</code><code>].&lt;/p&gt;</code></p><p><code>757</code><code>&lt;p id="P6"&gt;</code></p><p><code>758</code><code>&amp;#x00394;&lt;sup&gt;</code></p><p><code>759</code><code>9&lt;/sup&gt;</code></p><p><code>760</code><code>-THC and its apoptotic effects on immune cell populations have been studied extensively: in 1998, Zhu &lt;em&gt;</code></p><p><code>761</code><code>et al.&lt;/em&gt;</code></p><p><code>762</code><code> demonstrated that &lt;em&gt;</code></p><p><code>763</code><code>in vitro&lt;/em&gt;</code></p><p><code>764</code><code> THC induced apoptosis in murine macrophages and T cells. This study also showed that the process was mediated via activation of Bcl-2 and caspases [&lt;a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461516"&gt;</code></p><p><code>765</code><code>16&lt;/a&gt;</code></p><p><code>766</code><code>]. It was difficult to demonstrate the apoptotic effects of THC on lymphocytes, &lt;em&gt;</code></p><p><code>767</code><code>in vivo&lt;/em&gt;</code></p><p><code>768</code><code>, and our laboratory speculated that this might be due to rapid clearance of dead cells by phagocytic cells. Therefore, we exposed C57BL/6 mice to 10 mg/kg bodyweight THC and, after several time points, (4, 6, 24 and 72 h), obtained lymphocytes from the thymus and spleen of these animals. The cells were incubated for 12&amp;#x02013;24 h &lt;em&gt;</code></p><p><code>769</code><code>ex vivo&lt;/em&gt;</code></p><p><code>770</code><code> and, since the phagocytosis was excluded in the cultures, we detected significant levels of THC-induced apoptosis in T cells, B cells and macrophages [&lt;a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461374"&gt;</code></p><p><code>771</code><code>17&lt;/a&gt;</code></p><p><code>772</code><code>]. We have also demonstrated that THC induced higher levels of apoptosis in naive lymphocytes, when compared with mitogen-activated lymphocytes, because activated cells downregulated the levels of CB2 on their cell surface [&lt;a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461353"&gt;</code></p><p><code>773</code><code>17&lt;/a&gt;</code></p><p><code>774</code><code>]. Several studies also reported THC-induced apoptosis in antigen-presenting cells. In bone marrow-derived dendritic cells (DCs), THC induced apoptosis via ligation of both CB1 and CB2 and activation of caspases such as caspase 2, 8 and 9. &lt;em&gt;</code></p><p><code>775</code><code>In vivo&lt;/em&gt;</code></p><p><code>776</code><code>, THC administration decreased the number of splenic DCs, as well as MHCII expression by DCs [&lt;a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461450"&gt;</code></p><p><code>777</code><code>18&lt;/a&gt;</code></p><p><code>778</code><code>,&lt;a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461364"&gt;</code></p><p><code>779</code><code>19&lt;/a&gt;</code></p><p><code>780</code><code>]. Furthermore, THC increased Bcl-2 and caspase 1 activity in naive and lipopolysaccharide (LPS)-activated macrophages isolated from the peritoneal cavity of mice [&lt;a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461477"&gt;</code></p><p><code>781</code><code>16&lt;/a&gt;</code></p><p><code>782</code><code>].&lt;/p&gt;</code></p><p><code>783</code><code>&lt;p id="P7"&gt;</code></p><p><code>784</code><code>Other natural and synthetic cannabinoid compounds (CBD, AEA, ajulemic acid [AjA] and JWH-015), whose structures are depicted in &lt;a href="/pmc/articles/PMC2828614/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""&gt;</code></p><p><code>785</code><code>&lt;span&gt;</code></p><p><code>786</code><code>Table 1&lt;/span&gt;</code></p><p><code>787</code><code>&lt;/a&gt;</code></p><p><code>788</code><code>, have also been shown to induce apoptosis in murine and human T lymphocytes. Cannabidiol, the nonpsychoactive ingredient in cannabis, induced apoptosis in CD4&lt;sup&gt;</code></p><p><code>789</code><code>+&lt;/sup&gt;</code></p><p><code>790</code><code> and CD8&lt;sup&gt;</code></p><p><code>791</code><code>+&lt;/sup&gt;</code></p><p><code>792</code><code> T cells at 4&amp;#x02013;8-&amp;#x003bc;M concentrations by increasing reactive oxygen species (ROS) production as well as caspase 3 and 8 activity [&lt;a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461500"&gt;</code></p><p><code>793</code><code>20&lt;/a&gt;</code></p><p><code>794</code><code>].&lt;/p&gt;</code></p><p><code>795</code><code>&lt;p id="P8"&gt;</code></p><p><code>796</code><code>Ajulemic acid, a side-chain synthetic analog of &amp;#x00394;(8)-THC-11-oic acid, has been shown to induce apoptosis in human peripheral blood T lymphocytes via the intrinsic pathway at concentrations of 1, 3 and 10 &amp;#x003bc;M [&lt;a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461509"&gt;</code></p><p><code>797</code><code>21&lt;/a&gt;</code></p><p><code>798</code><code>]. In addition, the use of synthetic CB2 agonist JWH-015 treatment &lt;em&gt;</code></p><p><code>799</code><code>in vitro&lt;/em&gt;</code></p><p><code>800</code><code> led to cell death via both the death-receptor pathway and the intrinsic pathway. When JWH-015 was administered &lt;em&gt;</code></p><p><code>801</code><code>in vivo&lt;/em&gt;</code></p><p><code>802</code><code>, the antigen-specific response to &lt;em&gt;</code></p><p><code>803</code><code>Staphylococcal&lt;/em&gt;</code></p><p><code>804</code><code> enterotoxin A was inhibited significantly [&lt;a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461376"&gt;</code></p><p><code>805</code><code>22&lt;/a&gt;</code></p><p><code>806</code><code>].&lt;/p&gt;</code></p><p><code>807</code><code>&lt;p id="P9" class="p p-last"&gt;</code></p><p><code>808</code><code>It is important to note that, unlike in immune cells, cannabinoids can protect from apoptosis in nontransformed cells of the CNS, which can play a protective role in autoimmune conditions such as multiple sclerosis. Cannabinoids protect against apoptosis of oligodendrocytes via CB1 and CB2 receptors, by signaling through the PI3K/AKT pathway. &lt;em&gt;</code></p><p><code>809</code><code>In vivo&lt;/em&gt;</code></p><p><code>810</code><code> and &lt;em&gt;</code></p><p><code>811</code><code>in vitro&lt;/em&gt;</code></p><p><code>812</code><code> exposure to arachidonyl-2-ethylamide (ACEA) and WIN55,212-12 protected the cells, while pretreatment with CB1 receptor antagonist SR141716A and CB2 receptor antagonist SR144528 blocked the action of these cannabinoids [&lt;a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461400"&gt;</code></p><p><code>813</code><code>23&lt;/a&gt;</code></p><p><code>814</code><code>]. In a different study by Jackson &lt;em&gt;</code></p><p><code>815</code><code>et al.&lt;/em&gt;</code></p><p><code>816</code><code>, 3D mouse brain aggregate cell cultures were compared between wild-type mice and CB1 receptor knockout mice. IFN-&amp;#x003b3; treatment led to decrease in the neurofilament-H expression in knockout cultures but not in wild-type cultures. In addition, caspase 3 activation was higher in knockout cultures, indicating a protective role of CB1 in neuronal cells [&lt;a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461517"&gt;</code></p><p><code>817</code><code>24&lt;/a&gt;</code></p><p><code>818</code><code>].&lt;/p&gt;</code></p><p><code>819</code><code>&lt;/div&gt;</code></p><p><code>820</code><code>&lt;div id="S2" class="tsec sec"&gt;</code></p><p><code>821</code><code>&lt;h2 class="head no_bottom_margin" id="S2title"&gt;</code></p><p><code>822</code><code>Cannabinoid action on cytokines&lt;/h2&gt;</code></p><p><code>823</code><code>&lt;p id="P10" class="p p-first"&gt;</code></p><p><code>824</code><code>Cytokines are the signaling proteins synthesized and secreted by immune cells upon stimulation. They are the modulating factors that balance initiation and resolution of &lt;strong&gt;</code></p><p><code>825</code><code>inflammation&lt;/strong&gt;</code></p><p><code>826</code><code>. One of the possible mechanisms of immune control by cannabinoids during inflammation is the dys-regulation of cytokine production by immune cells and disruption of the well-regulated immune response [&lt;a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461491"&gt;</code></p><p><code>827</code><code>25&lt;/a&gt;</code></p><p><code>828</code><code>]. Furthermore, cannabinoids may affect immune responses and host resistance by perturbing the balance between the cytokines produced by T-helper subsets, Th1 and Th2. &lt;em&gt;</code></p><p><code>829</code><code>In vitro&lt;/em&gt;</code></p><p><code>830</code><code> studies were performed to compare the effect of THC and cannabinol on cytokine production by human T, B, CD8&lt;sup&gt;</code></p><p><code>831</code><code>+&lt;/sup&gt;</code></p><p><code>832</code><code>, NK and eosinophilic cell lines. However, the results were variable, depending on the cell line and the concentration used [&lt;a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461445"&gt;</code></p><p><code>833</code><code>26&lt;/a&gt;</code></p><p><code>834</code><code>]. Both pro-inflammatory and anti-inflammatory effects of THC were demonstrated in this study, proposing that different cell populations have varied thresholds of response to cannabinoids. Generally, TNF-&amp;#x003b1;, GM-CSF and IFN-&amp;#x003b3; levels decreased with drug treatment. Interestingly, while the anti-inflammatory cytokine IL-10 decreased following THC treatment, there was an increase in the proinflammatory cytokine IL-8. In other studies, cannabinoid CP55,940 at nanomolar concentrations was shown to have a stimulatory effect on several cytokines in the human promyelocytic cell line HL-60 [&lt;a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461506"&gt;</code></p><p><code>835</code><code>27&lt;/a&gt;</code></p><p><code>836</code><code>]. At the molecular level, THC has also been shown to inhibit LPS-stimulated mRNA expression of IL-1&amp;#x003b1;, IL-1&amp;#x003b2;, IL-6 and TNF-&amp;#x003b1; in cultured rat microglial cells; however, the effect was independent of the cannabinoid receptors [&lt;a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461423"&gt;</code></p><p><code>837</code><code>28&lt;/a&gt;</code></p><p><code>838</code><code>]. In a different study, mice were challenged with &lt;em&gt;</code></p><p><code>839</code><code>Corynebacterium parvum, in vivo&lt;/em&gt;</code></p><p><code>840</code><code>, following the administration of the synthetic cannabinoids WIN55,212-2 and HU210. The animals were then challenged with LPS. The results showed decreased levels of TNF-&amp;#x003b1; and IL-12 but increased levels of IL-10 in the serum [&lt;a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461502"&gt;</code></p><p><code>841</code><code>29&lt;/a&gt;</code></p><p><code>842</code><code>]. This effect was shown to be CB1 receptor dependent.&lt;/p&gt;</code></p><p><code>843</code><code>&lt;p id="P11"&gt;</code></p><p><code>844</code><code>During chronic inflammation, IL-6 suppression can decrease tissue injury [&lt;a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461462"&gt;</code></p><p><code>845</code><code>30&lt;/a&gt;</code></p><p><code>846</code><code>]. AjA has been reported to prevent joint-tissue injury in animal models of adjuvant arthritis [&lt;a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461358"&gt;</code></p><p><code>847</code><code>31&lt;/a&gt;</code></p><p><code>848</code><code>]. Recent studies showed that addition of AjA to human monocyte-derived macrophages &lt;em&gt;</code></p><p><code>849</code><code>in vitro&lt;/em&gt;</code></p><p><code>850</code><code> reduced the secretion of IL-6 from activated cells, suggesting that AjA may have a value for treatment of joint inflammation in patients with systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and osteoarthritis [&lt;a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461352"&gt;</code></p><p><code>851</code><code>32&lt;/a&gt;</code></p><p><code>852</code><code>]. It has been observed that the CB2 agonist HU-308 attenuated the hepatic ischemia/reperfusion injury by decreasing the levels of TNF-&amp;#x003b1;, MIP-1&amp;#x003b1; and MIP-2 in the serum and in liver homogenates [&lt;a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461404"&gt;</code></p><p><code>853</code><code>33&lt;/a&gt;</code></p><p><code>854</code><code>]. Recent &lt;em&gt;</code></p><p><code>855</code><code>in vitro&lt;/em&gt;</code></p><p><code>856</code><code> studies have also shown the potent anti-inflammatory effect of synthetic cannabinoids (CP55,940 and WIN55,212-2). Both CP55,940 and WIN55,212-2 downregulated IL-6 and IL-8 cytokine production from IL-1&amp;#x003b2;-stimulated rheumatoid fibroblast-like synoviocytes (FLS), via a non-CB1/CB2-mediated mechanism [&lt;a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461363"&gt;</code></p><p><code>857</code><code>34&lt;/a&gt;</code></p><p><code>858</code><code>].&lt;/p&gt;</code></p><p><code>859</code><code>&lt;p id="P12" class="p p-last"&gt;</code></p><p><code>860</code><code>Endocannabinoids have also been reported to affect the cytokine biology of various cell systems. Antiproliferative effects of endocannabinoids on cancer cell lines are well established and are discussed in the later section of the review. However, AEA has also been reported to increase cytokine-induced proliferation. Mouse bone marrow cells, when cultured in the presence of IL-3 and AEA, were observed to produce more hematopoietic colonies than with IL-3 alone [&lt;a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461416"&gt;</code></p><p><code>861</code><code>35&lt;/a&gt;</code></p><p><code>862</code><code>]. Significant suppression of IL-2 expression by 2-AG and the nonhydrolyzable 2-AG ether was observed in leukocytes via activation of peroxisome proliferator-activated receptor-&amp;#x003b3; (PPAR-&amp;#x003b3;) [&lt;a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461410"&gt;</code></p><p><code>863</code><code>36&lt;/a&gt;</code></p><p><code>864</code><code>]. Furthermore, in undifferentiated and macrophage-like differentiated HL-60 cells, 2-AG induced CB2-dependent acceleration in the production of IL-8 [&lt;a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461504"&gt;</code></p><p><code>865</code><code>37&lt;/a&gt;</code></p><p><code>866</code><code>]. In Theiler&amp;#x02019;s virus immune-mediated demyelinating disease, inactivation of endocannabinoids through the use of two selective inhibitors of their transport; (&lt;em&gt;</code></p><p><code>867</code><code>R&lt;/em&gt;</code></p><p><code>868</code><code>)-&lt;em&gt;</code></p><p><code>869</code><code>N&lt;/em&gt;</code></p><p><code>870</code><code>-oleoyl-(1&amp;#x02032;-hydroxybenzyl)-2&amp;#x02032;-ethanolamine] (OMDM2) and [(&lt;em&gt;</code></p><p><code>871</code><code>S&lt;/em&gt;</code></p><p><code>872</code><code>)-&lt;em&gt;</code></p><p><code>873</code><code>N&lt;/em&gt;</code></p><p><code>874</code><code>-oleoyl-(1&amp;#x02032;-hydroxybenzyl)-2&amp;#x02032;-ethanolamine (OMDM1) led to decreased production of the proinflammatory cytokines IL-1&amp;#x003b2; and IL-12 [&lt;a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461431"&gt;</code></p><p><code>875</code><code>38&lt;/a&gt;</code></p><p><code>876</code><code>]. On a contrary note, cytokines have also been shown to affect the endocannabinoid system. IL-12 and IFN-&amp;#x003b3; have been shown to reduce FAAH activity and protein expression of FAAH, whereas IL-4 or IL-10 stimulated FAAH activity [&lt;a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461458"&gt;</code></p><p><code>877</code><code>39&lt;/a&gt;</code></p><p><code>878</code><code>]. &lt;a href="/pmc/articles/PMC2828614/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""&gt;</code></p><p><code>879</code><code>&lt;span&gt;</code></p><p><code>880</code><code>Table 2&lt;/span&gt;</code></p><p><code>881</code><code>&lt;/a&gt;</code></p><p><code>882</code><code> provides a summary of the effect of cannabinoids on cytokines and chemokines in various cell models [&lt;a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461424"&gt;</code></p><p><code>883</code><code>26&lt;/a&gt;</code></p><p><code>884</code><code>,&lt;a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461370"&gt;</code></p><p><code>885</code><code>28&lt;/a&gt;</code></p><p><code>886</code><code>,&lt;a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461515"&gt;</code></p><p><code>887</code><code>29&lt;/a&gt;</code></p><p><code>888</code><code>,&lt;a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461433"&gt;</code></p><p><code>889</code><code>32&lt;/a&gt;</code></p><p><code>890</code><code>&amp;#x02013;&lt;a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461474"&gt;</code></p><p><code>891</code><code>34&lt;/a&gt;</code></p><p><code>892</code><code>,&lt;a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461383"&gt;</code></p><p><code>893</code><code>37&lt;/a&gt;</code></p><p><code>894</code><code>,&lt;a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461393"&gt;</code></p><p><code>895</code><code>40&lt;/a&gt;</code></p><p><code>896</code><code>,&lt;a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461505"&gt;</code></p><p><code>897</code><code>41&lt;/a&gt;</code></p><p><code>898</code><code>].&lt;/p&gt;</code></p><p><code>899</code><code>&lt;!--table ft1--&gt;</code></p><p><code>900</code><code>&lt;!--table-wrap mode="anchored" t5--&gt;</code></p><p><code>901</code><code>&lt;div class="table-wrap anchored whole_rhythm" id="T2"&gt;</code></p><p><code>902</code><code>&lt;h3&gt;</code></p><p><code>903</code><code>Table 2&lt;/h3&gt;</code></p><p><code>904</code><code>&lt;!--caption a7--&gt;</code></p><p><code>905</code><code>&lt;div class="caption"&gt;</code></p><p><code>906</code><code>&lt;p id="__p6"&gt;</code></p><p><code>907</code><code>Effect of cannabinoids on cytokine and chemokine production.&lt;/p&gt;</code></p><p><code>908</code><code>&lt;/div&gt;</code></p><p><code>909</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139818000293408" class="xtable"&gt;</code></p><p><code>910</code><code>&lt;table frame="box" rules="rows" class="rendered small default_table"&gt;</code></p><p><code>911</code><code>&lt;thead&gt;</code></p><p><code>912</code><code>&lt;tr&gt;</code></p><p><code>913</code><code>&lt;th valign="bottom" align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>914</code><code>Cannabinod&lt;/th&gt;</code></p><p><code>915</code><code>&lt;th valign="bottom" align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>916</code><code>Receptor&lt;/th&gt;</code></p><p><code>917</code><code>&lt;th valign="bottom" align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>918</code><code>Cell/tissue/serum&lt;/th&gt;</code></p><p><code>919</code><code>&lt;th valign="bottom" align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>920</code><code>Effect&lt;/th&gt;</code></p><p><code>921</code><code>&lt;th valign="bottom" align="right" rowspan="1" colspan="1"&gt;</code></p><p><code>922</code><code>Ref.&lt;/th&gt;</code></p><p><code>923</code><code>&lt;/tr&gt;</code></p><p><code>924</code><code>&lt;/thead&gt;</code></p><p><code>925</code><code>&lt;tbody&gt;</code></p><p><code>926</code><code>&lt;tr&gt;</code></p><p><code>927</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>928</code><code>THC&lt;/td&gt;</code></p><p><code>929</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>930</code><code>ND&lt;/td&gt;</code></p><p><code>931</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>932</code><code>Macrophage cell line (RAW264.7)&lt;/td&gt;</code></p><p><code>933</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>934</code><code>Decreases TNF-&amp;#x003b1;&lt;/td&gt;</code></p><p><code>935</code><code>&lt;td align="right" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>936</code><code>[&lt;a href="#R40" rid="R40" class=" bibr popnode"&gt;</code></p><p><code>937</code><code>40&lt;/a&gt;</code></p><p><code>938</code><code>]&lt;/td&gt;</code></p><p><code>939</code><code>&lt;/tr&gt;</code></p><p><code>940</code><code>&lt;tr&gt;</code></p><p><code>941</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>942</code><code>THC&lt;/td&gt;</code></p><p><code>943</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>944</code><code>ND&lt;/td&gt;</code></p><p><code>945</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>946</code><code>Peritoneal macrophages&lt;/td&gt;</code></p><p><code>947</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>948</code><code>Increases IL-1&amp;#x003b1; and IL-1&amp;#x003b2;&lt;/td&gt;</code></p><p><code>949</code><code>&lt;td align="right" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>950</code><code>[&lt;a href="#R41" rid="R41" class=" bibr popnode"&gt;</code></p><p><code>951</code><code>41&lt;/a&gt;</code></p><p><code>952</code><code>]&lt;/td&gt;</code></p><p><code>953</code><code>&lt;/tr&gt;</code></p><p><code>954</code><code>&lt;tr&gt;</code></p><p><code>955</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>956</code><code>THC&lt;/td&gt;</code></p><p><code>957</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>958</code><code>ND&lt;/td&gt;</code></p><p><code>959</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>960</code><code>Human cell lines&lt;/td&gt;</code></p><p><code>961</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>962</code><code>Decreases TNF-&amp;#x003b1;, GM-CSF and IFN-&amp;#x003b3;, IL-10&lt;br /&gt;</code></p><p><code>963</code><code>Increases IL-8&lt;/td&gt;</code></p><p><code>964</code><code>&lt;td align="right" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>965</code><code>[&lt;a href="#R26" rid="R26" class=" bibr popnode"&gt;</code></p><p><code>966</code><code>26&lt;/a&gt;</code></p><p><code>967</code><code>]&lt;/td&gt;</code></p><p><code>968</code><code>&lt;/tr&gt;</code></p><p><code>969</code><code>&lt;tr&gt;</code></p><p><code>970</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>971</code><code>THC&lt;/td&gt;</code></p><p><code>972</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>973</code><code>CB1 and CB2 independent&lt;/td&gt;</code></p><p><code>974</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>975</code><code>Rat microglial cells&lt;/td&gt;</code></p><p><code>976</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>977</code><code>Decreases TNF-&amp;#x003b1;, IL-1&amp;#x003b1;, IL-1&amp;#x003b2; and IL-6&lt;/td&gt;</code></p><p><code>978</code><code>&lt;td align="right" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>979</code><code>[&lt;a href="#R28" rid="R28" class=" bibr popnode"&gt;</code></p><p><code>980</code><code>28&lt;/a&gt;</code></p><p><code>981</code><code>]&lt;/td&gt;</code></p><p><code>982</code><code>&lt;/tr&gt;</code></p><p><code>983</code><code>&lt;tr&gt;</code></p><p><code>984</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>985</code><code>&lt;em&gt;</code></p><p><code>986</code><code>In vivo&lt;/em&gt;</code></p><p><code>987</code><code> WIN55,212-2 and HU-210&lt;/td&gt;</code></p><p><code>988</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>989</code><code>CB1 dependent&lt;/td&gt;</code></p><p><code>990</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>991</code><code>Serum&lt;/td&gt;</code></p><p><code>992</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>993</code><code>Decreases TNF-&amp;#x003b1;, IL-12&lt;br /&gt;</code></p><p><code>994</code><code>Increases IL-10&lt;/td&gt;</code></p><p><code>995</code><code>&lt;td align="right" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>996</code><code>[&lt;a href="#R29" rid="R29" class=" bibr popnode"&gt;</code></p><p><code>997</code><code>29&lt;/a&gt;</code></p><p><code>998</code><code>]&lt;/td&gt;</code></p><p><code>999</code><code>&lt;/tr&gt;</code></p><p><code>1000</code><code>&lt;tr&gt;</code></p><p><code>1001</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1002</code><code>Ajulemic acid&lt;/td&gt;</code></p><p><code>1003</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1004</code><code>ND&lt;/td&gt;</code></p><p><code>1005</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1006</code><code>Human synovial monocyte-derived macrophage&lt;/td&gt;</code></p><p><code>1007</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1008</code><code>Decreases IL-6 and IL-1&amp;#x003b2;&lt;/td&gt;</code></p><p><code>1009</code><code>&lt;td align="right" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1010</code><code>[&lt;a href="#R32" rid="R32" class=" bibr popnode"&gt;</code></p><p><code>1011</code><code>32&lt;/a&gt;</code></p><p><code>1012</code><code>]&lt;/td&gt;</code></p><p><code>1013</code><code>&lt;/tr&gt;</code></p><p><code>1014</code><code>&lt;tr&gt;</code></p><p><code>1015</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1016</code><code>HU-308&lt;/td&gt;</code></p><p><code>1017</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1018</code><code>CB2 dependent&lt;/td&gt;</code></p><p><code>1019</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1020</code><code>Serum and liver homogenates&lt;/td&gt;</code></p><p><code>1021</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1022</code><code>Decreases TNF-&amp;#x003b1;, MIP-1&amp;#x003b1; and MIP-2&lt;/td&gt;</code></p><p><code>1023</code><code>&lt;td align="right" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1024</code><code>[&lt;a href="#R33" rid="R33" class=" bibr popnode"&gt;</code></p><p><code>1025</code><code>33&lt;/a&gt;</code></p><p><code>1026</code><code>]&lt;/td&gt;</code></p><p><code>1027</code><code>&lt;/tr&gt;</code></p><p><code>1028</code><code>&lt;tr&gt;</code></p><p><code>1029</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1030</code><code>CP55,940 WIN55,212&amp;#x02013;2&lt;/td&gt;</code></p><p><code>1031</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1032</code><code>CB1 and CB2 independent&lt;/td&gt;</code></p><p><code>1033</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1034</code><code>Rheumatoid fibroblast-like synoviocytes&lt;/td&gt;</code></p><p><code>1035</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1036</code><code>IL-6 and IL-8&lt;/td&gt;</code></p><p><code>1037</code><code>&lt;td align="right" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1038</code><code>[&lt;a href="#R34" rid="R34" class=" bibr popnode"&gt;</code></p><p><code>1039</code><code>34&lt;/a&gt;</code></p><p><code>1040</code><code>]&lt;/td&gt;</code></p><p><code>1041</code><code>&lt;/tr&gt;</code></p><p><code>1042</code><code>&lt;tr&gt;</code></p><p><code>1043</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1044</code><code>2-AG&lt;/td&gt;</code></p><p><code>1045</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1046</code><code>CB2 dependent&lt;/td&gt;</code></p><p><code>1047</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1048</code><code>Promyelocytic leukemia cell line (HL-60)&lt;/td&gt;</code></p><p><code>1049</code><code>&lt;td align="left" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1050</code><code>Increases IL-8, CXCL8 and CCL2&lt;/td&gt;</code></p><p><code>1051</code><code>&lt;td align="right" valign="top" rowspan="1" colspan="1"&gt;</code></p><p><code>1052</code><code>[&lt;a href="#R37" rid="R37" class=" bibr popnode"&gt;</code></p><p><code>1053</code><code>37&lt;/a&gt;</code></p><p><code>1054</code><code>]&lt;/td&gt;</code></p><p><code>1055</code><code>&lt;/tr&gt;</code></p><p><code>1056</code><code>&lt;/tbody&gt;</code></p><p><code>1057</code><code>&lt;/table&gt;</code></p><p><code>1058</code><code>&lt;/div&gt;</code></p><p><code>1059</code><code>&lt;div id="largeobj_idm139818000293408" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>1060</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2828614/table/T2/?report=objectonly"&gt;</code></p><p><code>1061</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>1062</code><code>&lt;/div&gt;</code></p><p><code>1063</code><code>&lt;div class="tblwrap-foot"&gt;</code></p><p><code>1064</code><code>&lt;div id="TFN1"&gt;</code></p><p><code>1065</code><code>&lt;p id="__p7" class="p p-first-last"&gt;</code></p><p><code>1066</code><code>AG: Arachidonoylglycerol; CB: Cannabinoid receptor; CCL: CC-chemokine ligand; CXCL8: CXC-chemokine ligand 8; ND: Not determined; THC: Tetrahydrocannabinol.&lt;/p&gt;</code></p><p><code>1067</code><code>&lt;/div&gt;</code></p><p><code>1068</code><code>&lt;/div&gt;</code></p><p><code>1069</code><code>&lt;/div&gt;</code></p><p><code>1070</code><code>&lt;/div&gt;</code></p><p><code>1071</code><code>&lt;div id="S3" class="tsec sec"&gt;</code></p><p><code>1072</code><code>&lt;h2 class="head no_bottom_margin" id="S3title"&gt;</code></p><p><code>1073</code><code>Cannabinoids &amp;#x00026; multiple sclerosis&lt;/h2&gt;</code></p><p><code>1074</code><code>&lt;p id="P13" class="p p-first"&gt;</code></p><p><code>1075</code><code>Multiple sclerosis (MS) is an autoimmune disorder that is mediated by myelin-specific self-reactive T cells, macrophages/microglial cells and astrocytes [&lt;a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461411"&gt;</code></p><p><code>1076</code><code>3&lt;/a&gt;</code></p><p><code>1077</code><code>,&lt;a href="#R42" rid="R42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461427"&gt;</code></p><p><code>1078</code><code>42&lt;/a&gt;</code></p><p><code>1079</code><code>]. The action of these cells leads to the demyelination of nerve fibers and axons in the CNS of humans and results in many signs and symptoms, such as muscle spasms, tremor, ataxia, weakness or paralysis, constipation and loss of bladder control [&lt;a href="#R42" rid="R42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461482"&gt;</code></p><p><code>1080</code><code>42&lt;/a&gt;</code></p><p><code>1081</code><code>]. There is both anecdotal and clinical evidence to show the effectiveness of cannabinoids in the treatment of MS. In 1994, a survey of 112 MS patients (57 men and 55 women) from the USA and UK was conducted; all of the patients were self-medicating with a form of cannabis. The results of the survey showed that cannabis use improved symptoms such as spasticity, pain, tremor and depression in more than 90% of patients. In eight different clinical studies, MS patients have also reported the benefits of THC (administered via ingestion, inhalation, injection or rectal suppository), cannabis (administered via ingestion or inhalation) and the cannabinoid receptor agonist Nabilone&lt;sup&gt;</code></p><p><code>1082</code><code>&amp;#x02122;&lt;/sup&gt;</code></p><p><code>1083</code><code>, (administered via ingestion) in treating spasticity, pain, tremor and ataxia [&lt;a href="#R43" rid="R43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461497"&gt;</code></p><p><code>1084</code><code>43&lt;/a&gt;</code></p><p><code>1085</code><code>]. Use of cannabinoids also improved objective test results such as hand-writing tests and bladder control tests [&lt;a href="#R43" rid="R43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461417"&gt;</code></p><p><code>1086</code><code>43&lt;/a&gt;</code></p><p><code>1087</code><code>,&lt;a href="#R44" rid="R44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461496"&gt;</code></p><p><code>1088</code><code>44&lt;/a&gt;</code></p><p><code>1089</code><code>]. In general, cannabinoids are useful in treating MS because they have neuroprotective as well as immunosuppressive properties [&lt;a href="#R44" rid="R44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461390"&gt;</code></p><p><code>1090</code><code>44&lt;/a&gt;</code></p><p><code>1091</code><code>,&lt;a href="#R45" rid="R45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461513"&gt;</code></p><p><code>1092</code><code>45&lt;/a&gt;</code></p><p><code>1093</code><code>]. In this section, we will focus on the latter and discuss the action of endogenous, natural and synthetic cannabinoids on immune cells within the CNS during MS.&lt;/p&gt;</code></p><p><code>1094</code><code>&lt;p id="P14"&gt;</code></p><p><code>1095</code><code>The destruction of the blood&amp;#x02013;brain barrier in MS is initiated by myelin-specific self-reactive T cells. Infiltration of these cells into the spinal cord and CNS, and their subsequent activation, leads to the elimination of the myelin sheath around the nerves and axons [&lt;a href="#R46" rid="R46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461438"&gt;</code></p><p><code>1096</code><code>46&lt;/a&gt;</code></p><p><code>1097</code><code>,&lt;a href="#R47" rid="R47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461405"&gt;</code></p><p><code>1098</code><code>47&lt;/a&gt;</code></p><p><code>1099</code><code>]. The myelin- specific T cells are usually CD4&lt;sup&gt;</code></p><p><code>1100</code><code>+&lt;/sup&gt;</code></p><p><code>1101</code><code>, IL-2R&lt;sup&gt;</code></p><p><code>1102</code><code>+&lt;/sup&gt;</code></p><p><code>1103</code><code> or MHCII-restricted Th1 cells and they secrete proinflammatory cytokines such as IFN-&amp;#x003b3; and TNF-&amp;#x003b1; [&lt;a href="#R47" rid="R47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461379"&gt;</code></p><p><code>1104</code><code>47&lt;/a&gt;</code></p><p><code>1105</code><code>]. More recently, Th17 cells have been shown to be involved in the pathogenesis of MS [&lt;a href="#R48" rid="R48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461430"&gt;</code></p><p><code>1106</code><code>48&lt;/a&gt;</code></p><p><code>1107</code><code>,&lt;a href="#R49" rid="R49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461420"&gt;</code></p><p><code>1108</code><code>49&lt;/a&gt;</code></p><p><code>1109</code><code>]. One mechanism of immunosuppression by cannabinoids is the induction of apoptosis and Sanchez &lt;em&gt;</code></p><p><code>1110</code><code>et al.&lt;/em&gt;</code></p><p><code>1111</code><code> demonstrated that WIN55,212-2 blocks a passive form of experimental authoimmune encephalomyelitis (EAE) by inducing apoptosis in encephalitogenic cells through partial activation of the CB2 receptor [&lt;a href="#R50" rid="R50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461483"&gt;</code></p><p><code>1112</code><code>50&lt;/a&gt;</code></p><p><code>1113</code><code>]. A CB1-mediated suppressive pathway has also been shown in myelin-specific T cells [&lt;a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461441"&gt;</code></p><p><code>1114</code><code>24&lt;/a&gt;</code></p><p><code>1115</code><code>]. This study demonstrated that &lt;em&gt;</code></p><p><code>1116</code><code>ex vivo&lt;/em&gt;</code></p><p><code>1117</code><code> WIN55,212-2 inhibited T-cell recall response to myelin oligodendrocyte glycoprotein (MOG) peptide, as well as decreasing IL-2, IFN-&amp;#x003b3; and TNF-&amp;#x003b1; production by MOG-activated T cells. Other synthetic cannabinoids, such as JWH-015 and ACEA, also decreased the number of CD4&lt;sup&gt;</code></p><p><code>1118</code><code>+&lt;/sup&gt;</code></p><p><code>1119</code><code> infiltrates in the spinal cord of Theiler&amp;#x02019;s murine encephalomyelitis virus (TMEV)-infected mice [&lt;a href="#R51" rid="R51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_809316601"&gt;</code></p><p><code>1120</code><code>51&lt;/a&gt;</code></p><p><code>1121</code><code>]. Mestre &lt;em&gt;</code></p><p><code>1122</code><code>et al.&lt;/em&gt;</code></p><p><code>1123</code><code> showed that decreased infiltration of CD4&lt;sup&gt;</code></p><p><code>1124</code><code>+&lt;/sup&gt;</code></p><p><code>1125</code><code> T cells upon WIN55,212-2 treatment in EAE mice is due to decreased intercellular and vascular cell adhesion molecules (ICAM-1 and VCAM-1) expression by endothelial cells. Another novel finding of this study demonstrated that WIN55,212-2 exerted its effects by acting through nuclear receptor PPAR-&amp;#x003b3; [&lt;a href="#R52" rid="R52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461415"&gt;</code></p><p><code>1126</code><code>52&lt;/a&gt;</code></p><p><code>1127</code><code>].&lt;/p&gt;</code></p><p><code>1128</code><code>&lt;p id="P15"&gt;</code></p><p><code>1129</code><code>Microglial cells are the macrophages of the CNS and, during MS, they mediate tissue injury in two main ways: antigen presentation and cytokine/chemokine secretion [&lt;a href="#R51" rid="R51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_809316599"&gt;</code></p><p><code>1130</code><code>51&lt;/a&gt;</code></p><p><code>1131</code><code>,&lt;a href="#R52" rid="R52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461463"&gt;</code></p><p><code>1132</code><code>52&lt;/a&gt;</code></p><p><code>1133</code><code>]. In the initial stages of inflammation, after activation, microglial cells present antigens to myelin-specific T cells, which results in the activation and proliferation of Th1 lineage cells. Arevalo-Martin &lt;em&gt;</code></p><p><code>1134</code><code>et al.&lt;/em&gt;</code></p><p><code>1135</code><code> demonstrated that cannabinoid agonists WIN55,212-2, ACEA or JWH-015 inhibited the activation of microglial cells by TMEV [&lt;a href="#R51" rid="R51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_809316600"&gt;</code></p><p><code>1136</code><code>51&lt;/a&gt;</code></p><p><code>1137</code><code>]. The investigators confirmed this finding by studying the morphology of the cells (reactive vs resting) as well as by immunohistochemistry. They showed that, after TMEV activation, MHCII molecules co-localized with Mac-1 in the spinal cord sections; however, after 1-day treatment with various cannabinoid agonists, MHCII expression almost disappeared. During this initial stage, co-stimulatory molecule expression, such as that of CD40, also increased and resulted in TNF-&amp;#x003b1; production via the MAPK and JAK/STAT pathways. Ehrhart and colleagues demonstrated that selective stimulation of the CB2 receptor with JWH-015 on murine microglial cells decreased CD40 expression upon IFN-&amp;#x003b3; activation. This inhibition in CD40 levels translated into decreased JAK/STAT phosphorylation, and decreased TNF-&amp;#x003b1; and nitric oxide production [&lt;a href="#R53" rid="R53" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461367"&gt;</code></p><p><code>1138</code><code>53&lt;/a&gt;</code></p><p><code>1139</code><code>].&lt;/p&gt;</code></p><p><code>1140</code><code>&lt;p id="P16"&gt;</code></p><p><code>1141</code><code>In the later stages of disease, microglial cells secrete IL-12, IL-13 and IL-23, nitric oxide and glutamate and contribute to myelin sheath destruction. IL-12 drives the proliferation of Th1 cells while IL-23 is important in the maintenance of Th17 cells. A recent study by Correa &lt;em&gt;</code></p><p><code>1142</code><code>et al.&lt;/em&gt;</code></p><p><code>1143</code><code> showed that the endogenous cannabinoid AEA inhibited the expression of IL-12 as well as IL-23 in LPS/IFN-&amp;#x003b3;-activated human and murine microglia. This inhibition of cytokine production occurred via activation of CB2 and signaling through ERK1/2 and JNK pathways [&lt;a href="#R54" rid="R54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461512"&gt;</code></p><p><code>1144</code><code>54&lt;/a&gt;</code></p><p><code>1145</code><code>]. Palazuelos &lt;em&gt;</code></p><p><code>1146</code><code>et al.&lt;/em&gt;</code></p><p><code>1147</code><code> also showed that the CB2 receptor is involved in myeloid progenitor trafficking, which is necessary for microglia replenishment and activation during MS. Their studies demonstrated that &lt;em&gt;</code></p><p><code>1148</code><code>CB2&lt;/em&gt;</code></p><p><code>1149</code><code>&lt;sup&gt;</code></p><p><code>1150</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1151</code><code> mice had exacerbated EAE symptoms and CD34&lt;sup&gt;</code></p><p><code>1152</code><code>+&lt;/sup&gt;</code></p><p><code>1153</code><code> myeloid progenitor cells had greatly infiltrated into the spinal cords of these animals. As an explanation for the mechanism, they showed that, in the bone marrow, CB2 receptor manipulation with HU-308 increased the expression of chemokines and their receptors (CCL2, CCL3, CCL5, CCR1 and CCR2), which are important in trafficking of progenitor cells into the neuroinflamed tissue [&lt;a href="#R55" rid="R55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461356"&gt;</code></p><p><code>1154</code><code>55&lt;/a&gt;</code></p><p><code>1155</code><code>].&lt;/p&gt;</code></p><p><code>1156</code><code>&lt;p id="P17" class="p p-last"&gt;</code></p><p><code>1157</code><code>Cannabinoids also exert their immunosuppressive effects on astrocytes. Astrocytes make up 60&amp;#x02013;70% of brain cells in the CNS and play important roles in neuronal growth, neuronal signaling, glucose metabolism and glutamate removal [&lt;a href="#R54" rid="R54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461485"&gt;</code></p><p><code>1158</code><code>54&lt;/a&gt;</code></p><p><code>1159</code><code>]. During disease progression, astrocytes are activated to secrete cytokines, chemokines and nitric oxide, thereby contributing to the overall inflammatory response. Because astrocytes express both CB1 and CB2 receptors, several studies investigated the inhibitory role of cannabinoids on this cell population in the context of MS. One study investigated the effects of AEA on TMEV-activated primary murine astrocytes. This study showed that AEA stimulated astrocytes and triggered the production of IL-6 in a CB1-mediated pathway [&lt;a href="#R56" rid="R56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461464"&gt;</code></p><p><code>1160</code><code>56&lt;/a&gt;</code></p><p><code>1161</code><code>]. The precise role of IL-6 in the CNS is still unclear; however, it has been reported that IL-6 secretion potentiates neuronal growth factor production. In addition, IL-6 has been shown to inhibit TNF-&amp;#x003b1; production by IFN-&amp;#x003b3;/IL-1&amp;#x003b2;-stimulated glial cells [&lt;a href="#R57" rid="R57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461470"&gt;</code></p><p><code>1162</code><code>57&lt;/a&gt;</code></p><p><code>1163</code><code>]. In a different study, Molina-Holgado and coworkers showed that AEA and the synthetic CB1 agonist CP-55940 inhibited nitric oxide production by LPS-stimulated astrocytes isolated from 1-day-old mice in a CB1-dependent manner [&lt;a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461414"&gt;</code></p><p><code>1164</code><code>23&lt;/a&gt;</code></p><p><code>1165</code><code>]. In 2005, Sheng &lt;em&gt;</code></p><p><code>1166</code><code>et al.&lt;/em&gt;</code></p><p><code>1167</code><code> demonstrated that human fetal astrocytes express both CB1 and CB2 receptors and that treatment of IL-1&amp;#x003b2;-stimulated astrocytes with WIN55,212-2 decreased inflammatory products including nitric oxide, TNF-&amp;#x003b1;, CXCL10, CCL2 and CCL5 (&lt;a href="/pmc/articles/PMC2828614/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"&gt;</code></p><p><code>1168</code><code>&lt;span&gt;</code></p><p><code>1169</code><code>Figure 1&lt;/span&gt;</code></p><p><code>1170</code><code>&lt;/a&gt;</code></p><p><code>1171</code><code>) [&lt;a href="#R54" rid="R54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461439"&gt;</code></p><p><code>1172</code><code>54&lt;/a&gt;</code></p><p><code>1173</code><code>].&lt;/p&gt;</code></p><p><code>1174</code><code>&lt;!--fig ft0--&gt;</code></p><p><code>1175</code><code>&lt;!--fig mode=article f1--&gt;</code></p><p><code>1176</code><code>&lt;div class="fig iconblock whole_rhythm" id="F1" co-legend-rid="lgnd_F1"&gt;</code></p><p><code>1177</code><code>&lt;a href="/pmc/articles/PMC2828614/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"&gt;</code></p><p><code>1178</code><code>&lt;!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--&gt;</code></p><p><code>1179</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139817995698512" class="figure"&gt;</code></p><p><code>1180</code><code>&lt;a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;amp;p=PMC3&amp;amp;id=2828614_nihms155268f1.jpg" target="tileshopwindow" rel="noopener"&gt;</code></p><p><code>1181</code><code>&lt;div class="ts_bar small" title="Click on image to zoom"&gt;</code></p><p><code>1182</code><code>&lt;/div&gt;</code></p><p><code>1183</code><code>&lt;img loading="lazy" alt="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms155268f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2828614/bin/nihms155268f1.jpg" /&gt;</code></p><p><code>1184</code><code>&lt;/a&gt;</code></p><p><code>1185</code><code>&lt;/div&gt;</code></p><p><code>1186</code><code>&lt;div id="largeobj_idm139817995698512" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>1187</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2828614/figure/F1/?report=objectonly"&gt;</code></p><p><code>1188</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>1189</code><code>&lt;/div&gt;</code></p><p><code>1190</code><code>&lt;/a&gt;</code></p><p><code>1191</code><code>&lt;div class="icnblk_cntnt" id="lgnd_F1"&gt;</code></p><p><code>1192</code><code>&lt;div&gt;</code></p><p><code>1193</code><code>&lt;a class="figpopup" href="/pmc/articles/PMC2828614/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"&gt;</code></p><p><code>1194</code><code>Figure 1&lt;/a&gt;</code></p><p><code>1195</code><code>&lt;/div&gt;</code></p><p><code>1196</code><code>&lt;!--caption a7--&gt;</code></p><p><code>1197</code><code>&lt;div class="caption"&gt;</code></p><p><code>1198</code><code>&lt;!--caption a8--&gt;</code></p><p><code>1199</code><code>&lt;strong&gt;</code></p><p><code>1200</code><code>Cannabinoids and multiple sclerosis&lt;/strong&gt;</code></p><p><code>1201</code><code>&lt;p id="__p2"&gt;</code></p><p><code>1202</code><code>The three main cell types that are involved in demyelination of the nerve fibers and axons in the CNS include activated T-cells, microglia and astrocytes. In activated T-cells, treatment with WIN 55,212-12, AEA and JWH-015 has been shown to inhibit cytokine production, infiltration of cells into the spinal cord and &lt;em&gt;</code></p><p><code>1203</code><code>in vitro&lt;/em&gt;</code></p><p><code>1204</code><code> recall response to myelin oligodendrocyte glycoprotein by T-cells. Cannabinoids also inhibit the antigen presenting abilities of microglia by downregulating MHCII expression, costimulatory molecule CD40 expression, as well as cytokine secretion. Astrocytes, the major cell population in the brain, are also affected, as cannabinoid binding to the receptors leads to inhibition of inflammatory molecules, such as nitric oxide, cytokines and chemokines. In addition, anandamide binding leads to secretion of neural growth factor secretion and protection of the neurons in the CNS.&lt;/p&gt;</code></p><p><code>1205</code><code>&lt;p id="__p3"&gt;</code></p><p><code>1206</code><code>ACEA: Arachidonyl-2-ethylamide; NGF: Neuronal growth factor.&lt;/p&gt;</code></p><p><code>1207</code><code>&lt;/div&gt;</code></p><p><code>1208</code><code>&lt;/div&gt;</code></p><p><code>1209</code><code>&lt;/div&gt;</code></p><p><code>1210</code><code>&lt;/div&gt;</code></p><p><code>1211</code><code>&lt;div id="S4" class="tsec sec"&gt;</code></p><p><code>1212</code><code>&lt;h2 class="head no_bottom_margin" id="S4title"&gt;</code></p><p><code>1213</code><code>Cannabinoids &amp;#x00026; colitis&lt;/h2&gt;</code></p><p><code>1214</code><code>&lt;p id="P18" class="p p-first"&gt;</code></p><p><code>1215</code><code>During inflammation, several different cellular pathways are activated in the intestinal tract, leading to a pathological state [&lt;a href="#R58" rid="R58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461434"&gt;</code></p><p><code>1216</code><code>58&lt;/a&gt;</code></p><p><code>1217</code><code>]. Functional CB1 receptor has been shown to be expressed in the human ileum and colon and the number of CB1-expressing cells was found to be significantly increased after inflammation [&lt;a href="#R59" rid="R59" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461397"&gt;</code></p><p><code>1218</code><code>59&lt;/a&gt;</code></p><p><code>1219</code><code>,&lt;a href="#R60" rid="R60" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461359"&gt;</code></p><p><code>1220</code><code>60&lt;/a&gt;</code></p><p><code>1221</code><code>]. A protective role for these CB1 receptors during inflammation has been shown in a study analyzing the role of the endogenous cannabinoid system in the development of experimental colitis in mice, induced by intrarectal 2,4-dinitrobenzene sulfonic acid (DNBS) treatment or oral dextran sodium sulfate (DSS) administration [&lt;a href="#R59" rid="R59" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461428"&gt;</code></p><p><code>1222</code><code>59&lt;/a&gt;</code></p><p><code>1223</code><code>]. The DSS model, originally reported by Okayasu &lt;em&gt;</code></p><p><code>1224</code><code>et al.,&lt;/em&gt;</code></p><p><code>1225</code><code> has been used to investigate the role of leukocytes in the development of colitis [&lt;a href="#R61" rid="R61" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461394"&gt;</code></p><p><code>1226</code><code>61&lt;/a&gt;</code></p><p><code>1227</code><code>]. Oral administration of 5% DSS in drinking water can induce acute colitis due to chemical injury in the colon. Furthermore, long-term DSS administration produces colorectal carcinoma, which is similar to the dysplasia&amp;#x02013;carcinoma sequence seen in the course of cancer development in human ulcerative colitis [&lt;a href="#R62" rid="R62" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461354"&gt;</code></p><p><code>1228</code><code>62&lt;/a&gt;</code></p><p><code>1229</code><code>]. On the other hand, intestinal inflammation induced by the intrarectal administration of DNBS has many of the characteristic features of Crohn&amp;#x02019;s disease in humans, involving induction of an IL-12-driven inflammation with a massive Th1-mediated response [&lt;a href="#R63" rid="R63" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461481"&gt;</code></p><p><code>1230</code><code>63&lt;/a&gt;</code></p><p><code>1231</code><code>]. The involvement of the endogenous cannabinoid system in the modulation of the acute phase of DNBS-induced colitis was further supported by the increased levels of transcripts coding for CB1 in wild-type mice after induction of inflammation. It was observed that genetic ablation of CB1 receptors rendered mice more sensitive to inflammatory insults. Furthermore, similar to results observed in CB1-deficient mice, pharmacological blockade of CB1 with the specific antagonist SR141716A led to a worsening of colitis [&lt;a href="#R59" rid="R59" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461467"&gt;</code></p><p><code>1232</code><code>59&lt;/a&gt;</code></p><p><code>1233</code><code>]. The protective role of the endogenous cannabinoid system was observed 24 h after DNBS treatment and became more evident on days 2 and 3. However, increased spontaneous spiking activity of smooth muscle cell membrane in DNBS-treated colons from &lt;em&gt;</code></p><p><code>1234</code><code>CB1&lt;/em&gt;</code></p><p><code>1235</code><code>&lt;sup&gt;</code></p><p><code>1236</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1237</code><code> mice was already visible 8 h after DNBS treatment, indicating that inflammation-induced irritation of smooth muscle occurred at an earlier stage than in wild-type mice. This gives further support to the notion that the endogenous cannabinoid system is protective against inflammatory changes. These data indicated that the activation of CB1 and the endogenous cannabinoid system is an early and important physiological step in self-protection of the colon against inflammation.&lt;/p&gt;</code></p><p><code>1238</code><code>&lt;p id="P19"&gt;</code></p><p><code>1239</code><code>Pharmacological stimulation of cannabinoid receptors with the potent agonist HU210 also induced a reduction of experimental colitis. It has been reported that cannabinoid receptor stimulation could have a beneficial effect on experimental colitis [&lt;a href="#R64" rid="R64" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461403"&gt;</code></p><p><code>1240</code><code>64&lt;/a&gt;</code></p><p><code>1241</code><code>]. Intraperitoneal application of ACEA, a CB1-selective agonist, and JWH-133, a CB2-selective agonist, inhibited oil of mustard (OM)-induced colitis and subsequent symptoms such as induced distal colon weight gain, colon shrinkage, inflammatory damage, diarrhea and histological damage. This study demonstrated a role for CB2 activation in experimental colitis. The fact that both CB1 and CB2 agonists are active in colitis models lends additional support to the theory that signaling through cannabinoid receptors may mediate protective mechanisms in colitis.&lt;/p&gt;</code></p><p><code>1242</code><code>&lt;p id="P20"&gt;</code></p><p><code>1243</code><code>In the small intestine, the involvement of CB1 receptors in the control of intestinal motility during croton oil-induced inflammation was recently demonstrated. Izzo &lt;em&gt;</code></p><p><code>1244</code><code>et al.&lt;/em&gt;</code></p><p><code>1245</code><code> showed that pharmacological administration of cannabinoids is able to delay gastrointestinal transit in croton oil-treated mice [&lt;a href="#R65" rid="R65" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461375"&gt;</code></p><p><code>1246</code><code>65&lt;/a&gt;</code></p><p><code>1247</code><code>]. It was further suggested that increased levels of CB1 receptor expression in inflamed jejuna may contribute to this protective effect. CB1 receptors were shown to modulate gastrointestinal motility during croton oil-induced inflammation in mice.&lt;/p&gt;</code></p><p><code>1248</code><code>&lt;p id="P21"&gt;</code></p><p><code>1249</code><code>Fatty acid amide hydrolase is the major enzyme involved in the degradation of several bioactive fatty amides, in particular anandamide [&lt;a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461396"&gt;</code></p><p><code>1250</code><code>11&lt;/a&gt;</code></p><p><code>1251</code><code>], and its genetic deletion in mice leads to a strongly decreased ability to degrade this endocannabinoid and an increase of anandamide levels in several tissues [&lt;a href="#R66" rid="R66" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461468"&gt;</code></p><p><code>1252</code><code>66&lt;/a&gt;</code></p><p><code>1253</code><code>]. FAAH-deficient mice showed significant protection against DNBS treatment. However, because anandamide is believed to act not only through cannabinoid receptors but also through other targets, including the peripheral vanilloid receptor TRPV1 [&lt;a href="#R67" rid="R67" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461377"&gt;</code></p><p><code>1254</code><code>67&lt;/a&gt;</code></p><p><code>1255</code><code>], the decreased inflammation in &lt;em&gt;</code></p><p><code>1256</code><code>FAAH&lt;/em&gt;</code></p><p><code>1257</code><code>&lt;sup&gt;</code></p><p><code>1258</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1259</code><code> mice could also be due to the activation of targets other than cannabinoid receptors.&lt;/p&gt;</code></p><p><code>1260</code><code>&lt;p id="P22" class="p p-last"&gt;</code></p><p><code>1261</code><code>In conclusion, cannabinoids have been shown to regulate the tissue response to excessive inflammation in the colon, mediated by both dampening smooth-muscular irritation caused by inflammation and suppressing proinflammatory cytokines, thus controlling the cellular pathways leading to inflammatory responses. These results strongly suggest that modulation of the physiological activity of the cannabinoid system during colonic inflammation might be a promising therapeutic tool for the treatment of several diseases characterized by inflammation of the GI tract.&lt;/p&gt;</code></p><p><code>1262</code><code>&lt;/div&gt;</code></p><p><code>1263</code><code>&lt;div id="S5" class="tsec sec"&gt;</code></p><p><code>1264</code><code>&lt;h2 class="head no_bottom_margin" id="S5title"&gt;</code></p><p><code>1265</code><code>Cannabinoid system &amp;#x00026; liver injury&lt;/h2&gt;</code></p><p><code>1266</code><code>&lt;p id="P23" class="p p-first"&gt;</code></p><p><code>1267</code><code>During the past few years, awareness of the cannabinoid system in the pathophysiology of liver disease has gained momentum. Both CB1 and CB2 receptors have been shown to be upregulated in the early stages of liver injury [&lt;a href="#R68" rid="R68" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461362"&gt;</code></p><p><code>1268</code><code>68&lt;/a&gt;</code></p><p><code>1269</code><code>&amp;#x02013;&lt;a href="#R72" rid="R72" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461511"&gt;</code></p><p><code>1270</code><code>72&lt;/a&gt;</code></p><p><code>1271</code><code>]. Although embryonic liver has been shown to express CB2 receptor mRNA, adult liver hepatocytes and endothelial cells displayed only a faint physiological level of expression of CB1 receptors and were shown to produce low levels of endocannabinoids. CB1 receptors have been found to be upregulated in the vascular endothelium and in myofibroblasts located in fibrotic bands of cirrhotic livers in human and rodents [&lt;a href="#R72" rid="R72" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461385"&gt;</code></p><p><code>1272</code><code>72&lt;/a&gt;</code></p><p><code>1273</code><code>]. CB2 receptors are also expressed in myofibroblasts, inflammatory cells and biliary epithelial cells [&lt;a href="#R69" rid="R69" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461409"&gt;</code></p><p><code>1274</code><code>69&lt;/a&gt;</code></p><p><code>1275</code><code>]. There has been growing evidence in recent years to suggest that endocannabinoids may regulate the pathophysiology of liver diseases, including both acute forms of hepatic injury, liver fibrosis and cirrhosis. The endocannabinoids are found in low levels in normal liver, which may be due to high levels of expression of FAAH, which is responsible for the breakdown of AEA [&lt;a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461384"&gt;</code></p><p><code>1276</code><code>11&lt;/a&gt;</code></p><p><code>1277</code><code>]. The levels of AEA have been shown to increase in the liver and serum during acute hepatitis and fatty liver disease [&lt;a href="#R70" rid="R70" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461380"&gt;</code></p><p><code>1278</code><code>70&lt;/a&gt;</code></p><p><code>1279</code><code>]. In fatty liver, the increase in AEA results from decreased ability of FAAH to degrade AEA. Together, the above studies suggest that endocannabinoids and their receptors may play a critical role in regulating liver fibrogenesis; therefore, targeting the cannabinoid receptors may serve as a novel tool to prevent and treat liver injury.&lt;/p&gt;</code></p><p><code>1280</code><code>&lt;p id="P24"&gt;</code></p><p><code>1281</code><code>While the mechanisms of inflammatory liver injury are unclear, they are accompanied by infiltration of activated polymorphonuclear leukocytes, activation of Kupffer cells, production of proinflammatory cytokines and generation of ROS. Many recent studies indicated strongly the increased upregulation of the endocannabinoid system during liver diseases involving hepatocyte injury, inflammation, fibrogenesis, hepatic encephalopathy, cirrhotic cardiomyopathy and portal hypertension [&lt;a href="#R73" rid="R73" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461392"&gt;</code></p><p><code>1282</code><code>73&lt;/a&gt;</code></p><p><code>1283</code><code>]. The role of hepatic expression of anandamide and 2-AG is apparent in hepatic ischemia-reperfusion (I/R) injury, in which their levels are significantly increased, correlating with the extent of liver damage. Moreover, pretreatment of mice with JWH-133, a CB2 receptor agonist, was shown to decrease the degree of liver tissue injury and inflammatory cell infiltration and decrease serum levels of cytokines, chemokines and adhesion molecules [&lt;a href="#R74" rid="R74" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461369"&gt;</code></p><p><code>1284</code><code>74&lt;/a&gt;</code></p><p><code>1285</code><code>]. Furthermore, &lt;em&gt;</code></p><p><code>1286</code><code>CB2&lt;/em&gt;</code></p><p><code>1287</code><code>&lt;sup&gt;</code></p><p><code>1288</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1289</code><code> receptor mice were shown to develop greater inflammation and I/R-induced liver damage than their wild-type counterparts. The data also highlights the protective role of CB2 receptor activation in the inflammatory response associated with chronic liver diseases such as viral hepatitis and alcoholic or nonalcoholic fatty liver diseases.&lt;/p&gt;</code></p><p><code>1290</code><code>&lt;p id="P25"&gt;</code></p><p><code>1291</code><code>Viral hepatitis, alcohol abuse and nonalcoholic fatty liver are some of the conditions that can induce chronic liver injury and inflammation, leading to activation of fibrogenesis as a wound-healing mechanism. However, persistence of fibrogenic stimuli can enhance deposition of the extracellular matrix by hepatic myofibroblasts, thus disrupting normal liver architecture and, ultimately, leading to cirrhosis and liver failure. CB1 and CB2 receptors are shown to be markedly upregulated in cirrhotic human liver samples, demonstrating the impact of endocannabinoids in liver fibrogenesis. In addition, increases in circulating levels of anadamide and hepatic 2-AG have also been reported in cirrhosis and liver fibrosis, respectively [&lt;a href="#R73" rid="R73" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461407"&gt;</code></p><p><code>1292</code><code>73&lt;/a&gt;</code></p><p><code>1293</code><code>]. &lt;em&gt;</code></p><p><code>1294</code><code>CB2&lt;/em&gt;</code></p><p><code>1295</code><code>&lt;sup&gt;</code></p><p><code>1296</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1297</code><code> mice exposed to CCl4 showed enhanced liver fibrosis when compared with wild-type mice, thereby suggesting a protective role for CB2 receptor activation in liver fibrosis. By contrast, activation of CB1 receptors was found to promote profibrotic response [&lt;a href="#R72" rid="R72" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461387"&gt;</code></p><p><code>1298</code><code>72&lt;/a&gt;</code></p><p><code>1299</code><code>]. The pharmacological inactivation of CB1 with rimonabant&lt;sup&gt;</code></p><p><code>1300</code><code>&amp;#x000ae;&lt;/sup&gt;</code></p><p><code>1301</code><code> (SR141716) results in the reduction of obesity and hepatic steatosis in rodents [&lt;a href="#R75" rid="R75" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461440"&gt;</code></p><p><code>1302</code><code>75&lt;/a&gt;</code></p><p><code>1303</code><code>], demonstrating that CB1 and CB2 receptors exert opposite effects on liver fibrosis and further suggesting that endocannabinoid system regulates both pro- and anti-fibrogenic responses in the liver. Further effects of the endocannabinoids have also been shown to be receptor independent. AEA and 2-AG have been shown to induce necrosis and apoptosis, respectively, in activated hepatic stellate cells, through increased generation of ROS [&lt;a href="#R76" rid="R76" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461456"&gt;</code></p><p><code>1304</code><code>76&lt;/a&gt;</code></p><p><code>1305</code><code>].&lt;/p&gt;</code></p><p><code>1306</code><code>&lt;p id="P26"&gt;</code></p><p><code>1307</code><code>The abuse of cannabis has been shown to promote liver fibrosis in patients with chronic hepatitis C, indicating that cannabinoids may exacerbate liver fibrogenesis and that CB1 receptor antagonists may play a role as anti-fibrosing molecules [&lt;a href="#R71" rid="R71" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461422"&gt;</code></p><p><code>1308</code><code>71&lt;/a&gt;</code></p><p><code>1309</code><code>]. However, an alternative explanation could be that marijuana can trigger immunosuppression. For example, CB2 activation in immune cells can trigger apoptosis and this, in turn, can have an immunosuppressive effect in patients with hepatitis C. As such patients require immunocompetent cells to keep hepatitis under control, chronic marijuana abuse may promote fibrogenesis through the activation of CB2 and consequent suppression of antiviral immunity [&lt;a href="#R77" rid="R77" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461453"&gt;</code></p><p><code>1310</code><code>77&lt;/a&gt;</code></p><p><code>1311</code><code>].&lt;/p&gt;</code></p><p><code>1312</code><code>&lt;p id="P27"&gt;</code></p><p><code>1313</code><code>Endocannabinoids may also regulate liver cirrhosis by acting as mediators of vascular and cardiac functions. Endocannabinoids can trigger vasorelaxation, while an upregulated CB1-mediated cannabinoid tone causes enhanced mesenteric vasodialation leading to portal hypertension [&lt;a href="#R73" rid="R73" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461489"&gt;</code></p><p><code>1314</code><code>73&lt;/a&gt;</code></p><p><code>1315</code><code>,&lt;a href="#R75" rid="R75" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461378"&gt;</code></p><p><code>1316</code><code>75&lt;/a&gt;</code></p><p><code>1317</code><code>]. A recent &lt;em&gt;</code></p><p><code>1318</code><code>in vivo&lt;/em&gt;</code></p><p><code>1319</code><code> study by Batkai &lt;em&gt;</code></p><p><code>1320</code><code>et al.&lt;/em&gt;</code></p><p><code>1321</code><code> in rats with CCl&lt;sub&gt;</code></p><p><code>1322</code><code>4&lt;/sub&gt;</code></p><p><code>1323</code><code>-induced cirrhosis, indicated that increased local production of AEA mediated the inhibition of &amp;#x003b2;-adrenergic responsiveness. Further improvement in contractile function of isolated papillary muscles was observed following treatment with AM251, a CB1 receptor antagonist, suggesting therapeutic potential against cirrhotic cardiomyopathy [&lt;a href="#R75" rid="R75" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461413"&gt;</code></p><p><code>1324</code><code>75&lt;/a&gt;</code></p><p><code>1325</code><code>].&lt;/p&gt;</code></p><p><code>1326</code><code>&lt;p id="P28" class="p p-last"&gt;</code></p><p><code>1327</code><code>There are limited, but reliable, data on the neuroprotective role of the endocannabinoid system in hepatic encephalopathy. It has been demonstrated in a murine model that, during fulminant hepatic failure, levels of 2-AG in the brain are elevated, potentially as a response to liver damage. The administration of the CB2 endogenous ligand 2-AG, an antagonist of CB1 receptor SR141716A or an agonist of CB2 receptor HU308, resulted in a marked improvement in neurological score. Thus, influencing the endocannabinoid system with exogenous cannabinoid derivates specific for the CB1 or CB2 receptor may have a beneficial therapeutic effect on neurological dysfunction in liver diseases [&lt;a href="#R78" rid="R78" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461398"&gt;</code></p><p><code>1328</code><code>78&lt;/a&gt;</code></p><p><code>1329</code><code>]. Recently, we noted that both exogenous and endogenous cannabinoids protected mice from concanavalin-A (ConA)-induced acute hepatitis, a model that mimics viral or autoimmune hepatitis, in which T cells play a critical role in triggering liver injury. We found that administration of a single dose of THC or anandamide could ameliorate Con-A-induced hepatitis. We found that this effect was mediated through multiple pathways, including suppression of pro-inflammatory cytokines, induction of apoptosis in activated T cells and induction of forkhead helix transcription factor p3(Foxp3)&lt;sup&gt;</code></p><p><code>1330</code><code>+&lt;/sup&gt;</code></p><p><code>1331</code><code> Treg cells [&lt;a href="#R79" rid="R79" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461488"&gt;</code></p><p><code>1332</code><code>79&lt;/a&gt;</code></p><p><code>1333</code><code>]. This overwhelming evidence shows that the cannabinoid system must play a major role in the pathophysiology of various liver diseases and its therapeutic potential should be exploited for the treatment of chronic liver injuries (&lt;a href="/pmc/articles/PMC2828614/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"&gt;</code></p><p><code>1334</code><code>&lt;span&gt;</code></p><p><code>1335</code><code>Figure 2&lt;/span&gt;</code></p><p><code>1336</code><code>&lt;/a&gt;</code></p><p><code>1337</code><code>).&lt;/p&gt;</code></p><p><code>1338</code><code>&lt;!--fig ft0--&gt;</code></p><p><code>1339</code><code>&lt;!--fig mode=article f1--&gt;</code></p><p><code>1340</code><code>&lt;div class="fig iconblock whole_rhythm" id="F2" co-legend-rid="lgnd_F2"&gt;</code></p><p><code>1341</code><code>&lt;a href="/pmc/articles/PMC2828614/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"&gt;</code></p><p><code>1342</code><code>&lt;!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--&gt;</code></p><p><code>1343</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139818001512944" class="figure"&gt;</code></p><p><code>1344</code><code>&lt;a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;amp;p=PMC3&amp;amp;id=2828614_nihms155268f2.jpg" target="tileshopwindow" rel="noopener"&gt;</code></p><p><code>1345</code><code>&lt;div class="ts_bar small" title="Click on image to zoom"&gt;</code></p><p><code>1346</code><code>&lt;/div&gt;</code></p><p><code>1347</code><code>&lt;img loading="lazy" alt="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms155268f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2828614/bin/nihms155268f2.jpg" /&gt;</code></p><p><code>1348</code><code>&lt;/a&gt;</code></p><p><code>1349</code><code>&lt;/div&gt;</code></p><p><code>1350</code><code>&lt;div id="largeobj_idm139818001512944" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>1351</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2828614/figure/F2/?report=objectonly"&gt;</code></p><p><code>1352</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>1353</code><code>&lt;/div&gt;</code></p><p><code>1354</code><code>&lt;/a&gt;</code></p><p><code>1355</code><code>&lt;div class="icnblk_cntnt" id="lgnd_F2"&gt;</code></p><p><code>1356</code><code>&lt;div&gt;</code></p><p><code>1357</code><code>&lt;a class="figpopup" href="/pmc/articles/PMC2828614/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"&gt;</code></p><p><code>1358</code><code>Figure 2&lt;/a&gt;</code></p><p><code>1359</code><code>&lt;/div&gt;</code></p><p><code>1360</code><code>&lt;!--caption a7--&gt;</code></p><p><code>1361</code><code>&lt;div class="caption"&gt;</code></p><p><code>1362</code><code>&lt;p id="__p4"&gt;</code></p><p><code>1363</code><code>Endocannabinoids, CB1 antagonists and CB2 agonists as potential drugs for the treatment of liver injury.&lt;/p&gt;</code></p><p><code>1364</code><code>&lt;/div&gt;</code></p><p><code>1365</code><code>&lt;/div&gt;</code></p><p><code>1366</code><code>&lt;/div&gt;</code></p><p><code>1367</code><code>&lt;/div&gt;</code></p><p><code>1368</code><code>&lt;div id="S6" class="tsec sec"&gt;</code></p><p><code>1369</code><code>&lt;h2 class="head no_bottom_margin" id="S6title"&gt;</code></p><p><code>1370</code><code>Cannabinoids &amp;#x00026; RA&lt;/h2&gt;</code></p><p><code>1371</code><code>&lt;p id="P29" class="p p-first"&gt;</code></p><p><code>1372</code><code>Rheumatoid arthritis is a chronic inflammatory disease that affects approximately 1% of the human population and is manifested in joint destruction, deformity and loss of function associated with joint stiffness, pain, swelling and tenderness [&lt;a href="#R80" rid="R80" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461381"&gt;</code></p><p><code>1373</code><code>80&lt;/a&gt;</code></p><p><code>1374</code><code>]. The major immune cell populations involved in joint injury are macrophages, T cells, fibroblast-like synoviocytes and DCs. Major cytokines are TNF-&amp;#x003b1; and IL-1 [&lt;a href="#R80" rid="R80" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461371"&gt;</code></p><p><code>1375</code><code>80&lt;/a&gt;</code></p><p><code>1376</code><code>,&lt;a href="#R81" rid="R81" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461421"&gt;</code></p><p><code>1377</code><code>81&lt;/a&gt;</code></p><p><code>1378</code><code>]. Cannabinoids and their anti-inflammatory properties have been studied in animal models of RA and on human cells from RA patients and these studies demonstrate the anti-arthritic properties of these natural plant compounds [&lt;a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461451"&gt;</code></p><p><code>1379</code><code>32&lt;/a&gt;</code></p><p><code>1380</code><code>, &lt;a href="#R82" rid="R82" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461419"&gt;</code></p><p><code>1381</code><code>82&lt;/a&gt;</code></p><p><code>1382</code><code>&amp;#x02013;&lt;a href="#R84" rid="R84" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461499"&gt;</code></p><p><code>1383</code><code>84&lt;/a&gt;</code></p><p><code>1384</code><code>]. Interestingly, most of the studies on RA and cannabinoids focus on the use of nonpsychoactive cannabinoids.&lt;/p&gt;</code></p><p><code>1385</code><code>&lt;p id="P30"&gt;</code></p><p><code>1386</code><code>CBD is the major nonpsychoactive component of the cannabis plant and its protective effect has been shown in murine collagen-induced arthritis [&lt;a href="#R85" rid="R85" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461391"&gt;</code></p><p><code>1387</code><code>85&lt;/a&gt;</code></p><p><code>1388</code><code>]. In this study, the authors showed that daily oral (5 mg/kg) or intra-peritoneal (25 mg/kg) administration of CBD inhibited disease progression. Furthermore, the study demonstrated that CBD-treated mice had less proliferation in &lt;em&gt;</code></p><p><code>1389</code><code>ex vivo&lt;/em&gt;</code></p><p><code>1390</code><code>-activated draining lymph node cells, decreased levels of IFN-&amp;#x003b3; secreted by the activated lymph node cells and diminished TNF-&amp;#x003b1; production by knee synovial cells. Sumariwalla &lt;em&gt;</code></p><p><code>1391</code><code>et al.&lt;/em&gt;</code></p><p><code>1392</code><code> used another synthetic nonpsychoactive cannabinoid, HU-320, and demonstrated that this compound improved already established arthritis in mice [&lt;a href="#R86" rid="R86" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461361"&gt;</code></p><p><code>1393</code><code>86&lt;/a&gt;</code></p><p><code>1394</code><code>]. Lymph node cells from HU-320-treated mice showed decreased proliferative responses when the cells from 7-day post-inflammation mice were incubated with collagen II.&lt;/p&gt;</code></p><p><code>1395</code><code>&lt;p id="P31"&gt;</code></p><p><code>1396</code><code>Furthermore, AjA has been shown to inhibit IL-1&amp;#x003b2; production by human monocytes isolated from RA patients [&lt;a href="#R82" rid="R82" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461443"&gt;</code></p><p><code>1397</code><code>82&lt;/a&gt;</code></p><p><code>1398</code><code>]. In this study, the investigators isolated peripheral blood monocytes (PBMs) as well as synovial fluid monocytes (SFMs) from normal and RA patients. The isolated cells were pretreated with 0&amp;#x02013;30 &amp;#x003bc;M AjA and were then stimulated with LPS. The results showed that AjA treatment decreased IL-1&amp;#x003b2; production in both PBMs and SFMs, but did not affect TNF-&amp;#x003b1; production. In a different study, Parker &lt;em&gt;</code></p><p><code>1399</code><code>et al.&lt;/em&gt;</code></p><p><code>1400</code><code> demonstrated that AjA reduced IL-6 secretion by activated human monocyte-derived-macrophages [&lt;a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461426"&gt;</code></p><p><code>1401</code><code>32&lt;/a&gt;</code></p><p><code>1402</code><code>].&lt;/p&gt;</code></p><p><code>1403</code><code>&lt;p id="P32" class="p p-last"&gt;</code></p><p><code>1404</code><code>AjA also exerts its immunomodulatory effects by inducing apoptosis in mature osteoclast-like cells and, therefore, protecting the host from osteoclastogenesis. George &lt;em&gt;</code></p><p><code>1405</code><code>et al.&lt;/em&gt;</code></p><p><code>1406</code><code> demonstrated that treatment of osteoclast-like cells with 15 and 30 &amp;#x003bc;M of AjA led to induction of caspase 3 and 8 in these cells, resulting in apoptosis and protection from osteoclastogenesis [&lt;a href="#R83" rid="R83" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461452"&gt;</code></p><p><code>1407</code><code>83&lt;/a&gt;</code></p><p><code>1408</code><code>].&lt;/p&gt;</code></p><p><code>1409</code><code>&lt;/div&gt;</code></p><p><code>1410</code><code>&lt;div id="S7" class="tsec sec"&gt;</code></p><p><code>1411</code><code>&lt;h2 class="head no_bottom_margin" id="S7title"&gt;</code></p><p><code>1412</code><code>Cannabinoids &amp;#x00026; cancers with inflammatory components&lt;/h2&gt;</code></p><p><code>1413</code><code>&lt;p id="P33" class="p p-first-last"&gt;</code></p><p><code>1414</code><code>The role of inflammation in evolution of certain types of cancer has been strongly suggested, linking the inflammatory response to 15&amp;#x02013;20% of all deaths from cancer worldwide [&lt;a href="#R84" rid="R84" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461412"&gt;</code></p><p><code>1415</code><code>84&lt;/a&gt;</code></p><p><code>1416</code><code>]. The hallmarks of cancer-related inflammation include the presence of inflammatory cells in tumor tissue, and the regulation of tumor growth, metastasis and angiogenesis by inflammatory mediators (e.g., chemokines, cytokines and prostaglandins). The connection between inflammation and cancer is now generally accepted and nonsteroidal anti-inflammatory drugs have been shown to reduce varied cancer risk. Use of these drugs reduces colon cancer risk by 40&amp;#x02013;50% and is indicated to be preventative for lung, esophagus and stomach cancer [&lt;a href="#R87" rid="R87" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461471"&gt;</code></p><p><code>1417</code><code>87&lt;/a&gt;</code></p><p><code>1418</code><code>]. Hence, inflammation can be considered as a therapeutic opportunity in certain types of cancer. Recent applications of cannabinoids have been extended as antitumor agents [&lt;a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461510"&gt;</code></p><p><code>1419</code><code>1&lt;/a&gt;</code></p><p><code>1420</code><code>,&lt;a href="#R88" rid="R88" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461459"&gt;</code></p><p><code>1421</code><code>88&lt;/a&gt;</code></p><p><code>1422</code><code>], which relies on their ability to inhibit tumor angiogenesis [&lt;a href="#R89" rid="R89" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461437"&gt;</code></p><p><code>1423</code><code>89&lt;/a&gt;</code></p><p><code>1424</code><code>] or induce direct apoptosis or cell cycle arrest in neoplastic cells [&lt;a href="#R89" rid="R89" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461480"&gt;</code></p><p><code>1425</code><code>89&lt;/a&gt;</code></p><p><code>1426</code><code>&amp;#x02013;&lt;a href="#R92" rid="R92" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461368"&gt;</code></p><p><code>1427</code><code>92&lt;/a&gt;</code></p><p><code>1428</code><code>]. A focus on the antiproliferative effects of these compounds in various tumors, such as breast and prostate cancers, pheochromocytoma and malignant gliomas, has been proposed [&lt;a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461507"&gt;</code></p><p><code>1429</code><code>1&lt;/a&gt;</code></p><p><code>1430</code><code>,&lt;a href="#R92" rid="R92" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461357"&gt;</code></p><p><code>1431</code><code>92&lt;/a&gt;</code></p><p><code>1432</code><code>&amp;#x02013;&lt;a href="#R94" rid="R94" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461399"&gt;</code></p><p><code>1433</code><code>94&lt;/a&gt;</code></p><p><code>1434</code><code>]. Our laboratory reported that, &lt;em&gt;</code></p><p><code>1435</code><code>in vitro&lt;/em&gt;</code></p><p><code>1436</code><code>, THC and other cannabinoids could induce apoptosis in transformed murine and human T cells [&lt;a href="#R95" rid="R95" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461457"&gt;</code></p><p><code>1437</code><code>95&lt;/a&gt;</code></p><p><code>1438</code><code>], including primary acute lymphoblastic human leukemia cells. Furthermore, the treatment of mice bearing a T-cell leukemia with THC could cure approximately 25% of the mice [&lt;a href="#R95" rid="R95" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461386"&gt;</code></p><p><code>1439</code><code>95&lt;/a&gt;</code></p><p><code>1440</code><code>]. We further showed that treatment with THC caused interruption of the MAPK/ERK kinase/ERK signaling module that was required for apoptotic lethality [&lt;a href="#R96" rid="R96" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461498"&gt;</code></p><p><code>1441</code><code>96&lt;/a&gt;</code></p><p><code>1442</code><code>,&lt;a href="#R97" rid="R97" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461447"&gt;</code></p><p><code>1443</code><code>97&lt;/a&gt;</code></p><p><code>1444</code><code>]. The role of endocannabinoids as potential endogenous tumor growth inhibitors has been suggested in a study where it was observed that levels of both AEA and 2-AG were higher in precancerous polyps than in fully developed carcinomas in the colon [&lt;a href="#R98" rid="R98" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461425"&gt;</code></p><p><code>1445</code><code>98&lt;/a&gt;</code></p><p><code>1446</code><code>]. Recent &lt;em&gt;</code></p><p><code>1447</code><code>in vivo&lt;/em&gt;</code></p><p><code>1448</code><code> studies proposed that selective targeting of CB2 receptors resulted in colorectal tumor growth inhibition via apoptosis, which was mediated through the stimulation of ceramide [&lt;a href="#R98" rid="R98" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461408"&gt;</code></p><p><code>1449</code><code>98&lt;/a&gt;</code></p><p><code>1450</code><code>]. In a xenograft model of thyroid cancer, substances that blocked endocannabinoid degradation also increased the levels of AEA and 2-AG in the tissue and reduced tumor growth [&lt;a href="#R99" rid="R99" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461435"&gt;</code></p><p><code>1451</code><code>99&lt;/a&gt;</code></p><p><code>1452</code><code>]. Various attempts have been made to inactivate cannabinoid-degrading enzymes, thereby increasing the local concentration of endocannabinoids at the tumor cell surface. This leads to anti-tumor effects of CB receptor signaling in various cancer types, such as thyroid, brain and prostate cancer [&lt;a href="#R99" rid="R99" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461484"&gt;</code></p><p><code>1453</code><code>99&lt;/a&gt;</code></p><p><code>1454</code><code>&amp;#x02013;&lt;a href="#R103" rid="R103" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461487"&gt;</code></p><p><code>1455</code><code>103&lt;/a&gt;</code></p><p><code>1456</code><code>]. Although the majority of the effects of cannabinoids are CB receptor mediated, AEA has been shown to induce its effects on cancerous cells by interacting with TRPV1 receptor [&lt;a href="#R104" rid="R104" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461454"&gt;</code></p><p><code>1457</code><code>104&lt;/a&gt;</code></p><p><code>1458</code><code>,&lt;a href="#R105" rid="R105" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461402"&gt;</code></p><p><code>1459</code><code>105&lt;/a&gt;</code></p><p><code>1460</code><code>] or cholesterol-rich lipid rafts [&lt;a href="#R106" rid="R106" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461355"&gt;</code></p><p><code>1461</code><code>106&lt;/a&gt;</code></p><p><code>1462</code><code>]. Furthermore, it has been reported that signaling pathways are differentially regulated by cannabinoids in normal cells versus cancer cells. In malignancies, such as thyroid cancer, lymphoma, melanoma, pancreas and breast cancer, the levels of cannabinoid receptors are often higher in the tumor compared with normal cells of the same origin, resulting in increased sensitivity to cannabinoids in the malignancies [&lt;a href="#R89" rid="R89" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461478"&gt;</code></p><p><code>1463</code><code>89&lt;/a&gt;</code></p><p><code>1464</code><code>,&lt;a href="#R107" rid="R107" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461476"&gt;</code></p><p><code>1465</code><code>107&lt;/a&gt;</code></p><p><code>1466</code><code>&amp;#x02013;&lt;a href="#R110" rid="R110" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461490"&gt;</code></p><p><code>1467</code><code>110&lt;/a&gt;</code></p><p><code>1468</code><code>]. Moreover, many animal studies have reported antiproliferative and pro-apoptotic effects of cannabinoids on tumor cells but not on normal tissue [&lt;a href="#R89" rid="R89" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461492"&gt;</code></p><p><code>1469</code><code>89&lt;/a&gt;</code></p><p><code>1470</code><code>,&lt;a href="#R91" rid="R91" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461442"&gt;</code></p><p><code>1471</code><code>91&lt;/a&gt;</code></p><p><code>1472</code><code>]. Thus, the role of the cannabinoid system in cancer indicates that this system is involved in regulating many of the functions that are essential in cancer development.&lt;/p&gt;</code></p><p><code>1473</code><code>&lt;/div&gt;</code></p><p><code>1474</code><code>&lt;div id="S8" class="tsec sec"&gt;</code></p><p><code>1475</code><code>&lt;h2 class="head no_bottom_margin" id="S8title"&gt;</code></p><p><code>1476</code><code>Cannabinoids &amp;#x00026; other inflammatory diseases&lt;/h2&gt;</code></p><p><code>1477</code><code>&lt;p id="P34" class="p p-first"&gt;</code></p><p><code>1478</code><code>Allergic asthma is a complex inflammatory disorder characterized by airway hyper-responsiveness, elevated serum IgE, recruitment of eosinophils into the lung and mucus hypersecretion by goblet cells [&lt;a href="#R111" rid="R111" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461514"&gt;</code></p><p><code>1479</code><code>111&lt;/a&gt;</code></p><p><code>1480</code><code>]. Murine models of allergic airway disease, employing ovalbumin (OVA) as an aeroallergen, indicated that CD4&lt;sup&gt;</code></p><p><code>1481</code><code>+&lt;/sup&gt;</code></p><p><code>1482</code><code> Th2 cells (IL-4, IL-5 and IL-13) played a pivotal role in the pathophysiology of the allergic airway response [&lt;a href="#R112" rid="R112" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461472"&gt;</code></p><p><code>1483</code><code>112&lt;/a&gt;</code></p><p><code>1484</code><code>]. Intraperitoneal administration of THC or cannabinol (CBN) in OVA-sensitized and challenged A/J mice led to attenuation of serum IgE, IL-2, IL-4, IL-5 and IL-13 mRNA expression and decreased allergen-induced mucus production, indicating that cannabinoid-based compounds may represent a novel class of therapeutic agents for the treatment of allergic airway diseases [&lt;a href="#R113" rid="R113" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461503"&gt;</code></p><p><code>1485</code><code>113&lt;/a&gt;</code></p><p><code>1486</code><code>]. While most studies have shown that cannabinoids, such as THC, facilitate a Th1 to Th2 cytokine switch, as discussed previously, it is surprising that cannabinoids can also suppress allergic asthma triggered primarily by Th2 cytokines. It is possible that THC may affect other cells such as DCs and B cells directly in this model. Previous findings indicated that aerosolized THC was capable of causing significant bronchodilatation with minimal systemic side effects, but had a local irritating effect on the airways [&lt;a href="#R114" rid="R114" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461382"&gt;</code></p><p><code>1487</code><code>114&lt;/a&gt;</code></p><p><code>1488</code><code>]. Further bronchodilator effects of cannabinoids administered orally or by aerosol to asthmatic patients have also been reported [&lt;a href="#R115" rid="R115" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461455"&gt;</code></p><p><code>1489</code><code>115&lt;/a&gt;</code></p><p><code>1490</code><code>,&lt;a href="#R116" rid="R116" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461501"&gt;</code></p><p><code>1491</code><code>116&lt;/a&gt;</code></p><p><code>1492</code><code>]. Similarly, endogenous cannabinoids have been shown to regulate airway responsiveness. In rodent lungs, a Ca&lt;sup&gt;</code></p><p><code>1493</code><code>2+&lt;/sup&gt;</code></p><p><code>1494</code><code>-activated mechanism for the biosynthesis of anandamide was observed and CB1 receptors were found predominantly on axon terminals of airway nerves, indicating that endocannabinoids may regulate bronchial smooth muscle tone [&lt;a href="#R117" rid="R117" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461465"&gt;</code></p><p><code>1495</code><code>117&lt;/a&gt;</code></p><p><code>1496</code><code>]. It was reported that activation of CB1 receptors by locally released anandamide may participate in the control of bronchial contractility. Blocking of AEA-induced CB1 activity can enhance capsaicin-induced bronchospasm. However, the authors further suggested that the effects of AEA may depend on the state of the bronchial muscle. During capsaicin-evoked bronchospasm, AEA may reduce the muscle contraction, whereas AEA may cause bronchoconstriction in the absence of vagus nerve-constricting tone [&lt;a href="#R117" rid="R117" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461466"&gt;</code></p><p><code>1497</code><code>117&lt;/a&gt;</code></p><p><code>1498</code><code>].&lt;/p&gt;</code></p><p><code>1499</code><code>&lt;p id="P35"&gt;</code></p><p><code>1500</code><code>Cannabidiol has been shown to be effective in protecting endothelial function and integrity in human coronary artery endothelial cells (HCAECs). The study demonstrated that CBD reversed the harmful effects of high glucose on HCAECs by inhibiting [&lt;a href="#R118" rid="R118" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461406"&gt;</code></p><p><code>1501</code><code>118&lt;/a&gt;</code></p><p><code>1502</code><code>]:&lt;/p&gt;</code></p><p><code>1503</code><code>&lt;ul class="unordered" style="list-style-type:disc" id="L1"&gt;</code></p><p><code>1504</code><code>&lt;!--</code></p><p><code>1505</code><code>list-behavior=unordered</code></p><p><code>1506</code><code>prefix-word=</code></p><p><code>1507</code><code>mark-type=disc</code></p><p><code>1508</code><code>max-label-size=0</code></p><p><code>1509</code><code>--&gt;</code></p><p><code>1510</code><code>&lt;li&gt;</code></p><p><code>1511</code><code>&lt;p id="P36"&gt;</code></p><p><code>1512</code><code>Reactive oxygen species production by mitochondria&lt;/p&gt;</code></p><p><code>1513</code><code>&lt;/li&gt;</code></p><p><code>1514</code><code>&lt;li&gt;</code></p><p><code>1515</code><code>&lt;p id="P37"&gt;</code></p><p><code>1516</code><code>NF-&amp;#x003ba;B activation&lt;/p&gt;</code></p><p><code>1517</code><code>&lt;/li&gt;</code></p><p><code>1518</code><code>&lt;li&gt;</code></p><p><code>1519</code><code>&lt;p id="P38"&gt;</code></p><p><code>1520</code><code>Transendothelial migration of monocytes&lt;/p&gt;</code></p><p><code>1521</code><code>&lt;/li&gt;</code></p><p><code>1522</code><code>&lt;li&gt;</code></p><p><code>1523</code><code>&lt;p id="P39"&gt;</code></p><p><code>1524</code><code>Monocyte&amp;#x02013;endothelial adhesion in HCAECs&lt;/p&gt;</code></p><p><code>1525</code><code>&lt;/li&gt;</code></p><p><code>1526</code><code>&lt;/ul&gt;</code></p><p><code>1527</code><code>&lt;p id="P40"&gt;</code></p><p><code>1528</code><code>In a different experiment, HCAECs were stimulated with TNF-&amp;#x003b1; in order to mimic the inflammatory processes during atherosclerosis, and the effect of different CB2 receptor agonists on the activated cells was studied. It was demonstrated that activation of cells with TNF-&amp;#x003b1; led to increased expression of CB2 and activation of Ras, p38, MAPK, JNK and AKT pathways. In addition, proliferation and migration was markedly increased in activated cell populations. The use of CB2 agonists JWH-133 and HU-308 inhibited all activated pathways in a dose-dependent manner, establishing a novel use for these cannabinoid compounds [&lt;a href="#R119" rid="R119" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461493"&gt;</code></p><p><code>1529</code><code>119&lt;/a&gt;</code></p><p><code>1530</code><code>].&lt;/p&gt;</code></p><p><code>1531</code><code>&lt;p id="P41"&gt;</code></p><p><code>1532</code><code>Experimental autoimmune uveoretinitis (EAU), is a CD4&lt;sup&gt;</code></p><p><code>1533</code><code>+&lt;/sup&gt;</code></p><p><code>1534</code><code> T-cell-mediated autoimmune disease, which can be induced in rodents by challenge with retinal antigens or their peptides [&lt;a href="#R120" rid="R120" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461473"&gt;</code></p><p><code>1535</code><code>120&lt;/a&gt;</code></p><p><code>1536</code><code>]. In a recent study, it was observed that the CB2-selective agonist JWH-133 had a high &lt;em&gt;</code></p><p><code>1537</code><code>in vivo&lt;/em&gt;</code></p><p><code>1538</code><code> immunosuppressive effect in EAU model. EAU was strongly inhibited when the CB2 was engaged and the effects of CB2 engagement appeared to be mediated predominantly through downregulation of T-cell function with a less-marked effect on antigen presentation [&lt;a href="#R121" rid="R121" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461449"&gt;</code></p><p><code>1539</code><code>121&lt;/a&gt;</code></p><p><code>1540</code><code>]. An impaired T-cell-proliferative response in leukocytes from JWH-133-treated mice was also accompanied by marked reductions in cytokine production. A more recent study showed that JWH-133 (10 nM&amp;#x02013;5 &amp;#x003bc;M) suppressed IL-12p40 and enhanced IL-10 production in mouse macrophages induced by LPS [&lt;a href="#R122" rid="R122" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461460"&gt;</code></p><p><code>1541</code><code>122&lt;/a&gt;</code></p><p><code>1542</code><code>]. As IL-12p40 is critical for the development of EAU and IL-10 could suppress EAU [&lt;a href="#R123" rid="R123" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461495"&gt;</code></p><p><code>1543</code><code>123&lt;/a&gt;</code></p><p><code>1544</code><code>,&lt;a href="#R124" rid="R124" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461389"&gt;</code></p><p><code>1545</code><code>124&lt;/a&gt;</code></p><p><code>1546</code><code>], the authors suggested that this may also be one of the possible mechanisms responsible for the effect of JWH-133 on EAU.&lt;/p&gt;</code></p><p><code>1547</code><code>&lt;p id="P42" class="p p-last"&gt;</code></p><p><code>1548</code><code>Insulin-dependent Type 1 diabetes mellitus (T1DM) is an autoimmune disease resulting in destruction of insulin-producing pancreatic &amp;#x003b2; cells, a process that is assumed to be mediated mainly by CD4 Th1 and CD8 T lymphocytes [&lt;a href="#R125" rid="R125" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461418"&gt;</code></p><p><code>1549</code><code>125&lt;/a&gt;</code></p><p><code>1550</code><code>]. In rodents, T1D is induced by administration of multiple low doses of streptozotocin (MLDSTZ). This model is used for studying autoimmune processes associated with pancreatic &amp;#x003b2;-cell pathogenesis. A study performed by Li &lt;em&gt;</code></p><p><code>1551</code><code>et al.&lt;/em&gt;</code></p><p><code>1552</code><code> indicated that &amp;#x00394;&lt;sup&gt;</code></p><p><code>1553</code><code>9&lt;/sup&gt;</code></p><p><code>1554</code><code>-THC could exert a transient attenuation of MLDSTZ-induced autoimmune diabetes. &amp;#x00394;&lt;sup&gt;</code></p><p><code>1555</code><code>9&lt;/sup&gt;</code></p><p><code>1556</code><code>-THC treated (150 mg/kg) CD-1 mice exhibited reduced hyperglycemia and a significant decrease in the loss of pancreatic insulin. MLDSTZ-induced insulitis was also significantly attenuated by decreases in CD3&lt;sup&gt;</code></p><p><code>1557</code><code>+&lt;/sup&gt;</code></p><p><code>1558</code><code> inflammatory cells in the pancreatic islets and in mRNA expression for IL-12, IFN-&amp;#x003b3; and TNF-&amp;#x003b1;. It was suggested that in this model, the autoimmune component was most effectively modulated by &amp;#x00394;&lt;sup&gt;</code></p><p><code>1559</code><code>9&lt;/sup&gt;</code></p><p><code>1560</code><code>-THC treatment [&lt;a href="#R126" rid="R126" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461401"&gt;</code></p><p><code>1561</code><code>126&lt;/a&gt;</code></p><p><code>1562</code><code>]. Similarly, CBD treatment has been shown to significantly inhibit and delay destructive insulitis and inflammatory Th1-associated cytokine production in nonobese diabetes-prone (NOD) female mice. CBD-treated mice exhibited significant reduction of plasma levels of the proinflammatory cytokines IFN-&amp;#x003b3; and TNF-&amp;#x003b1;, whereas production of the Th2-associated cytokines IL-4 and IL-10 was increased when compared with untreated control mice, thus shifting the immune response from Th1 to Th2 dominance [&lt;a href="#R127" rid="R127" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461446"&gt;</code></p><p><code>1563</code><code>127&lt;/a&gt;</code></p><p><code>1564</code><code>]. A recent study indicated that treatment of 11&amp;#x02013;14-week-old female NOD mice, either in a latent diabetes stage (after 14 weeks) or with initial symptoms of diabetes (appearing up to 14 weeks) with CBD for 4 weeks, could lead to sustained inhibition of insulitis [&lt;a href="#R128" rid="R128" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461479"&gt;</code></p><p><code>1565</code><code>128&lt;/a&gt;</code></p><p><code>1566</code><code>]. CBD treatment inhibited specific destruction of the islets and reduced the infiltrates by mononuclear cells into the islets, thus preventing diabetes. Furthermore, cannabinoids have also been demonstrated to possess additional beneficial effects in animal models of diabetes. It has been reported that rats treated with CBD for periods of 1&amp;#x02013;4 weeks experienced significant protection from diabetic retinopathy [&lt;a href="#R129" rid="R129" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461360"&gt;</code></p><p><code>1567</code><code>129&lt;/a&gt;</code></p><p><code>1568</code><code>]. Cannabinoids have also been shown to alleviate neuropathic pain associated with the disease. Mice injected with a cannabis receptor agonist experienced a reduction in diabetic-related tactile allodynia compared with nontreated controls [&lt;a href="#R130" rid="R130" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_276461475"&gt;</code></p><p><code>1569</code><code>130&lt;/a&gt;</code></p><p><code>1570</code><code>]. Thus, cannabinoids can be considered useful for controlling T1D due to their anti-inflammatory properties.&lt;/p&gt;</code></p><p><code>1571</code><code>&lt;/div&gt;</code></p><p><code>1572</code><code>&lt;div id="S9" class="tsec sec"&gt;</code></p><p><code>1573</code><code>&lt;h2 class="head no_bottom_margin" id="S9title"&gt;</code></p><p><code>1574</code><code>Future perspective&lt;/h2&gt;</code></p><p><code>1575</code><code>&lt;p id="P43" class="p p-first"&gt;</code></p><p><code>1576</code><code>It is becoming increasingly clear that cannabinoid receptors and their endogenous ligands play a crucial role in the regulation of the immune system. Exogenous cannabinoids have been shown to suppress T-cell-mediated immune responses by primarily inducing apoptosis and suppressing inflammatory cytokines and chemokines. Such observations indicate that targeting cannabinoid receptor&amp;#x02013;ligand interactions may constitute a novel window of opportunity to treat inflammatory and autoimmune disorders. As CB2 receptors are primarily expressed on immune cells, targeting CB2 may result in selective immunomodulation without overt toxicity. The future challenges for the use of cannabinoids as anti-inflammatory drugs include synthesis of cannabinoid receptor agonists that are nonpsychoactive with anti-inflammatory activity and then identifying their mode of action. Although current studies suggest that cannabinoids are useful therapeutic agents in the treatment of various inflammatory disorders, further evaluation of the mechanisms that account for their anti-inflammatory properties is necessary. Such studies may involve the use of cannabinoid receptor-knockout mice and use of receptor-specific compounds. While most studies have focused on the effect of cannabinoids on cytokines, apoptosis and Th1 cell functions in the past, additional investigations on their effect on Th17 cells, DCs, NK cells, B cells and Fox-P3&lt;sup&gt;</code></p><p><code>1577</code><code>+&lt;/sup&gt;</code></p><p><code>1578</code><code> regulatory T cells is critical as such cells play an important role in the regulation and mediation of inflammatory or autoimmune disease response. Whether endocannabinoids and cannabinoid receptors play a critical role during normal inflammatory response also requires further consideration. Moreover, cannabinoid receptor signaling and effect of cannabinoids on adhesion molecules, co-stimulatory molecules and chemokines require further study in order to increase our understanding of cannabinoids and their intricate effects on immune system disorders. Overall, cannabinoids have exhibited significant potential to be used as novel anti-inflammatory agents and specific targeting of CB2 receptors holds the promise of mediating immunosuppressive effects without exerting psychotropic side effects.&lt;/p&gt;</code></p><p><code>1579</code><code>&lt;div class="boxed-text-box whole_rhythm hide-overflow" id="BX1"&gt;</code></p><p><code>1580</code><code>&lt;div class="sec" id="S10"&gt;</code></p><p><code>1581</code><code>&lt;h3 id="S10title"&gt;</code></p><p><code>1582</code><code>Executive summary&lt;/h3&gt;</code></p><p><code>1583</code><code>&lt;ul class="unordered" style="list-style-type:disc" id="L2"&gt;</code></p><p><code>1584</code><code>&lt;!--</code></p><p><code>1585</code><code>list-behavior=unordered</code></p><p><code>1586</code><code>prefix-word=</code></p><p><code>1587</code><code>mark-type=disc</code></p><p><code>1588</code><code>max-label-size=0</code></p><p><code>1589</code><code>--&gt;</code></p><p><code>1590</code><code>&lt;li&gt;</code></p><p><code>1591</code><code>&lt;p id="P44"&gt;</code></p><p><code>1592</code><code>Cannabinoids, the active components of &lt;em&gt;</code></p><p><code>1593</code><code>Cannabis sativa,&lt;/em&gt;</code></p><p><code>1594</code><code> and endogenous cannabinoids mediate their effects through activation of specific cannabinoid receptors known as cannabinoid receptor 1 and 2 (CB1 and CB2).&lt;/p&gt;</code></p><p><code>1595</code><code>&lt;/li&gt;</code></p><p><code>1596</code><code>&lt;li&gt;</code></p><p><code>1597</code><code>&lt;p id="P45"&gt;</code></p><p><code>1598</code><code>The cannabinoid system has been shown both &lt;em&gt;</code></p><p><code>1599</code><code>in vivo&lt;/em&gt;</code></p><p><code>1600</code><code> and &lt;em&gt;</code></p><p><code>1601</code><code>in vitro&lt;/em&gt;</code></p><p><code>1602</code><code> to be involved in regulating the immune system through its immunomodulatory properties.&lt;/p&gt;</code></p><p><code>1603</code><code>&lt;/li&gt;</code></p><p><code>1604</code><code>&lt;li&gt;</code></p><p><code>1605</code><code>&lt;p id="P46"&gt;</code></p><p><code>1606</code><code>Cannabinoids suppress inflammatory response and subsequently attenuate disease symptoms. This property of cannabinoids is mediated through multiple pathways such as induction of apoptosis in activated immune cells, suppression of cytokines and chemokines at inflammatory sites and upregulation of FoxP3&lt;sup&gt;</code></p><p><code>1607</code><code>+&lt;/sup&gt;</code></p><p><code>1608</code><code> regulatory T cells.&lt;/p&gt;</code></p><p><code>1609</code><code>&lt;/li&gt;</code></p><p><code>1610</code><code>&lt;li&gt;</code></p><p><code>1611</code><code>&lt;p id="P47"&gt;</code></p><p><code>1612</code><code>Cannabinoids have been tested in several experimental models of autoimmune disorders such as multiple sclerosis, rheumatoid arthritis, colitis and hepatitis and have been shown to protect the host from the pathogenesis through induction of multiple anti-inflammatory pathways.&lt;/p&gt;</code></p><p><code>1613</code><code>&lt;/li&gt;</code></p><p><code>1614</code><code>&lt;li&gt;</code></p><p><code>1615</code><code>&lt;p id="P48"&gt;</code></p><p><code>1616</code><code>Cannabinoids may also be beneficial in certain types of cancers that are triggered by chronic inflammation. In such instances, cannabinoids can either directly inhibit tumor growth or suppress inflammation and tumor angiogenesis.&lt;/p&gt;</code></p><p><code>1617</code><code>&lt;/li&gt;</code></p><p><code>1618</code><code>&lt;/ul&gt;</code></p><p><code>1619</code><code>&lt;/div&gt;</code></p><p><code>1620</code><code>&lt;/div&gt;</code></p><p><code>1621</code><code>&lt;/div&gt;</code></p><p><code>1622</code><code>&lt;div id="S12" class="tsec sec"&gt;</code></p><p><code>1623</code><code>&lt;h2 class="head no_bottom_margin" id="S12title"&gt;</code></p><p><code>1624</code><code>Acknowledgments&lt;/h2&gt;</code></p><p><code>1625</code><code>&lt;div class="sec"&gt;</code></p><p><code>1626</code><code>&lt;p id="__p8"&gt;</code></p><p><code>1627</code><code>This work was supported in part by NIH grants R01AI053703, R01ES09098, R01AI058300, R01DA016545, R01HL058641 and P01AT003961. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.&lt;/p&gt;</code></p><p><code>1628</code><code>&lt;/div&gt;</code></p><p><code>1629</code><code>&lt;/div&gt;</code></p><p><code>1630</code><code>&lt;div id="GL" class="tsec sec"&gt;</code></p><p><code>1631</code><code>&lt;h2 class="head no_bottom_margin" id="GLtitle"&gt;</code></p><p><code>1632</code><code>Glossary&lt;/h2&gt;</code></p><p><code>1633</code><code>&lt;div class="bk-sec"&gt;</code></p><p><code>1634</code><code>&lt;div class="def-list"&gt;</code></p><p><code>1635</code><code>&lt;dl class="labeled-list"&gt;</code></p><p><code>1636</code><code>&lt;dt id="G1"&gt;</code></p><p><code>1637</code><code>Cannabinoids&lt;/dt&gt;</code></p><p><code>1638</code><code>&lt;dd&gt;</code></p><p><code>1639</code><code>Active components extracted from &lt;em&gt;</code></p><p><code>1640</code><code>Cannabis sativa&lt;/em&gt;</code></p><p><code>1641</code><code> that act through cannabinoid receptors&lt;/dd&gt;</code></p><p><code>1642</code><code>&lt;dt id="G2"&gt;</code></p><p><code>1643</code><code>Cannabinoid receptors&lt;/dt&gt;</code></p><p><code>1644</code><code>&lt;dd&gt;</code></p><p><code>1645</code><code>G-protein-coupled receptors that mediate the action of cannabinoids&lt;/dd&gt;</code></p><p><code>1646</code><code>&lt;dt id="G3"&gt;</code></p><p><code>1647</code><code>Cytokines&lt;/dt&gt;</code></p><p><code>1648</code><code>&lt;dd&gt;</code></p><p><code>1649</code><code>Signaling proteins synthesized and secreted by immune cells upon activation&lt;/dd&gt;</code></p><p><code>1650</code><code>&lt;dt id="G4"&gt;</code></p><p><code>1651</code><code>Autoimmune diseases&lt;/dt&gt;</code></p><p><code>1652</code><code>&lt;dd&gt;</code></p><p><code>1653</code><code>Disorders in which the immune system starts recognizing an individual&amp;#x02019;s own cells as foreign and mounts a reaction, leading to tissue injury&lt;/dd&gt;</code></p><p><code>1654</code><code>&lt;dt id="G5"&gt;</code></p><p><code>1655</code><code>Inflammation&lt;/dt&gt;</code></p><p><code>1656</code><code>&lt;dd&gt;</code></p><p><code>1657</code><code>A defense mechanism that results from the action of activated immune cells in response to foreign antigens. Sometimes, response to self antigens can trigger severe tissue injury&lt;/dd&gt;</code></p><p><code>1658</code><code>&lt;/dl&gt;</code></p><p><code>1659</code><code>&lt;/div&gt;</code></p><p><code>1660</code><code>&lt;/div&gt;</code></p><p><code>1661</code><code>&lt;/div&gt;</code></p><p><code>1662</code><code>&lt;div id="idm139818001861760" class="tsec sec"&gt;</code></p><p><code>1663</code><code>&lt;h2 class="head no_bottom_margin" id="idm139818001861760title"&gt;</code></p><p><code>1664</code><code>Footnotes&lt;/h2&gt;</code></p><p><code>1665</code><code>&lt;!--back/fn-group--&gt;</code></p><p><code>1666</code><code>&lt;div class="fm-sec half_rhythm small"&gt;</code></p><p><code>1667</code><code>&lt;p class="fn sec" id="FN3"&gt;</code></p><p><code>1668</code><code>&lt;p id="__p9" class="p p-first-last"&gt;</code></p><p><code>1669</code><code>For reprint orders, please contact &lt;a href="mailto:dev@null" data-email="moc.ecneicserutuf@stnirper" class="oemail"&gt;</code></p><p><code>1670</code><code>moc.ecneicserutuf@stnirper&lt;/a&gt;</code></p><p><code>1671</code><code>&lt;/p&gt;</code></p><p><code>1672</code><code>&lt;/p&gt;</code></p><p><code>1673</code><code>&lt;p class="fn sec" id="FN4"&gt;</code></p><p><code>1674</code><code>&lt;p id="__p10" class="p p-first"&gt;</code></p><p><code>1675</code><code>&lt;strong&gt;</code></p><p><code>1676</code><code>Financial &amp;#x00026; competing interests disclosure&lt;/strong&gt;</code></p><p><code>1677</code><code>&lt;/p&gt;</code></p><p><code>1678</code><code>&lt;p id="__p11" class="p p-last"&gt;</code></p><p><code>1679</code><code>No writing assistance was utilized in the production of this manuscript.&lt;/p&gt;</code></p><p><code>1680</code><code>&lt;/p&gt;</code></p><p><code>1681</code><code>&lt;/div&gt;</code></p><p><code>1682</code><code>&lt;/div&gt;</code></p><p><code>1683</code><code>&lt;div id="idm139818001478192" class="tsec sec"&gt;</code></p><p><code>1684</code><code>&lt;h2 class="head no_bottom_margin" id="idm139818001478192title"&gt;</code></p><p><code>1685</code><code>Bibliography&lt;/h2&gt;</code></p><p><code>1686</code><code>&lt;div class="ref-list-sec sec" id="reference-list"&gt;</code></p><p><code>1687</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R1"&gt;</code></p><p><code>1688</code><code>1. &lt;span class="citation"&gt;</code></p><p><code>1689</code><code>Guzman M. Cannabinoids: potential anticancer agents. &lt;span&gt;</code></p><p><code>1690</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1691</code><code>Nat Rev Cancer. &lt;/span&gt;</code></p><p><code>1692</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>1693</code><code>3&lt;/span&gt;</code></p><p><code>1694</code><code>:745–755.&lt;/span&gt;</code></p><p><code>1695</code><code> [&lt;a href="/pubmed/14570037" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1696</code><code>PubMed&lt;/a&gt;</code></p><p><code>1697</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1698</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;amp;title=Cannabinoids:+potential+anticancer+agents&amp;amp;author=M+Guzman&amp;amp;volume=3&amp;amp;publication_year=2003&amp;amp;pages=745-755&amp;amp;pmid=14570037&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1699</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1700</code><code>]&lt;/span&gt;</code></p><p><code>1701</code><code>&lt;/span&gt;</code></p><p><code>1702</code><code>&lt;/div&gt;</code></p><p><code>1703</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R2"&gt;</code></p><p><code>1704</code><code>2. &lt;span class="citation"&gt;</code></p><p><code>1705</code><code>Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. &lt;span&gt;</code></p><p><code>1706</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1707</code><code>CA Cancer J Clin. &lt;/span&gt;</code></p><p><code>1708</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>1709</code><code>52&lt;/span&gt;</code></p><p><code>1710</code><code>:72–91.&lt;/span&gt;</code></p><p><code>1711</code><code> [&lt;a href="/pubmed/11929007" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1712</code><code>PubMed&lt;/a&gt;</code></p><p><code>1713</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1714</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=CA+Cancer+J+Clin&amp;amp;title=Cancer+anorexia-cachexia+syndrome:+current+issues+in+research+and+management&amp;amp;author=A+Inui&amp;amp;volume=52&amp;amp;publication_year=2002&amp;amp;pages=72-91&amp;amp;pmid=11929007&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1715</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1716</code><code>]&lt;/span&gt;</code></p><p><code>1717</code><code>&lt;/span&gt;</code></p><p><code>1718</code><code>&lt;/div&gt;</code></p><p><code>1719</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R3"&gt;</code></p><p><code>1720</code><code>3. &lt;span class="citation"&gt;</code></p><p><code>1721</code><code>Pollmann W, Feneberg W. Current management of pain associated with multiple sclerosis. &lt;span&gt;</code></p><p><code>1722</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1723</code><code>CNS Drugs. &lt;/span&gt;</code></p><p><code>1724</code><code>2008;&lt;span class="ref-vol"&gt;</code></p><p><code>1725</code><code>22&lt;/span&gt;</code></p><p><code>1726</code><code>:291–324.&lt;/span&gt;</code></p><p><code>1727</code><code> [&lt;a href="/pubmed/18336059" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1728</code><code>PubMed&lt;/a&gt;</code></p><p><code>1729</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1730</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=CNS+Drugs&amp;amp;title=Current+management+of+pain+associated+with+multiple+sclerosis&amp;amp;author=W+Pollmann&amp;amp;author=W+Feneberg&amp;amp;volume=22&amp;amp;publication_year=2008&amp;amp;pages=291-324&amp;amp;pmid=18336059&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1731</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1732</code><code>]&lt;/span&gt;</code></p><p><code>1733</code><code>&lt;/span&gt;</code></p><p><code>1734</code><code>&lt;/div&gt;</code></p><p><code>1735</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R4"&gt;</code></p><p><code>1736</code><code>4. &lt;span class="citation"&gt;</code></p><p><code>1737</code><code>Tramer MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. &lt;span&gt;</code></p><p><code>1738</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1739</code><code>BMJ. &lt;/span&gt;</code></p><p><code>1740</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>1741</code><code>323&lt;/span&gt;</code></p><p><code>1742</code><code>:16–21.&lt;/span&gt;</code></p><p><code>1743</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>1744</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC34325/"&gt;</code></p><p><code>1745</code><code>PMC free article&lt;/a&gt;</code></p><p><code>1746</code><code>]&lt;/span&gt;</code></p><p><code>1747</code><code> [&lt;a href="/pubmed/11440936" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1748</code><code>PubMed&lt;/a&gt;</code></p><p><code>1749</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1750</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;amp;title=Cannabinoids+for+control+of+chemotherapy+induced+nausea+and+vomiting:+quantitative+systematic+review&amp;amp;author=MR+Tramer&amp;amp;author=D+Carroll&amp;amp;author=FA+Campbell&amp;amp;author=DJ+Reynolds&amp;amp;author=RA+Moore&amp;amp;volume=323&amp;amp;publication_year=2001&amp;amp;pages=16-21&amp;amp;pmid=11440936&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1751</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1752</code><code>]&lt;/span&gt;</code></p><p><code>1753</code><code>&lt;/span&gt;</code></p><p><code>1754</code><code>&lt;/div&gt;</code></p><p><code>1755</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R5"&gt;</code></p><p><code>1756</code><code>5. &lt;span class="citation"&gt;</code></p><p><code>1757</code><code>Croxford JL, Yamamura T. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? &lt;span&gt;</code></p><p><code>1758</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1759</code><code>J Neuroimmunol. &lt;/span&gt;</code></p><p><code>1760</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>1761</code><code>166&lt;/span&gt;</code></p><p><code>1762</code><code>:3–18.&lt;/span&gt;</code></p><p><code>1763</code><code> [&lt;a href="/pubmed/16023222" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1764</code><code>PubMed&lt;/a&gt;</code></p><p><code>1765</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1766</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neuroimmunol&amp;amp;title=Cannabinoids+and+the+immune+system:+potential+for+the+treatment+of+inflammatory+diseases?&amp;amp;author=JL+Croxford&amp;amp;author=T+Yamamura&amp;amp;volume=166&amp;amp;publication_year=2005&amp;amp;pages=3-18&amp;amp;pmid=16023222&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1767</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1768</code><code>]&lt;/span&gt;</code></p><p><code>1769</code><code>&lt;/span&gt;</code></p><p><code>1770</code><code>&lt;/div&gt;</code></p><p><code>1771</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R6"&gt;</code></p><p><code>1772</code><code>6. &lt;span class="citation"&gt;</code></p><p><code>1773</code><code>Mackie K. Cannabinoid receptors as therapeutic targets. &lt;span&gt;</code></p><p><code>1774</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1775</code><code>Annu Rev Pharmacol Toxicol. &lt;/span&gt;</code></p><p><code>1776</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>1777</code><code>46&lt;/span&gt;</code></p><p><code>1778</code><code>:101–122.&lt;/span&gt;</code></p><p><code>1779</code><code> [&lt;a href="/pubmed/16402900" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1780</code><code>PubMed&lt;/a&gt;</code></p><p><code>1781</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1782</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Pharmacol+Toxicol&amp;amp;title=Cannabinoid+receptors+as+therapeutic+targets&amp;amp;author=K+Mackie&amp;amp;volume=46&amp;amp;publication_year=2006&amp;amp;pages=101-122&amp;amp;pmid=16402900&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1783</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1784</code><code>]&lt;/span&gt;</code></p><p><code>1785</code><code>&lt;/span&gt;</code></p><p><code>1786</code><code>&lt;/div&gt;</code></p><p><code>1787</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R7"&gt;</code></p><p><code>1788</code><code>7. &lt;span class="citation"&gt;</code></p><p><code>1789</code><code>Stefano GB, Liu Y, Goligorsky MS. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. &lt;span&gt;</code></p><p><code>1790</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1791</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>1792</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>1793</code><code>271&lt;/span&gt;</code></p><p><code>1794</code><code>:19238–19242.&lt;/span&gt;</code></p><p><code>1795</code><code> [&lt;a href="/pubmed/8702604" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1796</code><code>PubMed&lt;/a&gt;</code></p><p><code>1797</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1798</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Cannabinoid+receptors+are+coupled+to+nitric+oxide+release+in+invertebrate+immunocytes,+microglia,+and+human+monocytes&amp;amp;author=GB+Stefano&amp;amp;author=Y+Liu&amp;amp;author=MS+Goligorsky&amp;amp;volume=271&amp;amp;publication_year=1996&amp;amp;pages=19238-19242&amp;amp;pmid=8702604&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1799</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1800</code><code>]&lt;/span&gt;</code></p><p><code>1801</code><code>&lt;/span&gt;</code></p><p><code>1802</code><code>&lt;/div&gt;</code></p><p><code>1803</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R8"&gt;</code></p><p><code>1804</code><code>8. &lt;span class="citation"&gt;</code></p><p><code>1805</code><code>Devane WA, Hanus L, Breuer A, et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. &lt;span&gt;</code></p><p><code>1806</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1807</code><code>Science. &lt;/span&gt;</code></p><p><code>1808</code><code>1992;&lt;span class="ref-vol"&gt;</code></p><p><code>1809</code><code>258&lt;/span&gt;</code></p><p><code>1810</code><code>:1946–1949.&lt;/span&gt;</code></p><p><code>1811</code><code> [&lt;a href="/pubmed/1470919" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1812</code><code>PubMed&lt;/a&gt;</code></p><p><code>1813</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1814</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;amp;title=Isolation+and+structure+of+a+brain+constituent+that+binds+to+the+cannabinoid+receptor&amp;amp;author=WA+Devane&amp;amp;author=L+Hanus&amp;amp;author=A+Breuer&amp;amp;volume=258&amp;amp;publication_year=1992&amp;amp;pages=1946-1949&amp;amp;pmid=1470919&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1815</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1816</code><code>]&lt;/span&gt;</code></p><p><code>1817</code><code>&lt;/span&gt;</code></p><p><code>1818</code><code>&lt;/div&gt;</code></p><p><code>1819</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R9"&gt;</code></p><p><code>1820</code><code>9. &lt;span class="citation"&gt;</code></p><p><code>1821</code><code>Mechoulam R, Ben-Shabat S, Hanus L, et al.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. &lt;span&gt;</code></p><p><code>1822</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1823</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>1824</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>1825</code><code>50&lt;/span&gt;</code></p><p><code>1826</code><code>:83–90.&lt;/span&gt;</code></p><p><code>1827</code><code> [&lt;a href="/pubmed/7605349" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1828</code><code>PubMed&lt;/a&gt;</code></p><p><code>1829</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1830</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=Identification+of+an+endogenous+2-monoglyceride,+present+in+canine+gut,+that+binds+to+cannabinoid+receptors&amp;amp;author=R+Mechoulam&amp;amp;author=S+Ben-Shabat&amp;amp;author=L+Hanus&amp;amp;volume=50&amp;amp;publication_year=1995&amp;amp;pages=83-90&amp;amp;pmid=7605349&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1831</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1832</code><code>]&lt;/span&gt;</code></p><p><code>1833</code><code>&lt;/span&gt;</code></p><p><code>1834</code><code>&lt;/div&gt;</code></p><p><code>1835</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R10"&gt;</code></p><p><code>1836</code><code>10. &lt;span class="citation"&gt;</code></p><p><code>1837</code><code>Sugiura T, Kondo S, Sukagawa A, et al.  2-arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. &lt;span&gt;</code></p><p><code>1838</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1839</code><code>Biochem Biophys Res Commun. &lt;/span&gt;</code></p><p><code>1840</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>1841</code><code>215&lt;/span&gt;</code></p><p><code>1842</code><code>:89–97.&lt;/span&gt;</code></p><p><code>1843</code><code> [&lt;a href="/pubmed/7575630" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1844</code><code>PubMed&lt;/a&gt;</code></p><p><code>1845</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1846</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;amp;title=2-arachidonoylglycerol:+a+possible+endogenous+cannabinoid+receptor+ligand+in+brain&amp;amp;author=T+Sugiura&amp;amp;author=S+Kondo&amp;amp;author=A+Sukagawa&amp;amp;volume=215&amp;amp;publication_year=1995&amp;amp;pages=89-97&amp;amp;pmid=7575630&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1847</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1848</code><code>]&lt;/span&gt;</code></p><p><code>1849</code><code>&lt;/span&gt;</code></p><p><code>1850</code><code>&lt;/div&gt;</code></p><p><code>1851</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R11"&gt;</code></p><p><code>1852</code><code>11. &lt;span class="citation"&gt;</code></p><p><code>1853</code><code>Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. &lt;span&gt;</code></p><p><code>1854</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1855</code><code>Nature. &lt;/span&gt;</code></p><p><code>1856</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>1857</code><code>384&lt;/span&gt;</code></p><p><code>1858</code><code>:83–87.&lt;/span&gt;</code></p><p><code>1859</code><code> [&lt;a href="/pubmed/8900284" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1860</code><code>PubMed&lt;/a&gt;</code></p><p><code>1861</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1862</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;amp;title=Molecular+characterization+of+an+enzyme+that+degrades+neuromodulatory+fatty-acid+amides&amp;amp;author=BF+Cravatt&amp;amp;author=DK+Giang&amp;amp;author=SP+Mayfield&amp;amp;author=DL+Boger&amp;amp;author=RA+Lerner&amp;amp;volume=384&amp;amp;publication_year=1996&amp;amp;pages=83-87&amp;amp;pmid=8900284&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1863</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1864</code><code>]&lt;/span&gt;</code></p><p><code>1865</code><code>&lt;/span&gt;</code></p><p><code>1866</code><code>&lt;/div&gt;</code></p><p><code>1867</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R12"&gt;</code></p><p><code>1868</code><code>12. &lt;span class="citation"&gt;</code></p><p><code>1869</code><code>Kaczocha M, Glaser ST, Deutsch DG. Identification of intracellular carriers for the endocannabinoid anandamide. &lt;span&gt;</code></p><p><code>1870</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1871</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>1872</code><code>2009;&lt;span class="ref-vol"&gt;</code></p><p><code>1873</code><code>106&lt;/span&gt;</code></p><p><code>1874</code><code>:6375–6380.&lt;/span&gt;</code></p><p><code>1875</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>1876</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2669397/"&gt;</code></p><p><code>1877</code><code>PMC free article&lt;/a&gt;</code></p><p><code>1878</code><code>]&lt;/span&gt;</code></p><p><code>1879</code><code> [&lt;a href="/pubmed/19307565" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1880</code><code>PubMed&lt;/a&gt;</code></p><p><code>1881</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1882</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Identification+of+intracellular+carriers+for+the+endocannabinoid+anandamide&amp;amp;author=M+Kaczocha&amp;amp;author=ST+Glaser&amp;amp;author=DG+Deutsch&amp;amp;volume=106&amp;amp;publication_year=2009&amp;amp;pages=6375-6380&amp;amp;pmid=19307565&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1883</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1884</code><code>]&lt;/span&gt;</code></p><p><code>1885</code><code>&lt;/span&gt;</code></p><p><code>1886</code><code>&lt;/div&gt;</code></p><p><code>1887</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R13"&gt;</code></p><p><code>1888</code><code>13. &lt;span class="citation"&gt;</code></p><p><code>1889</code><code>Rodriguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M. The endocannabinoid system: physiology and pharmacology. &lt;span&gt;</code></p><p><code>1890</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1891</code><code>Alcohol Alcoholism. &lt;/span&gt;</code></p><p><code>1892</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>1893</code><code>40&lt;/span&gt;</code></p><p><code>1894</code><code>:2–14.&lt;/span&gt;</code></p><p><code>1895</code><code> [&lt;a href="/pubmed/15550444" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1896</code><code>PubMed&lt;/a&gt;</code></p><p><code>1897</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1898</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Alcohol+Alcoholism&amp;amp;title=The+endocannabinoid+system:+physiology+and+pharmacology&amp;amp;author=F+Rodriguez+de+Fonseca&amp;amp;author=I+Del+Arco&amp;amp;author=FJ+Bermudez-Silva&amp;amp;author=A+Bilbao&amp;amp;author=A+Cippitelli&amp;amp;volume=40&amp;amp;publication_year=2005&amp;amp;pages=2-14&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1899</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1900</code><code>]&lt;/span&gt;</code></p><p><code>1901</code><code>&lt;/span&gt;</code></p><p><code>1902</code><code>&lt;/div&gt;</code></p><p><code>1903</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R14"&gt;</code></p><p><code>1904</code><code>14. &lt;span class="citation"&gt;</code></p><p><code>1905</code><code>Hengartner MO. The biochemistry of apoptosis. &lt;span&gt;</code></p><p><code>1906</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1907</code><code>Nature. &lt;/span&gt;</code></p><p><code>1908</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>1909</code><code>407&lt;/span&gt;</code></p><p><code>1910</code><code>:770–776.&lt;/span&gt;</code></p><p><code>1911</code><code> [&lt;a href="/pubmed/11048727" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1912</code><code>PubMed&lt;/a&gt;</code></p><p><code>1913</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1914</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;amp;title=The+biochemistry+of+apoptosis&amp;amp;author=MO+Hengartner&amp;amp;volume=407&amp;amp;publication_year=2000&amp;amp;pages=770-776&amp;amp;pmid=11048727&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1915</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1916</code><code>]&lt;/span&gt;</code></p><p><code>1917</code><code>&lt;/span&gt;</code></p><p><code>1918</code><code>&lt;/div&gt;</code></p><p><code>1919</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R15"&gt;</code></p><p><code>1920</code><code>15. &lt;span class="citation"&gt;</code></p><p><code>1921</code><code>Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. &lt;span&gt;</code></p><p><code>1922</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1923</code><code>Nat Rev Cancer. &lt;/span&gt;</code></p><p><code>1924</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>1925</code><code>2&lt;/span&gt;</code></p><p><code>1926</code><code>:277–288.&lt;/span&gt;</code></p><p><code>1927</code><code> [&lt;a href="/pubmed/12001989" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1928</code><code>PubMed&lt;/a&gt;</code></p><p><code>1929</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1930</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;amp;title=Death+and+anti-death:+tumour+resistance+to+apoptosis&amp;amp;author=FH+Igney&amp;amp;author=PH+Krammer&amp;amp;volume=2&amp;amp;publication_year=2002&amp;amp;pages=277-288&amp;amp;pmid=12001989&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1931</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1932</code><code>]&lt;/span&gt;</code></p><p><code>1933</code><code>&lt;/span&gt;</code></p><p><code>1934</code><code>&lt;/div&gt;</code></p><p><code>1935</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R16"&gt;</code></p><p><code>1936</code><code>16. &lt;span class="citation"&gt;</code></p><p><code>1937</code><code>Zhu W, Friedman H, Klein TW. &amp;#x00394;9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1. &lt;span&gt;</code></p><p><code>1938</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1939</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>1940</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>1941</code><code>286&lt;/span&gt;</code></p><p><code>1942</code><code>:1103–1109.&lt;/span&gt;</code></p><p><code>1943</code><code> [&lt;a href="/pubmed/9694974" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1944</code><code>PubMed&lt;/a&gt;</code></p><p><code>1945</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1946</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=&amp;#x00394;9-tetrahydrocannabinol+induces+apoptosis+in+macrophages+and+lymphocytes:+involvement+of+Bcl-2+and+caspase-1&amp;amp;author=W+Zhu&amp;amp;author=H+Friedman&amp;amp;author=TW+Klein&amp;amp;volume=286&amp;amp;publication_year=1998&amp;amp;pages=1103-1109&amp;amp;pmid=9694974&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1947</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1948</code><code>]&lt;/span&gt;</code></p><p><code>1949</code><code>&lt;/span&gt;</code></p><p><code>1950</code><code>&lt;/div&gt;</code></p><p><code>1951</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R17"&gt;</code></p><p><code>1952</code><code>17. &lt;span class="citation"&gt;</code></p><p><code>1953</code><code>McKallip RJ, Lombard C, Martin BR, Nagarkatti M, Nagarkatti PS. &amp;#x00394;(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression &lt;em&gt;</code></p><p><code>1954</code><code>in vitro&lt;/em&gt;</code></p><p><code>1955</code><code> and &lt;em&gt;</code></p><p><code>1956</code><code>in vivo&lt;/em&gt;</code></p><p><code>1957</code><code>. &lt;span&gt;</code></p><p><code>1958</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1959</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>1960</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>1961</code><code>302&lt;/span&gt;</code></p><p><code>1962</code><code>:451–465.&lt;/span&gt;</code></p><p><code>1963</code><code> [&lt;a href="/pubmed/12130702" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1964</code><code>PubMed&lt;/a&gt;</code></p><p><code>1965</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1966</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=&amp;#x00394;(9)-tetrahydrocannabinol-induced+apoptosis+in+the+thymus+and+spleen+as+a+mechanism+of+immunosuppression+in+vitro+and+in+vivo&amp;amp;author=RJ+McKallip&amp;amp;author=C+Lombard&amp;amp;author=BR+Martin&amp;amp;author=M+Nagarkatti&amp;amp;author=PS+Nagarkatti&amp;amp;volume=302&amp;amp;publication_year=2002&amp;amp;pages=451-465&amp;amp;pmid=12130702&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1967</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1968</code><code>]&lt;/span&gt;</code></p><p><code>1969</code><code>&lt;/span&gt;</code></p><p><code>1970</code><code>&lt;/div&gt;</code></p><p><code>1971</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R18"&gt;</code></p><p><code>1972</code><code>18. &lt;span class="citation"&gt;</code></p><p><code>1973</code><code>Do Y, McKallip RJ, Nagarkatti M, Nagarkatti PS. Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-&amp;#x003ba;B-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation. &lt;span&gt;</code></p><p><code>1974</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1975</code><code>J Immunol. &lt;/span&gt;</code></p><p><code>1976</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>1977</code><code>173&lt;/span&gt;</code></p><p><code>1978</code><code>:2373–2382.&lt;/span&gt;</code></p><p><code>1979</code><code> [&lt;a href="/pubmed/15294950" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1980</code><code>PubMed&lt;/a&gt;</code></p><p><code>1981</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>1982</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;amp;title=Activation+through+cannabinoid+receptors+1+and+2+on+dendritic+cells+triggers+NF-&amp;#x003ba;B-dependent+apoptosis:+novel+role+for+endogenous+and+exogenous+cannabinoids+in+immunoregulation&amp;amp;author=Y+Do&amp;amp;author=RJ+McKallip&amp;amp;author=M+Nagarkatti&amp;amp;author=PS+Nagarkatti&amp;amp;volume=173&amp;amp;publication_year=2004&amp;amp;pages=2373-2382&amp;amp;pmid=15294950&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>1983</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>1984</code><code>]&lt;/span&gt;</code></p><p><code>1985</code><code>&lt;/span&gt;</code></p><p><code>1986</code><code>&lt;/div&gt;</code></p><p><code>1987</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R19"&gt;</code></p><p><code>1988</code><code>19. &lt;span class="citation"&gt;</code></p><p><code>1989</code><code>Lu T, Newton C, Perkins I, Friedman H, Klein TW. Cannabinoid treatment suppresses the T-helper cell-polarizing function of mouse dendritic cells stimulated with &lt;em&gt;</code></p><p><code>1990</code><code>Legionella pneumophila&lt;/em&gt;</code></p><p><code>1991</code><code> infection. &lt;span&gt;</code></p><p><code>1992</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>1993</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>1994</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>1995</code><code>319&lt;/span&gt;</code></p><p><code>1996</code><code>:269–276.&lt;/span&gt;</code></p><p><code>1997</code><code> [&lt;a href="/pubmed/16837556" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>1998</code><code>PubMed&lt;/a&gt;</code></p><p><code>1999</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2000</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Cannabinoid+treatment+suppresses+the+T-helper+cell-polarizing+function+of+mouse+dendritic+cells+stimulated+with+Legionella+pneumophila+infection&amp;amp;author=T+Lu&amp;amp;author=C+Newton&amp;amp;author=I+Perkins&amp;amp;author=H+Friedman&amp;amp;author=TW+Klein&amp;amp;volume=319&amp;amp;publication_year=2006&amp;amp;pages=269-276&amp;amp;pmid=16837556&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2001</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2002</code><code>]&lt;/span&gt;</code></p><p><code>2003</code><code>&lt;/span&gt;</code></p><p><code>2004</code><code>&lt;/div&gt;</code></p><p><code>2005</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R20"&gt;</code></p><p><code>2006</code><code>20. &lt;span class="citation"&gt;</code></p><p><code>2007</code><code>Lee CY, Wey SP, Liao MH, et al.  A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells. &lt;span&gt;</code></p><p><code>2008</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2009</code><code>Int Immunopharmacol. &lt;/span&gt;</code></p><p><code>2010</code><code>2008;&lt;span class="ref-vol"&gt;</code></p><p><code>2011</code><code>8&lt;/span&gt;</code></p><p><code>2012</code><code>:732–740.&lt;/span&gt;</code></p><p><code>2013</code><code> [&lt;a href="/pubmed/18387516" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2014</code><code>PubMed&lt;/a&gt;</code></p><p><code>2015</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2016</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+Immunopharmacol&amp;amp;title=A+comparative+study+on+cannabidiol-induced+apoptosis+in+murine+thymocytes+and+EL-4+thymoma+cells&amp;amp;author=CY+Lee&amp;amp;author=SP+Wey&amp;amp;author=MH+Liao&amp;amp;volume=8&amp;amp;publication_year=2008&amp;amp;pages=732-740&amp;amp;pmid=18387516&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2017</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2018</code><code>]&lt;/span&gt;</code></p><p><code>2019</code><code>&lt;/span&gt;</code></p><p><code>2020</code><code>&lt;/div&gt;</code></p><p><code>2021</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R21"&gt;</code></p><p><code>2022</code><code>21. &lt;span class="citation"&gt;</code></p><p><code>2023</code><code>Bidinger B, Torres R, Rossetti RG, et al.  Ajulemic acid, a nonpsychoactive cannabinoid acid, induces apoptosis in human T lymphocytes. &lt;span&gt;</code></p><p><code>2024</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2025</code><code>Clin Immunol. &lt;/span&gt;</code></p><p><code>2026</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>2027</code><code>108&lt;/span&gt;</code></p><p><code>2028</code><code>:95–102.&lt;/span&gt;</code></p><p><code>2029</code><code> [&lt;a href="/pubmed/12921755" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2030</code><code>PubMed&lt;/a&gt;</code></p><p><code>2031</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2032</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Immunol&amp;amp;title=Ajulemic+acid,+a+nonpsychoactive+cannabinoid+acid,+induces+apoptosis+in+human+T+lymphocytes&amp;amp;author=B+Bidinger&amp;amp;author=R+Torres&amp;amp;author=RG+Rossetti&amp;amp;volume=108&amp;amp;publication_year=2003&amp;amp;pages=95-102&amp;amp;pmid=12921755&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2033</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2034</code><code>]&lt;/span&gt;</code></p><p><code>2035</code><code>&lt;/span&gt;</code></p><p><code>2036</code><code>&lt;/div&gt;</code></p><p><code>2037</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R22"&gt;</code></p><p><code>2038</code><code>22. &lt;span class="citation"&gt;</code></p><p><code>2039</code><code>Lombard C, Nagarkatti M, Nagarkatti P. CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents. &lt;span&gt;</code></p><p><code>2040</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2041</code><code>Clin Immunol. &lt;/span&gt;</code></p><p><code>2042</code><code>2007;&lt;span class="ref-vol"&gt;</code></p><p><code>2043</code><code>122&lt;/span&gt;</code></p><p><code>2044</code><code>:259–270.&lt;/span&gt;</code></p><p><code>2045</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>2046</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1864948/"&gt;</code></p><p><code>2047</code><code>PMC free article&lt;/a&gt;</code></p><p><code>2048</code><code>]&lt;/span&gt;</code></p><p><code>2049</code><code> [&lt;a href="/pubmed/17185040" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2050</code><code>PubMed&lt;/a&gt;</code></p><p><code>2051</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2052</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Immunol&amp;amp;title=CB2+cannabinoid+receptor+agonist,+JWH-015,+triggers+apoptosis+in+immune+cells:+potential+role+for+CB2-selective+ligands+as+immunosuppressive+agents&amp;amp;author=C+Lombard&amp;amp;author=M+Nagarkatti&amp;amp;author=P+Nagarkatti&amp;amp;volume=122&amp;amp;publication_year=2007&amp;amp;pages=259-270&amp;amp;pmid=17185040&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2053</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2054</code><code>]&lt;/span&gt;</code></p><p><code>2055</code><code>&lt;/span&gt;</code></p><p><code>2056</code><code>&lt;/div&gt;</code></p><p><code>2057</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R23"&gt;</code></p><p><code>2058</code><code>23. &lt;span class="citation"&gt;</code></p><p><code>2059</code><code>Molina-Holgado F, Molina-Holgado E, Guaza C, Rothwell NJ. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures. &lt;span&gt;</code></p><p><code>2060</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2061</code><code>J Neurosci Res. &lt;/span&gt;</code></p><p><code>2062</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>2063</code><code>67&lt;/span&gt;</code></p><p><code>2064</code><code>:829–836.&lt;/span&gt;</code></p><p><code>2065</code><code> [&lt;a href="/pubmed/11891798" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2066</code><code>PubMed&lt;/a&gt;</code></p><p><code>2067</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2068</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci+Res&amp;amp;title=Role+of+CB1+and+CB2+receptors+in+the+inhibitory+effects+of+cannabinoids+on+lipopolysaccharide-induced+nitric+oxide+release+in+astrocyte+cultures&amp;amp;author=F+Molina-Holgado&amp;amp;author=E+Molina-Holgado&amp;amp;author=C+Guaza&amp;amp;author=NJ+Rothwell&amp;amp;volume=67&amp;amp;publication_year=2002&amp;amp;pages=829-836&amp;amp;pmid=11891798&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2069</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2070</code><code>]&lt;/span&gt;</code></p><p><code>2071</code><code>&lt;/span&gt;</code></p><p><code>2072</code><code>&lt;/div&gt;</code></p><p><code>2073</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R24"&gt;</code></p><p><code>2074</code><code>24. &lt;span class="citation"&gt;</code></p><p><code>2075</code><code>Croxford JL, Pryce G, Jackson SJ, et al.  Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis. &lt;span&gt;</code></p><p><code>2076</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2077</code><code>J Neuroimmunol. &lt;/span&gt;</code></p><p><code>2078</code><code>2008;&lt;span class="ref-vol"&gt;</code></p><p><code>2079</code><code>193&lt;/span&gt;</code></p><p><code>2080</code><code>:120–129.&lt;/span&gt;</code></p><p><code>2081</code><code> [&lt;a href="/pubmed/18037503" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2082</code><code>PubMed&lt;/a&gt;</code></p><p><code>2083</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2084</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neuroimmunol&amp;amp;title=Cannabinoid-mediated+neuroprotection,+not+immunosuppression,+may+be+more+relevant+to+multiple+sclerosis&amp;amp;author=JL+Croxford&amp;amp;author=G+Pryce&amp;amp;author=SJ+Jackson&amp;amp;volume=193&amp;amp;publication_year=2008&amp;amp;pages=120-129&amp;amp;pmid=18037503&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2085</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2086</code><code>]&lt;/span&gt;</code></p><p><code>2087</code><code>&lt;/span&gt;</code></p><p><code>2088</code><code>&lt;/div&gt;</code></p><p><code>2089</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R25"&gt;</code></p><p><code>2090</code><code>25. &lt;span class="citation"&gt;</code></p><p><code>2091</code><code>Klein TW, Newton CA, Nakachi N, Friedman H. &amp;#x00394;9-tetrahydrocannabinol treatment suppresses immunity and early IFN-&amp;#x003b3;, IL-12, and IL-12 receptor &amp;#x003b2; 2 responses to &lt;em&gt;</code></p><p><code>2092</code><code>Legionella pneumophila&lt;/em&gt;</code></p><p><code>2093</code><code> infection. &lt;span&gt;</code></p><p><code>2094</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2095</code><code>J Immunol. &lt;/span&gt;</code></p><p><code>2096</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>2097</code><code>164&lt;/span&gt;</code></p><p><code>2098</code><code>:6461–6466.&lt;/span&gt;</code></p><p><code>2099</code><code> [&lt;a href="/pubmed/10843702" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2100</code><code>PubMed&lt;/a&gt;</code></p><p><code>2101</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2102</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;amp;title=&amp;#x00394;9-tetrahydrocannabinol+treatment+suppresses+immunity+and+early+IFN-&amp;#x003b3;,+IL-12,+and+IL-12+receptor+&amp;#x003b2;+2+responses+to+Legionella+pneumophila+infection&amp;amp;author=TW+Klein&amp;amp;author=CA+Newton&amp;amp;author=N+Nakachi&amp;amp;author=H+Friedman&amp;amp;volume=164&amp;amp;publication_year=2000&amp;amp;pages=6461-6466&amp;amp;pmid=10843702&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2103</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2104</code><code>]&lt;/span&gt;</code></p><p><code>2105</code><code>&lt;/span&gt;</code></p><p><code>2106</code><code>&lt;/div&gt;</code></p><p><code>2107</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R26"&gt;</code></p><p><code>2108</code><code>26. &lt;span class="citation"&gt;</code></p><p><code>2109</code><code>Srivastava MD, Srivastava BI, Brouhard B. &amp;#x00394;9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. &lt;span&gt;</code></p><p><code>2110</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2111</code><code>Immunopharmacology. &lt;/span&gt;</code></p><p><code>2112</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>2113</code><code>40&lt;/span&gt;</code></p><p><code>2114</code><code>:179–185.&lt;/span&gt;</code></p><p><code>2115</code><code> [&lt;a href="/pubmed/9858061" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2116</code><code>PubMed&lt;/a&gt;</code></p><p><code>2117</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2118</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Immunopharmacology&amp;amp;title=&amp;#x00394;9+tetrahydrocannabinol+and+cannabidiol+alter+cytokine+production+by+human+immune+cells&amp;amp;author=MD+Srivastava&amp;amp;author=BI+Srivastava&amp;amp;author=B+Brouhard&amp;amp;volume=40&amp;amp;publication_year=1998&amp;amp;pages=179-185&amp;amp;pmid=9858061&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2119</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2120</code><code>]&lt;/span&gt;</code></p><p><code>2121</code><code>&lt;/span&gt;</code></p><p><code>2122</code><code>&lt;/div&gt;</code></p><p><code>2123</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R27"&gt;</code></p><p><code>2124</code><code>27. &lt;span class="citation"&gt;</code></p><p><code>2125</code><code>Derocq JM, Jbilo O, Bouaboula M, Segui M, Clere C, Casellas P. Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation. &lt;span&gt;</code></p><p><code>2126</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2127</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>2128</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>2129</code><code>275&lt;/span&gt;</code></p><p><code>2130</code><code>:15621–15628.&lt;/span&gt;</code></p><p><code>2131</code><code> [&lt;a href="/pubmed/10821843" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2132</code><code>PubMed&lt;/a&gt;</code></p><p><code>2133</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2134</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Genomic+and+functional+changes+induced+by+the+activation+of+the+peripheral+cannabinoid+receptor+CB2+in+the+promyelocytic+cells+HL-60.+Possible+involvement+of+the+CB2+receptor+in+cell+differentiation&amp;amp;author=JM+Derocq&amp;amp;author=O+Jbilo&amp;amp;author=M+Bouaboula&amp;amp;author=M+Segui&amp;amp;author=C+Clere&amp;amp;volume=275&amp;amp;publication_year=2000&amp;amp;pages=15621-15628&amp;amp;pmid=10821843&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2135</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2136</code><code>]&lt;/span&gt;</code></p><p><code>2137</code><code>&lt;/span&gt;</code></p><p><code>2138</code><code>&lt;/div&gt;</code></p><p><code>2139</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R28"&gt;</code></p><p><code>2140</code><code>28. &lt;span class="citation"&gt;</code></p><p><code>2141</code><code>Puffenbarger RA, Boothe AC, Cabral GA. Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. &lt;span&gt;</code></p><p><code>2142</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2143</code><code>Glia. &lt;/span&gt;</code></p><p><code>2144</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>2145</code><code>29&lt;/span&gt;</code></p><p><code>2146</code><code>:58–69.&lt;/span&gt;</code></p><p><code>2147</code><code> [&lt;a href="/pubmed/10594923" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2148</code><code>PubMed&lt;/a&gt;</code></p><p><code>2149</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2150</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Glia&amp;amp;title=Cannabinoids+inhibit+LPS-inducible+cytokine+mRNA+expression+in+rat+microglial+cells&amp;amp;author=RA+Puffenbarger&amp;amp;author=AC+Boothe&amp;amp;author=GA+Cabral&amp;amp;volume=29&amp;amp;publication_year=2000&amp;amp;pages=58-69&amp;amp;pmid=10594923&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2151</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2152</code><code>]&lt;/span&gt;</code></p><p><code>2153</code><code>&lt;/span&gt;</code></p><p><code>2154</code><code>&lt;/div&gt;</code></p><p><code>2155</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R29"&gt;</code></p><p><code>2156</code><code>29. &lt;span class="citation"&gt;</code></p><p><code>2157</code><code>Smith SR, Terminelli C, Denhardt G. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice. &lt;span&gt;</code></p><p><code>2158</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2159</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>2160</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>2161</code><code>293&lt;/span&gt;</code></p><p><code>2162</code><code>:136–150.&lt;/span&gt;</code></p><p><code>2163</code><code> [&lt;a href="/pubmed/10734163" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2164</code><code>PubMed&lt;/a&gt;</code></p><p><code>2165</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2166</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Effects+of+cannabinoid+receptor+agonist+and+antagonist+ligands+on+production+of+inflammatory+cytokines+and+anti-inflammatory+interleukin-10+in+endotoxemic+mice&amp;amp;author=SR+Smith&amp;amp;author=C+Terminelli&amp;amp;author=G+Denhardt&amp;amp;volume=293&amp;amp;publication_year=2000&amp;amp;pages=136-150&amp;amp;pmid=10734163&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2167</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2168</code><code>]&lt;/span&gt;</code></p><p><code>2169</code><code>&lt;/span&gt;</code></p><p><code>2170</code><code>&lt;/div&gt;</code></p><p><code>2171</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R30"&gt;</code></p><p><code>2172</code><code>30. &lt;span class="citation"&gt;</code></p><p><code>2173</code><code>Smolen JS, Maini RN. Interleukin-6: a new therapeutic target. &lt;span&gt;</code></p><p><code>2174</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2175</code><code>Arthritis Res Ther. &lt;/span&gt;</code></p><p><code>2176</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>2177</code><code>8&lt;/span&gt;</code></p><p><code>2178</code><code>(Suppl. 2):S5.&lt;/span&gt;</code></p><p><code>2179</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>2180</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC3226077/"&gt;</code></p><p><code>2181</code><code>PMC free article&lt;/a&gt;</code></p><p><code>2182</code><code>]&lt;/span&gt;</code></p><p><code>2183</code><code> [&lt;a href="/pubmed/16899109" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2184</code><code>PubMed&lt;/a&gt;</code></p><p><code>2185</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2186</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Res+Ther&amp;amp;title=Interleukin-6:+a+new+therapeutic+target&amp;amp;author=JS+Smolen&amp;amp;author=RN+Maini&amp;amp;volume=8&amp;amp;issue=Suppl.+2&amp;amp;publication_year=2006&amp;amp;pages=S5&amp;amp;pmid=16899109&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2187</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2188</code><code>]&lt;/span&gt;</code></p><p><code>2189</code><code>&lt;/span&gt;</code></p><p><code>2190</code><code>&lt;/div&gt;</code></p><p><code>2191</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R31"&gt;</code></p><p><code>2192</code><code>31. &lt;span class="citation"&gt;</code></p><p><code>2193</code><code>Zurier RB, Rossetti RG, Lane JH, Goldberg JM, Hunter SA, Burstein SH. Dimethylheptyl-THC-11 oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure. &lt;span&gt;</code></p><p><code>2194</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2195</code><code>Arthritis Rheum. &lt;/span&gt;</code></p><p><code>2196</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>2197</code><code>41&lt;/span&gt;</code></p><p><code>2198</code><code>:163–170.&lt;/span&gt;</code></p><p><code>2199</code><code> [&lt;a href="/pubmed/9433882" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2200</code><code>PubMed&lt;/a&gt;</code></p><p><code>2201</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2202</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;amp;title=Dimethylheptyl-THC-11+oic+acid:+a+nonpsychoactive+antiinflammatory+agent+with+a+cannabinoid+template+structure&amp;amp;author=RB+Zurier&amp;amp;author=RG+Rossetti&amp;amp;author=JH+Lane&amp;amp;author=JM+Goldberg&amp;amp;author=SA+Hunter&amp;amp;volume=41&amp;amp;publication_year=1998&amp;amp;pages=163-170&amp;amp;pmid=9433882&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2203</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2204</code><code>]&lt;/span&gt;</code></p><p><code>2205</code><code>&lt;/span&gt;</code></p><p><code>2206</code><code>&lt;/div&gt;</code></p><p><code>2207</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R32"&gt;</code></p><p><code>2208</code><code>32. &lt;span class="citation"&gt;</code></p><p><code>2209</code><code>Parker J, Atez F, Rossetti RG, Skulas A, Patel R, Zurier RB. Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid. &lt;span&gt;</code></p><p><code>2210</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2211</code><code>Rheumatol Int. &lt;/span&gt;</code></p><p><code>2212</code><code>2008;&lt;span class="ref-vol"&gt;</code></p><p><code>2213</code><code>28&lt;/span&gt;</code></p><p><code>2214</code><code>:631–635.&lt;/span&gt;</code></p><p><code>2215</code><code> [&lt;a href="/pubmed/18040689" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2216</code><code>PubMed&lt;/a&gt;</code></p><p><code>2217</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2218</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Rheumatol+Int&amp;amp;title=Suppression+of+human+macrophage+interleukin-6+by+a+nonpsychoactive+cannabinoid+acid&amp;amp;author=J+Parker&amp;amp;author=F+Atez&amp;amp;author=RG+Rossetti&amp;amp;author=A+Skulas&amp;amp;author=R+Patel&amp;amp;volume=28&amp;amp;publication_year=2008&amp;amp;pages=631-635&amp;amp;pmid=18040689&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2219</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2220</code><code>]&lt;/span&gt;</code></p><p><code>2221</code><code>&lt;/span&gt;</code></p><p><code>2222</code><code>&lt;/div&gt;</code></p><p><code>2223</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R33"&gt;</code></p><p><code>2224</code><code>33. &lt;span class="citation"&gt;</code></p><p><code>2225</code><code>Rajesh M, Pan H, Mukhopadhyay P, et al.  Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. &lt;span&gt;</code></p><p><code>2226</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2227</code><code>J Leukoc Biol. &lt;/span&gt;</code></p><p><code>2228</code><code>2007;&lt;span class="ref-vol"&gt;</code></p><p><code>2229</code><code>82&lt;/span&gt;</code></p><p><code>2230</code><code>:1382–1389.&lt;/span&gt;</code></p><p><code>2231</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>2232</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2225476/"&gt;</code></p><p><code>2233</code><code>PMC free article&lt;/a&gt;</code></p><p><code>2234</code><code>]&lt;/span&gt;</code></p><p><code>2235</code><code> [&lt;a href="/pubmed/17652447" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2236</code><code>PubMed&lt;/a&gt;</code></p><p><code>2237</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2238</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Leukoc+Biol&amp;amp;title=Cannabinoid-2+receptor+agonist+HU-308+protects+against+hepatic+ischemia/reperfusion+injury+by+attenuating+oxidative+stress,+inflammatory+response,+and+apoptosis&amp;amp;author=M+Rajesh&amp;amp;author=H+Pan&amp;amp;author=P+Mukhopadhyay&amp;amp;volume=82&amp;amp;publication_year=2007&amp;amp;pages=1382-1389&amp;amp;pmid=17652447&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2239</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2240</code><code>]&lt;/span&gt;</code></p><p><code>2241</code><code>&lt;/span&gt;</code></p><p><code>2242</code><code>&lt;/div&gt;</code></p><p><code>2243</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R34"&gt;</code></p><p><code>2244</code><code>34. &lt;span class="citation"&gt;</code></p><p><code>2245</code><code>Selvi E, Lorenzini S, Garcia-Gonzalez E, et al.  Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes. &lt;span&gt;</code></p><p><code>2246</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2247</code><code>Clin Exp Rheumatol. &lt;/span&gt;</code></p><p><code>2248</code><code>2008;&lt;span class="ref-vol"&gt;</code></p><p><code>2249</code><code>26&lt;/span&gt;</code></p><p><code>2250</code><code>:574–581.&lt;/span&gt;</code></p><p><code>2251</code><code> [&lt;a href="/pubmed/18799087" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2252</code><code>PubMed&lt;/a&gt;</code></p><p><code>2253</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2254</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Rheumatol&amp;amp;title=Inhibitory+effect+of+synthetic+cannabinoids+on+cytokine+production+in+rheumatoid+fibroblast-like+synoviocytes&amp;amp;author=E+Selvi&amp;amp;author=S+Lorenzini&amp;amp;author=E+Garcia-Gonzalez&amp;amp;volume=26&amp;amp;publication_year=2008&amp;amp;pages=574-581&amp;amp;pmid=18799087&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2255</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2256</code><code>]&lt;/span&gt;</code></p><p><code>2257</code><code>&lt;/span&gt;</code></p><p><code>2258</code><code>&lt;/div&gt;</code></p><p><code>2259</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R35"&gt;</code></p><p><code>2260</code><code>35. &lt;span class="citation"&gt;</code></p><p><code>2261</code><code>Valk P, Verbakel S, Vankan Y, et al.  Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells. &lt;span&gt;</code></p><p><code>2262</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2263</code><code>Blood. &lt;/span&gt;</code></p><p><code>2264</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>2265</code><code>90&lt;/span&gt;</code></p><p><code>2266</code><code>:1448–1457.&lt;/span&gt;</code></p><p><code>2267</code><code> [&lt;a href="/pubmed/9269762" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2268</code><code>PubMed&lt;/a&gt;</code></p><p><code>2269</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2270</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;amp;title=Anandamide,+a+natural+ligand+for+the+peripheral+cannabinoid+receptor+is+a+novel+synergistic+growth+factor+for+hematopoietic+cells&amp;amp;author=P+Valk&amp;amp;author=S+Verbakel&amp;amp;author=Y+Vankan&amp;amp;volume=90&amp;amp;publication_year=1997&amp;amp;pages=1448-1457&amp;amp;pmid=9269762&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2271</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2272</code><code>]&lt;/span&gt;</code></p><p><code>2273</code><code>&lt;/span&gt;</code></p><p><code>2274</code><code>&lt;/div&gt;</code></p><p><code>2275</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R36"&gt;</code></p><p><code>2276</code><code>36. &lt;span class="citation"&gt;</code></p><p><code>2277</code><code>Rockwell CE, Snider NT, Thompson JT, Vanden Heuvel JP, Kaminski NE. Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor &amp;#x003b3; independently of cannabinoid receptors 1 and 2. &lt;span&gt;</code></p><p><code>2278</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2279</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>2280</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>2281</code><code>70&lt;/span&gt;</code></p><p><code>2282</code><code>:101–111.&lt;/span&gt;</code></p><p><code>2283</code><code> [&lt;a href="/pubmed/16611855" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2284</code><code>PubMed&lt;/a&gt;</code></p><p><code>2285</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2286</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Interleukin-2+suppression+by+2-arachidonyl+glycerol+is+mediated+through+peroxisome+proliferator-activated+receptor+&amp;#x003b3;+independently+of+cannabinoid+receptors+1+and+2&amp;amp;author=CE+Rockwell&amp;amp;author=NT+Snider&amp;amp;author=JT+Thompson&amp;amp;author=JP+Vanden+Heuvel&amp;amp;author=NE+Kaminski&amp;amp;volume=70&amp;amp;publication_year=2006&amp;amp;pages=101-111&amp;amp;pmid=16611855&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2287</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2288</code><code>]&lt;/span&gt;</code></p><p><code>2289</code><code>&lt;/span&gt;</code></p><p><code>2290</code><code>&lt;/div&gt;</code></p><p><code>2291</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R37"&gt;</code></p><p><code>2292</code><code>37. &lt;span class="citation"&gt;</code></p><p><code>2293</code><code>Kishimoto S, Kobayashi Y, Oka S, Gokoh M, Waku K, Sugiura T. 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. &lt;span&gt;</code></p><p><code>2294</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2295</code><code>J Biochem. &lt;/span&gt;</code></p><p><code>2296</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>2297</code><code>135&lt;/span&gt;</code></p><p><code>2298</code><code>:517–524.&lt;/span&gt;</code></p><p><code>2299</code><code> [&lt;a href="/pubmed/15115777" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2300</code><code>PubMed&lt;/a&gt;</code></p><p><code>2301</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2302</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biochem&amp;amp;title=2-arachidonoylglycerol,+an+endogenous+cannabinoid+receptor+ligand,+induces+accelerated+production+of+chemokines+in+HL-60+cells&amp;amp;author=S+Kishimoto&amp;amp;author=Y+Kobayashi&amp;amp;author=S+Oka&amp;amp;author=M+Gokoh&amp;amp;author=K+Waku&amp;amp;volume=135&amp;amp;publication_year=2004&amp;amp;pages=517-524&amp;amp;pmid=15115777&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2303</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2304</code><code>]&lt;/span&gt;</code></p><p><code>2305</code><code>&lt;/span&gt;</code></p><p><code>2306</code><code>&lt;/div&gt;</code></p><p><code>2307</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R38"&gt;</code></p><p><code>2308</code><code>38. &lt;span class="citation"&gt;</code></p><p><code>2309</code><code>Mestre L, Correa F, Arevalo-Martin A, et al.  Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis. &lt;span&gt;</code></p><p><code>2310</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2311</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>2312</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>2313</code><code>92&lt;/span&gt;</code></p><p><code>2314</code><code>:1327–1339.&lt;/span&gt;</code></p><p><code>2315</code><code> [&lt;a href="/pubmed/15748152" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2316</code><code>PubMed&lt;/a&gt;</code></p><p><code>2317</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2318</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Pharmacological+modulation+of+the+endocannabinoid+system+in+a+viral+model+of+multiple+sclerosis&amp;amp;author=L+Mestre&amp;amp;author=F+Correa&amp;amp;author=A+Arevalo-Martin&amp;amp;volume=92&amp;amp;publication_year=2005&amp;amp;pages=1327-1339&amp;amp;pmid=15748152&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2319</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2320</code><code>]&lt;/span&gt;</code></p><p><code>2321</code><code>&lt;/span&gt;</code></p><p><code>2322</code><code>&lt;/div&gt;</code></p><p><code>2323</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R39"&gt;</code></p><p><code>2324</code><code>39. &lt;span class="citation"&gt;</code></p><p><code>2325</code><code>Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agro A. Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility. &lt;span&gt;</code></p><p><code>2326</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2327</code><code>J Immunol. &lt;/span&gt;</code></p><p><code>2328</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>2329</code><code>166&lt;/span&gt;</code></p><p><code>2330</code><code>:7183–7189.&lt;/span&gt;</code></p><p><code>2331</code><code> [&lt;a href="/pubmed/11390466" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2332</code><code>PubMed&lt;/a&gt;</code></p><p><code>2333</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2334</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;amp;title=Progesterone+up-regulates+anandamide+hydrolase+in+human+lymphocytes:+role+of+cytokines+and+implications+for+fertility&amp;amp;author=M+Maccarrone&amp;amp;author=H+Valensise&amp;amp;author=M+Bari&amp;amp;author=N+Lazzarin&amp;amp;author=C+Romanini&amp;amp;volume=166&amp;amp;publication_year=2001&amp;amp;pages=7183-7189&amp;amp;pmid=11390466&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2335</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2336</code><code>]&lt;/span&gt;</code></p><p><code>2337</code><code>&lt;/span&gt;</code></p><p><code>2338</code><code>&lt;/div&gt;</code></p><p><code>2339</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R40"&gt;</code></p><p><code>2340</code><code>40. &lt;span class="citation"&gt;</code></p><p><code>2341</code><code>Fischer-Stenger K, Dove Pettit DA, Cabral GA. &amp;#x00394;9-tetrahydrocannabinol inhibition of tumor necrosis factor-&amp;#x003b1;: suppression of post-translational events. &lt;span&gt;</code></p><p><code>2342</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2343</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>2344</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>2345</code><code>267&lt;/span&gt;</code></p><p><code>2346</code><code>:1558–1565.&lt;/span&gt;</code></p><p><code>2347</code><code> [&lt;a href="/pubmed/8263818" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2348</code><code>PubMed&lt;/a&gt;</code></p><p><code>2349</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2350</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=&amp;#x00394;9-tetrahydrocannabinol+inhibition+of+tumor+necrosis+factor-&amp;#x003b1;:+suppression+of+post-translational+events&amp;amp;author=K+Fischer-Stenger&amp;amp;author=DA+Dove+Pettit&amp;amp;author=GA+Cabral&amp;amp;volume=267&amp;amp;publication_year=1993&amp;amp;pages=1558-1565&amp;amp;pmid=8263818&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2351</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2352</code><code>]&lt;/span&gt;</code></p><p><code>2353</code><code>&lt;/span&gt;</code></p><p><code>2354</code><code>&lt;/div&gt;</code></p><p><code>2355</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R41"&gt;</code></p><p><code>2356</code><code>41. &lt;span class="citation"&gt;</code></p><p><code>2357</code><code>Zhu W, Newton C, Dka Y, Friedman H, Klein TW. &amp;#x00394;9-tetrahydrocannabinol enhances the secretion of interleukin 1 from endotoxin-stimulated macrophages. &lt;span&gt;</code></p><p><code>2358</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2359</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>2360</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>2361</code><code>270&lt;/span&gt;</code></p><p><code>2362</code><code>:1334–1339.&lt;/span&gt;</code></p><p><code>2363</code><code> [&lt;a href="/pubmed/7932187" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2364</code><code>PubMed&lt;/a&gt;</code></p><p><code>2365</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2366</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=&amp;#x00394;9-tetrahydrocannabinol+enhances+the+secretion+of+interleukin+1+from+endotoxin-stimulated+macrophages&amp;amp;author=W+Zhu&amp;amp;author=C+Newton&amp;amp;author=Y+Dka&amp;amp;author=H+Friedman&amp;amp;author=TW+Klein&amp;amp;volume=270&amp;amp;publication_year=1994&amp;amp;pages=1334-1339&amp;amp;pmid=7932187&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2367</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2368</code><code>]&lt;/span&gt;</code></p><p><code>2369</code><code>&lt;/span&gt;</code></p><p><code>2370</code><code>&lt;/div&gt;</code></p><p><code>2371</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R42"&gt;</code></p><p><code>2372</code><code>42. &lt;span class="citation"&gt;</code></p><p><code>2373</code><code>Weiner HL. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? &lt;span&gt;</code></p><p><code>2374</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2375</code><code>Ann Neurol. &lt;/span&gt;</code></p><p><code>2376</code><code>2009;&lt;span class="ref-vol"&gt;</code></p><p><code>2377</code><code>65&lt;/span&gt;</code></p><p><code>2378</code><code>:239–248.&lt;/span&gt;</code></p><p><code>2379</code><code> [&lt;a href="/pubmed/19334069" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2380</code><code>PubMed&lt;/a&gt;</code></p><p><code>2381</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2382</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Ann+Neurol&amp;amp;title=The+challenge+of+multiple+sclerosis:+how+do+we+cure+a+chronic+heterogeneous+disease?&amp;amp;author=HL+Weiner&amp;amp;volume=65&amp;amp;publication_year=2009&amp;amp;pages=239-248&amp;amp;pmid=19334069&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2383</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2384</code><code>]&lt;/span&gt;</code></p><p><code>2385</code><code>&lt;/span&gt;</code></p><p><code>2386</code><code>&lt;/div&gt;</code></p><p><code>2387</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R43"&gt;</code></p><p><code>2388</code><code>43. &lt;span class="citation"&gt;</code></p><p><code>2389</code><code>Pertwee RG. Cannabinoids and multiple sclerosis. &lt;span&gt;</code></p><p><code>2390</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2391</code><code>Pharmacol Ther. &lt;/span&gt;</code></p><p><code>2392</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>2393</code><code>95&lt;/span&gt;</code></p><p><code>2394</code><code>:165–174.&lt;/span&gt;</code></p><p><code>2395</code><code> [&lt;a href="/pubmed/12182963" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2396</code><code>PubMed&lt;/a&gt;</code></p><p><code>2397</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2398</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Ther&amp;amp;title=Cannabinoids+and+multiple+sclerosis&amp;amp;author=RG+Pertwee&amp;amp;volume=95&amp;amp;publication_year=2002&amp;amp;pages=165-174&amp;amp;pmid=12182963&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2399</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2400</code><code>]&lt;/span&gt;</code></p><p><code>2401</code><code>&lt;/span&gt;</code></p><p><code>2402</code><code>&lt;/div&gt;</code></p><p><code>2403</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R44"&gt;</code></p><p><code>2404</code><code>44. &lt;span class="citation"&gt;</code></p><p><code>2405</code><code>Arevalo-Martin A, Garcia-Ovejero D, Gomez O, et al.  CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies. &lt;span&gt;</code></p><p><code>2406</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2407</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>2408</code><code>2008;&lt;span class="ref-vol"&gt;</code></p><p><code>2409</code><code>153&lt;/span&gt;</code></p><p><code>2410</code><code>:216–225.&lt;/span&gt;</code></p><p><code>2411</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>2412</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2219542/"&gt;</code></p><p><code>2413</code><code>PMC free article&lt;/a&gt;</code></p><p><code>2414</code><code>]&lt;/span&gt;</code></p><p><code>2415</code><code> [&lt;a href="/pubmed/17891163" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2416</code><code>PubMed&lt;/a&gt;</code></p><p><code>2417</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2418</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=CB2+cannabinoid+receptors+as+an+emerging+target+for+demyelinating+diseases:+from+neuroimmune+interactions+to+cell+replacement+strategies&amp;amp;author=A+Arevalo-Martin&amp;amp;author=D+Garcia-Ovejero&amp;amp;author=O+Gomez&amp;amp;volume=153&amp;amp;publication_year=2008&amp;amp;pages=216-225&amp;amp;pmid=17891163&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2419</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2420</code><code>]&lt;/span&gt;</code></p><p><code>2421</code><code>&lt;/span&gt;</code></p><p><code>2422</code><code>&lt;/div&gt;</code></p><p><code>2423</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R45"&gt;</code></p><p><code>2424</code><code>45. &lt;span class="citation"&gt;</code></p><p><code>2425</code><code>Centonze D, Bari M, Rossi S, et al.  The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. &lt;span&gt;</code></p><p><code>2426</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2427</code><code>Brain. &lt;/span&gt;</code></p><p><code>2428</code><code>2007;&lt;span class="ref-vol"&gt;</code></p><p><code>2429</code><code>130&lt;/span&gt;</code></p><p><code>2430</code><code>:2543–2553.&lt;/span&gt;</code></p><p><code>2431</code><code> [&lt;a href="/pubmed/17626034" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2432</code><code>PubMed&lt;/a&gt;</code></p><p><code>2433</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2434</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;amp;title=The+endocannabinoid+system+is+dysregulated+in+multiple+sclerosis+and+in+experimental+autoimmune+encephalomyelitis&amp;amp;author=D+Centonze&amp;amp;author=M+Bari&amp;amp;author=S+Rossi&amp;amp;volume=130&amp;amp;publication_year=2007&amp;amp;pages=2543-2553&amp;amp;pmid=17626034&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2435</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2436</code><code>]&lt;/span&gt;</code></p><p><code>2437</code><code>&lt;/span&gt;</code></p><p><code>2438</code><code>&lt;/div&gt;</code></p><p><code>2439</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R46"&gt;</code></p><p><code>2440</code><code>46. &lt;span class="citation"&gt;</code></p><p><code>2441</code><code>Ghosh S, Preet A, Groopman JE, Ganju RK. Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes. &lt;span&gt;</code></p><p><code>2442</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2443</code><code>Mol Immunol. &lt;/span&gt;</code></p><p><code>2444</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>2445</code><code>43&lt;/span&gt;</code></p><p><code>2446</code><code>:2169–2179.&lt;/span&gt;</code></p><p><code>2447</code><code> [&lt;a href="/pubmed/16503355" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2448</code><code>PubMed&lt;/a&gt;</code></p><p><code>2449</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2450</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Immunol&amp;amp;title=Cannabinoid+receptor+CB2+modulates+the+CXCL12/CXCR4-mediated+chemotaxis+of+T+lymphocytes&amp;amp;author=S+Ghosh&amp;amp;author=A+Preet&amp;amp;author=JE+Groopman&amp;amp;author=RK+Ganju&amp;amp;volume=43&amp;amp;publication_year=2006&amp;amp;pages=2169-2179&amp;amp;pmid=16503355&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2451</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2452</code><code>]&lt;/span&gt;</code></p><p><code>2453</code><code>&lt;/span&gt;</code></p><p><code>2454</code><code>&lt;/div&gt;</code></p><p><code>2455</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R47"&gt;</code></p><p><code>2456</code><code>47. &lt;span class="citation"&gt;</code></p><p><code>2457</code><code>Iglesias A, Bauer J, Litzenburger T, Schubart A, Linington C. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. &lt;span&gt;</code></p><p><code>2458</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2459</code><code>Glia. &lt;/span&gt;</code></p><p><code>2460</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>2461</code><code>36&lt;/span&gt;</code></p><p><code>2462</code><code>:220–234.&lt;/span&gt;</code></p><p><code>2463</code><code> [&lt;a href="/pubmed/11596130" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2464</code><code>PubMed&lt;/a&gt;</code></p><p><code>2465</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2466</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Glia&amp;amp;title=T-+and+B-cell+responses+to+myelin+oligodendrocyte+glycoprotein+in+experimental+autoimmune+encephalomyelitis+and+multiple+sclerosis&amp;amp;author=A+Iglesias&amp;amp;author=J+Bauer&amp;amp;author=T+Litzenburger&amp;amp;author=A+Schubart&amp;amp;author=C+Linington&amp;amp;volume=36&amp;amp;publication_year=2001&amp;amp;pages=220-234&amp;amp;pmid=11596130&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2467</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2468</code><code>]&lt;/span&gt;</code></p><p><code>2469</code><code>&lt;/span&gt;</code></p><p><code>2470</code><code>&lt;/div&gt;</code></p><p><code>2471</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R48"&gt;</code></p><p><code>2472</code><code>48. &lt;span class="citation"&gt;</code></p><p><code>2473</code><code>Aranami T, Yamamura T. Th17 Cells and autoimmune encephalomyelitis (EAE/MS) &lt;span&gt;</code></p><p><code>2474</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2475</code><code>Allergol Int. &lt;/span&gt;</code></p><p><code>2476</code><code>2008;&lt;span class="ref-vol"&gt;</code></p><p><code>2477</code><code>57&lt;/span&gt;</code></p><p><code>2478</code><code>:115–120.&lt;/span&gt;</code></p><p><code>2479</code><code> [&lt;a href="/pubmed/18427164" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2480</code><code>PubMed&lt;/a&gt;</code></p><p><code>2481</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2482</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Allergol+Int&amp;amp;title=Th17+Cells+and+autoimmune+encephalomyelitis+(EAE/MS)&amp;amp;author=T+Aranami&amp;amp;author=T+Yamamura&amp;amp;volume=57&amp;amp;publication_year=2008&amp;amp;pages=115-120&amp;amp;pmid=18427164&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2483</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2484</code><code>]&lt;/span&gt;</code></p><p><code>2485</code><code>&lt;/span&gt;</code></p><p><code>2486</code><code>&lt;/div&gt;</code></p><p><code>2487</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R49"&gt;</code></p><p><code>2488</code><code>49. &lt;span class="citation"&gt;</code></p><p><code>2489</code><code>Frisullo G, Nociti V, Iorio R, et al.  IL17 and IFN&amp;#x003b3; production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. &lt;span&gt;</code></p><p><code>2490</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2491</code><code>Cytokine. &lt;/span&gt;</code></p><p><code>2492</code><code>2008;&lt;span class="ref-vol"&gt;</code></p><p><code>2493</code><code>44&lt;/span&gt;</code></p><p><code>2494</code><code>:22–25.&lt;/span&gt;</code></p><p><code>2495</code><code> [&lt;a href="/pubmed/18793860" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2496</code><code>PubMed&lt;/a&gt;</code></p><p><code>2497</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2498</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cytokine&amp;amp;title=IL17+and+IFN&amp;#x003b3;+production+by+peripheral+blood+mononuclear+cells+from+clinically+isolated+syndrome+to+secondary+progressive+multiple+sclerosis&amp;amp;author=G+Frisullo&amp;amp;author=V+Nociti&amp;amp;author=R+Iorio&amp;amp;volume=44&amp;amp;publication_year=2008&amp;amp;pages=22-25&amp;amp;pmid=18793860&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2499</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2500</code><code>]&lt;/span&gt;</code></p><p><code>2501</code><code>&lt;/span&gt;</code></p><p><code>2502</code><code>&lt;/div&gt;</code></p><p><code>2503</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R50"&gt;</code></p><p><code>2504</code><code>50. &lt;span class="citation"&gt;</code></p><p><code>2505</code><code>Sanchez AJ, Gonzalez-Perez P, Galve-Roperh I, Garcia-Merino A. &lt;em&gt;</code></p><p><code>2506</code><code>R&lt;/em&gt;</code></p><p><code>2507</code><code>-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4 -benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor. &lt;span&gt;</code></p><p><code>2508</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2509</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>2510</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>2511</code><code>72&lt;/span&gt;</code></p><p><code>2512</code><code>:1697–1706.&lt;/span&gt;</code></p><p><code>2513</code><code> [&lt;a href="/pubmed/17007821" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2514</code><code>PubMed&lt;/a&gt;</code></p><p><code>2515</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2516</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=R-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4+-benzoxazin-6-yl]-1-naphtalenylmethanone+(WIN-2)+ameliorates+experimental+autoimmune+encephalomyelitis+and+induces+encephalitogenic+T+cell+apoptosis:+partial+involvement+of+the+CB(2)+receptor&amp;amp;author=AJ+Sanchez&amp;amp;author=P+Gonzalez-Perez&amp;amp;author=I+Galve-Roperh&amp;amp;author=A+Garcia-Merino&amp;amp;volume=72&amp;amp;publication_year=2006&amp;amp;pages=1697-1706&amp;amp;pmid=17007821&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2517</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2518</code><code>]&lt;/span&gt;</code></p><p><code>2519</code><code>&lt;/span&gt;</code></p><p><code>2520</code><code>&lt;/div&gt;</code></p><p><code>2521</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R51"&gt;</code></p><p><code>2522</code><code>51. &lt;span class="citation"&gt;</code></p><p><code>2523</code><code>Arevalo-Martin A, Vela JM, Molina-Holgado E, Borrell J, Guaza C. Therapeutic action of cannabinoids in a murine model of multiple sclerosis. &lt;span&gt;</code></p><p><code>2524</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2525</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>2526</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>2527</code><code>23&lt;/span&gt;</code></p><p><code>2528</code><code>:2511–2516.&lt;/span&gt;</code></p><p><code>2529</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>2530</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6742100/"&gt;</code></p><p><code>2531</code><code>PMC free article&lt;/a&gt;</code></p><p><code>2532</code><code>]&lt;/span&gt;</code></p><p><code>2533</code><code> [&lt;a href="/pubmed/12684434" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2534</code><code>PubMed&lt;/a&gt;</code></p><p><code>2535</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2536</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Therapeutic+action+of+cannabinoids+in+a+murine+model+of+multiple+sclerosis&amp;amp;author=A+Arevalo-Martin&amp;amp;author=JM+Vela&amp;amp;author=E+Molina-Holgado&amp;amp;author=J+Borrell&amp;amp;author=C+Guaza&amp;amp;volume=23&amp;amp;publication_year=2003&amp;amp;pages=2511-2516&amp;amp;pmid=12684434&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2537</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2538</code><code>]&lt;/span&gt;</code></p><p><code>2539</code><code>&lt;/span&gt;</code></p><p><code>2540</code><code>&lt;/div&gt;</code></p><p><code>2541</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R52"&gt;</code></p><p><code>2542</code><code>52. &lt;span class="citation"&gt;</code></p><p><code>2543</code><code>Mestre L, Docagne F, Correa F, et al.  A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules. &lt;span&gt;</code></p><p><code>2544</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2545</code><code>Mol Cell Neurosci. &lt;/span&gt;</code></p><p><code>2546</code><code>2009;&lt;span class="ref-vol"&gt;</code></p><p><code>2547</code><code>40&lt;/span&gt;</code></p><p><code>2548</code><code>:258–266.&lt;/span&gt;</code></p><p><code>2549</code><code> [&lt;a href="/pubmed/19059482" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2550</code><code>PubMed&lt;/a&gt;</code></p><p><code>2551</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2552</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Neurosci&amp;amp;title=A+cannabinoid+agonist+interferes+with+the+progression+of+a+chronic+model+of+multiple+sclerosis+by+downregulating+adhesion+molecules&amp;amp;author=L+Mestre&amp;amp;author=F+Docagne&amp;amp;author=F+Correa&amp;amp;volume=40&amp;amp;publication_year=2009&amp;amp;pages=258-266&amp;amp;pmid=19059482&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2553</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2554</code><code>]&lt;/span&gt;</code></p><p><code>2555</code><code>&lt;/span&gt;</code></p><p><code>2556</code><code>&lt;/div&gt;</code></p><p><code>2557</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R53"&gt;</code></p><p><code>2558</code><code>53. &lt;span class="citation"&gt;</code></p><p><code>2559</code><code>Ehrhart J, Obregon D, Mori T, et al.  Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. &lt;span&gt;</code></p><p><code>2560</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2561</code><code>J Neuroinflammation. &lt;/span&gt;</code></p><p><code>2562</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>2563</code><code>2&lt;/span&gt;</code></p><p><code>2564</code><code>:29.&lt;/span&gt;</code></p><p><code>2565</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>2566</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1352348/"&gt;</code></p><p><code>2567</code><code>PMC free article&lt;/a&gt;</code></p><p><code>2568</code><code>]&lt;/span&gt;</code></p><p><code>2569</code><code> [&lt;a href="/pubmed/16343349" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2570</code><code>PubMed&lt;/a&gt;</code></p><p><code>2571</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2572</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neuroinflammation&amp;amp;title=Stimulation+of+cannabinoid+receptor+2+(CB2)+suppresses+microglial+activation&amp;amp;author=J+Ehrhart&amp;amp;author=D+Obregon&amp;amp;author=T+Mori&amp;amp;volume=2&amp;amp;publication_year=2005&amp;amp;pages=29&amp;amp;pmid=16343349&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2573</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2574</code><code>]&lt;/span&gt;</code></p><p><code>2575</code><code>&lt;/span&gt;</code></p><p><code>2576</code><code>&lt;/div&gt;</code></p><p><code>2577</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R54"&gt;</code></p><p><code>2578</code><code>54. &lt;span class="citation"&gt;</code></p><p><code>2579</code><code>Correa F, Docagne F, Mestre L, et al.  A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells. &lt;span&gt;</code></p><p><code>2580</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2581</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>2582</code><code>2009;&lt;span class="ref-vol"&gt;</code></p><p><code>2583</code><code>77&lt;/span&gt;</code></p><p><code>2584</code><code>:86–100.&lt;/span&gt;</code></p><p><code>2585</code><code> [&lt;a href="/pubmed/18848818" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2586</code><code>PubMed&lt;/a&gt;</code></p><p><code>2587</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2588</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=A+role+for+CB2+receptors+in+anandamide+signalling+pathways+involved+in+the+regulation+of+IL-12+and+IL-23+in+microglial+cells&amp;amp;author=F+Correa&amp;amp;author=F+Docagne&amp;amp;author=L+Mestre&amp;amp;volume=77&amp;amp;publication_year=2009&amp;amp;pages=86-100&amp;amp;pmid=18848818&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2589</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2590</code><code>]&lt;/span&gt;</code></p><p><code>2591</code><code>&lt;/span&gt;</code></p><p><code>2592</code><code>&lt;/div&gt;</code></p><p><code>2593</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R55"&gt;</code></p><p><code>2594</code><code>55. &lt;span class="citation"&gt;</code></p><p><code>2595</code><code>Palazuelos J, Davoust N, Julien B, et al.  The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis. &lt;span&gt;</code></p><p><code>2596</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2597</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>2598</code><code>2008;&lt;span class="ref-vol"&gt;</code></p><p><code>2599</code><code>283&lt;/span&gt;</code></p><p><code>2600</code><code>:13320–13329.&lt;/span&gt;</code></p><p><code>2601</code><code> [&lt;a href="/pubmed/18334483" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2602</code><code>PubMed&lt;/a&gt;</code></p><p><code>2603</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2604</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=The+CB(2)+cannabinoid+receptor+controls+myeloid+progenitor+trafficking:+involvement+in+the+pathogenesis+of+an+animal+model+of+multiple+sclerosis&amp;amp;author=J+Palazuelos&amp;amp;author=N+Davoust&amp;amp;author=B+Julien&amp;amp;volume=283&amp;amp;publication_year=2008&amp;amp;pages=13320-13329&amp;amp;pmid=18334483&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2605</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2606</code><code>]&lt;/span&gt;</code></p><p><code>2607</code><code>&lt;/span&gt;</code></p><p><code>2608</code><code>&lt;/div&gt;</code></p><p><code>2609</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R56"&gt;</code></p><p><code>2610</code><code>56. &lt;span class="citation"&gt;</code></p><p><code>2611</code><code>Sheng WS, Hu S, Min X, Cabral GA, Lokensgard JR, Peterson PK. Synthetic cannabinoid WIN55,212&amp;#x02013;212 inhibits generation of inflammatory mediators by IL-1&amp;#x003b2;-stimulated human astrocytes. &lt;span&gt;</code></p><p><code>2612</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2613</code><code>Glia. &lt;/span&gt;</code></p><p><code>2614</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>2615</code><code>49&lt;/span&gt;</code></p><p><code>2616</code><code>:211–219.&lt;/span&gt;</code></p><p><code>2617</code><code> [&lt;a href="/pubmed/15390091" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2618</code><code>PubMed&lt;/a&gt;</code></p><p><code>2619</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2620</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Glia&amp;amp;title=Synthetic+cannabinoid+WIN55,212&amp;#x02013;212+inhibits+generation+of+inflammatory+mediators+by+IL-1&amp;#x003b2;-stimulated+human+astrocytes&amp;amp;author=WS+Sheng&amp;amp;author=S+Hu&amp;amp;author=X+Min&amp;amp;author=GA+Cabral&amp;amp;author=JR+Lokensgard&amp;amp;volume=49&amp;amp;publication_year=2005&amp;amp;pages=211-219&amp;amp;pmid=15390091&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2621</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2622</code><code>]&lt;/span&gt;</code></p><p><code>2623</code><code>&lt;/span&gt;</code></p><p><code>2624</code><code>&lt;/div&gt;</code></p><p><code>2625</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R57"&gt;</code></p><p><code>2626</code><code>57. &lt;span class="citation"&gt;</code></p><p><code>2627</code><code>Molina-Holgado F, Molina-Holgado E, Guaza C. The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler&amp;#x02019;s murine encephalomyelitis virus by a receptor-mediated pathway. &lt;span&gt;</code></p><p><code>2628</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2629</code><code>FEBS Lett. &lt;/span&gt;</code></p><p><code>2630</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>2631</code><code>433&lt;/span&gt;</code></p><p><code>2632</code><code>:139–142.&lt;/span&gt;</code></p><p><code>2633</code><code> [&lt;a href="/pubmed/9738948" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2634</code><code>PubMed&lt;/a&gt;</code></p><p><code>2635</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2636</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;amp;title=The+endogenous+cannabinoid+anandamide+potentiates+interleukin-6+production+by+astrocytes+infected+with+Theiler&amp;#x02019;s+murine+encephalomyelitis+virus+by+a+receptor-mediated+pathway&amp;amp;author=F+Molina-Holgado&amp;amp;author=E+Molina-Holgado&amp;amp;author=C+Guaza&amp;amp;volume=433&amp;amp;publication_year=1998&amp;amp;pages=139-142&amp;amp;pmid=9738948&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2637</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2638</code><code>]&lt;/span&gt;</code></p><p><code>2639</code><code>&lt;/span&gt;</code></p><p><code>2640</code><code>&lt;/div&gt;</code></p><p><code>2641</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R58"&gt;</code></p><p><code>2642</code><code>58. &lt;span class="citation"&gt;</code></p><p><code>2643</code><code>Wood JD, Alpers DH, Andrews PL. Fundamentals of neurogastroenterology. &lt;span&gt;</code></p><p><code>2644</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2645</code><code>Gut. &lt;/span&gt;</code></p><p><code>2646</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>2647</code><code>45&lt;/span&gt;</code></p><p><code>2648</code><code>(Suppl. 2):II6–II16.&lt;/span&gt;</code></p><p><code>2649</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>2650</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1766686/"&gt;</code></p><p><code>2651</code><code>PMC free article&lt;/a&gt;</code></p><p><code>2652</code><code>]&lt;/span&gt;</code></p><p><code>2653</code><code> [&lt;a href="/pubmed/10457039" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2654</code><code>PubMed&lt;/a&gt;</code></p><p><code>2655</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2656</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;amp;title=Fundamentals+of+neurogastroenterology&amp;amp;author=JD+Wood&amp;amp;author=DH+Alpers&amp;amp;author=PL+Andrews&amp;amp;volume=45&amp;amp;issue=Suppl.+2&amp;amp;publication_year=1999&amp;amp;pages=II6-II16&amp;amp;pmid=10457039&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2657</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2658</code><code>]&lt;/span&gt;</code></p><p><code>2659</code><code>&lt;/span&gt;</code></p><p><code>2660</code><code>&lt;/div&gt;</code></p><p><code>2661</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R59"&gt;</code></p><p><code>2662</code><code>59. &lt;span class="citation"&gt;</code></p><p><code>2663</code><code>Massa F, Marsicano G, Hermann H, et al.  The endogenous cannabinoid system protects against colonic inflammation. &lt;span&gt;</code></p><p><code>2664</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2665</code><code>J Clin Invest. &lt;/span&gt;</code></p><p><code>2666</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>2667</code><code>113&lt;/span&gt;</code></p><p><code>2668</code><code>:1202–1209.&lt;/span&gt;</code></p><p><code>2669</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>2670</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC385396/"&gt;</code></p><p><code>2671</code><code>PMC free article&lt;/a&gt;</code></p><p><code>2672</code><code>]&lt;/span&gt;</code></p><p><code>2673</code><code> [&lt;a href="/pubmed/15085199" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2674</code><code>PubMed&lt;/a&gt;</code></p><p><code>2675</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2676</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;amp;title=The+endogenous+cannabinoid+system+protects+against+colonic+inflammation&amp;amp;author=F+Massa&amp;amp;author=G+Marsicano&amp;amp;author=H+Hermann&amp;amp;volume=113&amp;amp;publication_year=2004&amp;amp;pages=1202-1209&amp;amp;pmid=15085199&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2677</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2678</code><code>]&lt;/span&gt;</code></p><p><code>2679</code><code>&lt;/span&gt;</code></p><p><code>2680</code><code>&lt;/div&gt;</code></p><p><code>2681</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R60"&gt;</code></p><p><code>2682</code><code>60. &lt;span class="citation"&gt;</code></p><p><code>2683</code><code>Pertwee RG. Cannabinoids and the gastrointestinal tract. &lt;span&gt;</code></p><p><code>2684</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2685</code><code>Gut. &lt;/span&gt;</code></p><p><code>2686</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>2687</code><code>48&lt;/span&gt;</code></p><p><code>2688</code><code>:859–867.&lt;/span&gt;</code></p><p><code>2689</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>2690</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1728337/"&gt;</code></p><p><code>2691</code><code>PMC free article&lt;/a&gt;</code></p><p><code>2692</code><code>]&lt;/span&gt;</code></p><p><code>2693</code><code> [&lt;a href="/pubmed/11358910" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2694</code><code>PubMed&lt;/a&gt;</code></p><p><code>2695</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2696</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;amp;title=Cannabinoids+and+the+gastrointestinal+tract&amp;amp;author=RG+Pertwee&amp;amp;volume=48&amp;amp;publication_year=2001&amp;amp;pages=859-867&amp;amp;pmid=11358910&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2697</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2698</code><code>]&lt;/span&gt;</code></p><p><code>2699</code><code>&lt;/span&gt;</code></p><p><code>2700</code><code>&lt;/div&gt;</code></p><p><code>2701</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R61"&gt;</code></p><p><code>2702</code><code>61. &lt;span class="citation"&gt;</code></p><p><code>2703</code><code>Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. &lt;span&gt;</code></p><p><code>2704</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2705</code><code>Gastroenterology. &lt;/span&gt;</code></p><p><code>2706</code><code>1990;&lt;span class="ref-vol"&gt;</code></p><p><code>2707</code><code>98&lt;/span&gt;</code></p><p><code>2708</code><code>:694–702.&lt;/span&gt;</code></p><p><code>2709</code><code> [&lt;a href="/pubmed/1688816" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2710</code><code>PubMed&lt;/a&gt;</code></p><p><code>2711</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2712</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;amp;title=A+novel+method+in+the+induction+of+reliable+experimental+acute+and+chronic+ulcerative+colitis+in+mice&amp;amp;author=I+Okayasu&amp;amp;author=S+Hatakeyama&amp;amp;author=M+Yamada&amp;amp;author=T+Ohkusa&amp;amp;author=Y+Inagaki&amp;amp;volume=98&amp;amp;publication_year=1990&amp;amp;pages=694-702&amp;amp;pmid=1688816&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2713</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2714</code><code>]&lt;/span&gt;</code></p><p><code>2715</code><code>&lt;/span&gt;</code></p><p><code>2716</code><code>&lt;/div&gt;</code></p><p><code>2717</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R62"&gt;</code></p><p><code>2718</code><code>62. &lt;span class="citation"&gt;</code></p><p><code>2719</code><code>Yamada Y, Marshall S, Specian RD, Grisham MB. A comparative analysis of two models of colitis in rats. &lt;span&gt;</code></p><p><code>2720</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2721</code><code>Gastroenterology. &lt;/span&gt;</code></p><p><code>2722</code><code>1992;&lt;span class="ref-vol"&gt;</code></p><p><code>2723</code><code>102&lt;/span&gt;</code></p><p><code>2724</code><code>:1524–1534.&lt;/span&gt;</code></p><p><code>2725</code><code> [&lt;a href="/pubmed/1314749" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2726</code><code>PubMed&lt;/a&gt;</code></p><p><code>2727</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2728</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;amp;title=A+comparative+analysis+of+two+models+of+colitis+in+rats&amp;amp;author=Y+Yamada&amp;amp;author=S+Marshall&amp;amp;author=RD+Specian&amp;amp;author=MB+Grisham&amp;amp;volume=102&amp;amp;publication_year=1992&amp;amp;pages=1524-1534&amp;amp;pmid=1314749&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2729</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2730</code><code>]&lt;/span&gt;</code></p><p><code>2731</code><code>&lt;/span&gt;</code></p><p><code>2732</code><code>&lt;/div&gt;</code></p><p><code>2733</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R63"&gt;</code></p><p><code>2734</code><code>63. &lt;span class="citation"&gt;</code></p><p><code>2735</code><code>Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. &lt;span&gt;</code></p><p><code>2736</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2737</code><code>J Exp Med. &lt;/span&gt;</code></p><p><code>2738</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>2739</code><code>182&lt;/span&gt;</code></p><p><code>2740</code><code>:1281–1290.&lt;/span&gt;</code></p><p><code>2741</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>2742</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2192205/"&gt;</code></p><p><code>2743</code><code>PMC free article&lt;/a&gt;</code></p><p><code>2744</code><code>]&lt;/span&gt;</code></p><p><code>2745</code><code> [&lt;a href="/pubmed/7595199" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2746</code><code>PubMed&lt;/a&gt;</code></p><p><code>2747</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2748</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;amp;title=Antibodies+to+interleukin+12+abrogate+established+experimental+colitis+in+mice&amp;amp;author=MF+Neurath&amp;amp;author=I+Fuss&amp;amp;author=BL+Kelsall&amp;amp;author=E+Stuber&amp;amp;author=W+Strober&amp;amp;volume=182&amp;amp;publication_year=1995&amp;amp;pages=1281-1290&amp;amp;pmid=7595199&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2749</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2750</code><code>]&lt;/span&gt;</code></p><p><code>2751</code><code>&lt;/span&gt;</code></p><p><code>2752</code><code>&lt;/div&gt;</code></p><p><code>2753</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R64"&gt;</code></p><p><code>2754</code><code>64. &lt;span class="citation"&gt;</code></p><p><code>2755</code><code>Kimball ES, Schneider CR, Wallace NH, Hornby PJ. Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium. &lt;span&gt;</code></p><p><code>2756</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2757</code><code>Am J Physiol Gastrointest Liver Physiol. &lt;/span&gt;</code></p><p><code>2758</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>2759</code><code>291&lt;/span&gt;</code></p><p><code>2760</code><code>:G364–G371.&lt;/span&gt;</code></p><p><code>2761</code><code> [&lt;a href="/pubmed/16574988" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2762</code><code>PubMed&lt;/a&gt;</code></p><p><code>2763</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2764</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Gastrointest+Liver+Physiol&amp;amp;title=Agonists+of+cannabinoid+receptor+1+and+2+inhibit+experimental+colitis+induced+by+oil+of+mustard+and+by+dextran+sulfate+sodium&amp;amp;author=ES+Kimball&amp;amp;author=CR+Schneider&amp;amp;author=NH+Wallace&amp;amp;author=PJ+Hornby&amp;amp;volume=291&amp;amp;publication_year=2006&amp;amp;pages=G364-G371&amp;amp;pmid=16574988&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2765</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2766</code><code>]&lt;/span&gt;</code></p><p><code>2767</code><code>&lt;/span&gt;</code></p><p><code>2768</code><code>&lt;/div&gt;</code></p><p><code>2769</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R65"&gt;</code></p><p><code>2770</code><code>65. &lt;span class="citation"&gt;</code></p><p><code>2771</code><code>Izzo AA, Fezza F, Capasso R, et al.  Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. &lt;span&gt;</code></p><p><code>2772</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2773</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>2774</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>2775</code><code>134&lt;/span&gt;</code></p><p><code>2776</code><code>:563–570.&lt;/span&gt;</code></p><p><code>2777</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>2778</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1572987/"&gt;</code></p><p><code>2779</code><code>PMC free article&lt;/a&gt;</code></p><p><code>2780</code><code>]&lt;/span&gt;</code></p><p><code>2781</code><code> [&lt;a href="/pubmed/11588110" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2782</code><code>PubMed&lt;/a&gt;</code></p><p><code>2783</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2784</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Cannabinoid+CB1-receptor+mediated+regulation+of+gastrointestinal+motility+in+mice+in+a+model+of+intestinal+inflammation&amp;amp;author=AA+Izzo&amp;amp;author=F+Fezza&amp;amp;author=R+Capasso&amp;amp;volume=134&amp;amp;publication_year=2001&amp;amp;pages=563-570&amp;amp;pmid=11588110&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2785</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2786</code><code>]&lt;/span&gt;</code></p><p><code>2787</code><code>&lt;/span&gt;</code></p><p><code>2788</code><code>&lt;/div&gt;</code></p><p><code>2789</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R66"&gt;</code></p><p><code>2790</code><code>66. &lt;span class="citation"&gt;</code></p><p><code>2791</code><code>Cravatt BF, Demarest K, Patricelli MP, et al.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. &lt;span&gt;</code></p><p><code>2792</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2793</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>2794</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>2795</code><code>98&lt;/span&gt;</code></p><p><code>2796</code><code>:9371–9376.&lt;/span&gt;</code></p><p><code>2797</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>2798</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC55427/"&gt;</code></p><p><code>2799</code><code>PMC free article&lt;/a&gt;</code></p><p><code>2800</code><code>]&lt;/span&gt;</code></p><p><code>2801</code><code> [&lt;a href="/pubmed/11470906" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2802</code><code>PubMed&lt;/a&gt;</code></p><p><code>2803</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2804</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Supersensitivity+to+anandamide+and+enhanced+endogenous+cannabinoid+signaling+in+mice+lacking+fatty+acid+amide+hydrolase&amp;amp;author=BF+Cravatt&amp;amp;author=K+Demarest&amp;amp;author=MP+Patricelli&amp;amp;volume=98&amp;amp;publication_year=2001&amp;amp;pages=9371-9376&amp;amp;pmid=11470906&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2805</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2806</code><code>]&lt;/span&gt;</code></p><p><code>2807</code><code>&lt;/span&gt;</code></p><p><code>2808</code><code>&lt;/div&gt;</code></p><p><code>2809</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R67"&gt;</code></p><p><code>2810</code><code>67. &lt;span class="citation"&gt;</code></p><p><code>2811</code><code>Di Marzo V, De Petrocellis L, Fezza F, Ligresti A, Bisogno T. Anandamide receptors. &lt;span&gt;</code></p><p><code>2812</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2813</code><code>Prostaglandins Leukot Essent Fatty Acids. &lt;/span&gt;</code></p><p><code>2814</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>2815</code><code>66&lt;/span&gt;</code></p><p><code>2816</code><code>:377–391.&lt;/span&gt;</code></p><p><code>2817</code><code> [&lt;a href="/pubmed/12052051" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2818</code><code>PubMed&lt;/a&gt;</code></p><p><code>2819</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2820</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Prostaglandins+Leukot+Essent+Fatty+Acids&amp;amp;title=Anandamide+receptors&amp;amp;author=V+Di+Marzo&amp;amp;author=L+De+Petrocellis&amp;amp;author=F+Fezza&amp;amp;author=A+Ligresti&amp;amp;author=T+Bisogno&amp;amp;volume=66&amp;amp;publication_year=2002&amp;amp;pages=377-391&amp;amp;pmid=12052051&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2821</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2822</code><code>]&lt;/span&gt;</code></p><p><code>2823</code><code>&lt;/span&gt;</code></p><p><code>2824</code><code>&lt;/div&gt;</code></p><p><code>2825</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R68"&gt;</code></p><p><code>2826</code><code>68. &lt;span class="citation"&gt;</code></p><p><code>2827</code><code>Biecker E, Sagesser H, Reichen J. Vasodilator mRNA levels are increased in the livers of portal hypertensive NO-synthase 3-deficient mice. &lt;span&gt;</code></p><p><code>2828</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2829</code><code>Eur J Clin Invest. &lt;/span&gt;</code></p><p><code>2830</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>2831</code><code>34&lt;/span&gt;</code></p><p><code>2832</code><code>:283–289.&lt;/span&gt;</code></p><p><code>2833</code><code> [&lt;a href="/pubmed/15086360" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2834</code><code>PubMed&lt;/a&gt;</code></p><p><code>2835</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2836</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Clin+Invest&amp;amp;title=Vasodilator+mRNA+levels+are+increased+in+the+livers+of+portal+hypertensive+NO-synthase+3-deficient+mice&amp;amp;author=E+Biecker&amp;amp;author=H+Sagesser&amp;amp;author=J+Reichen&amp;amp;volume=34&amp;amp;publication_year=2004&amp;amp;pages=283-289&amp;amp;pmid=15086360&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2837</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2838</code><code>]&lt;/span&gt;</code></p><p><code>2839</code><code>&lt;/span&gt;</code></p><p><code>2840</code><code>&lt;/div&gt;</code></p><p><code>2841</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R69"&gt;</code></p><p><code>2842</code><code>69. &lt;span class="citation"&gt;</code></p><p><code>2843</code><code>Julien B, Grenard P, Teixeira-Clerc F, et al.  Antifibrogenic role of the cannabinoid receptor CB2 in the liver. &lt;span&gt;</code></p><p><code>2844</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2845</code><code>Gastroenterology. &lt;/span&gt;</code></p><p><code>2846</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>2847</code><code>128&lt;/span&gt;</code></p><p><code>2848</code><code>:742–755.&lt;/span&gt;</code></p><p><code>2849</code><code> [&lt;a href="/pubmed/15765409" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2850</code><code>PubMed&lt;/a&gt;</code></p><p><code>2851</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2852</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;amp;title=Antifibrogenic+role+of+the+cannabinoid+receptor+CB2+in+the+liver&amp;amp;author=B+Julien&amp;amp;author=P+Grenard&amp;amp;author=F+Teixeira-Clerc&amp;amp;volume=128&amp;amp;publication_year=2005&amp;amp;pages=742-755&amp;amp;pmid=15765409&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2853</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2854</code><code>]&lt;/span&gt;</code></p><p><code>2855</code><code>&lt;/span&gt;</code></p><p><code>2856</code><code>&lt;/div&gt;</code></p><p><code>2857</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R70"&gt;</code></p><p><code>2858</code><code>70. &lt;span class="citation"&gt;</code></p><p><code>2859</code><code>Osei-Hyiaman D, DePetrillo M, Pacher P, et al.  Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. &lt;span&gt;</code></p><p><code>2860</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2861</code><code>J Clin Invest. &lt;/span&gt;</code></p><p><code>2862</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>2863</code><code>115&lt;/span&gt;</code></p><p><code>2864</code><code>:1298–1305.&lt;/span&gt;</code></p><p><code>2865</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>2866</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1087161/"&gt;</code></p><p><code>2867</code><code>PMC free article&lt;/a&gt;</code></p><p><code>2868</code><code>]&lt;/span&gt;</code></p><p><code>2869</code><code> [&lt;a href="/pubmed/15864349" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2870</code><code>PubMed&lt;/a&gt;</code></p><p><code>2871</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2872</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;amp;title=Endocannabinoid+activation+at+hepatic+CB1+receptors+stimulates+fatty+acid+synthesis+and+contributes+to+diet-induced+obesity&amp;amp;author=D+Osei-Hyiaman&amp;amp;author=M+DePetrillo&amp;amp;author=P+Pacher&amp;amp;volume=115&amp;amp;publication_year=2005&amp;amp;pages=1298-1305&amp;amp;pmid=15864349&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2873</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2874</code><code>]&lt;/span&gt;</code></p><p><code>2875</code><code>&lt;/span&gt;</code></p><p><code>2876</code><code>&lt;/div&gt;</code></p><p><code>2877</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R71"&gt;</code></p><p><code>2878</code><code>71. &lt;span class="citation"&gt;</code></p><p><code>2879</code><code>Schwabe RF, Siegmund SV. Potential role of CB2 receptors in cannabis smokers with chronic hepatitis C. &lt;span&gt;</code></p><p><code>2880</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2881</code><code>Hepatology. &lt;/span&gt;</code></p><p><code>2882</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>2883</code><code>42&lt;/span&gt;</code></p><p><code>2884</code><code>:975–977.&lt;/span&gt;</code></p><p><code>2885</code><code> [&lt;a href="/pubmed/16175591" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2886</code><code>PubMed&lt;/a&gt;</code></p><p><code>2887</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2888</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;amp;title=Potential+role+of+CB2+receptors+in+cannabis+smokers+with+chronic+hepatitis+C&amp;amp;author=RF+Schwabe&amp;amp;author=SV+Siegmund&amp;amp;volume=42&amp;amp;publication_year=2005&amp;amp;pages=975-977&amp;amp;pmid=16175591&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2889</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2890</code><code>]&lt;/span&gt;</code></p><p><code>2891</code><code>&lt;/span&gt;</code></p><p><code>2892</code><code>&lt;/div&gt;</code></p><p><code>2893</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R72"&gt;</code></p><p><code>2894</code><code>72. &lt;span class="citation"&gt;</code></p><p><code>2895</code><code>Teixeira-Clerc F, Julien B, Grenard P, et al.  CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. &lt;span&gt;</code></p><p><code>2896</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2897</code><code>Nat Med. &lt;/span&gt;</code></p><p><code>2898</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>2899</code><code>12&lt;/span&gt;</code></p><p><code>2900</code><code>:671–676.&lt;/span&gt;</code></p><p><code>2901</code><code> [&lt;a href="/pubmed/16715087" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2902</code><code>PubMed&lt;/a&gt;</code></p><p><code>2903</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2904</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;amp;title=CB1+cannabinoid+receptor+antagonism:+a+new+strategy+for+the+treatment+of+liver+fibrosis&amp;amp;author=F+Teixeira-Clerc&amp;amp;author=B+Julien&amp;amp;author=P+Grenard&amp;amp;volume=12&amp;amp;publication_year=2006&amp;amp;pages=671-676&amp;amp;pmid=16715087&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2905</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2906</code><code>]&lt;/span&gt;</code></p><p><code>2907</code><code>&lt;/span&gt;</code></p><p><code>2908</code><code>&lt;/div&gt;</code></p><p><code>2909</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R73"&gt;</code></p><p><code>2910</code><code>73. &lt;span class="citation"&gt;</code></p><p><code>2911</code><code>Batkai S, Jarai Z, Wagner JA, et al.  Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. &lt;span&gt;</code></p><p><code>2912</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2913</code><code>Nat Med. &lt;/span&gt;</code></p><p><code>2914</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>2915</code><code>7&lt;/span&gt;</code></p><p><code>2916</code><code>:827–832.&lt;/span&gt;</code></p><p><code>2917</code><code> [&lt;a href="/pubmed/11433348" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2918</code><code>PubMed&lt;/a&gt;</code></p><p><code>2919</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2920</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;amp;title=Endocannabinoids+acting+at+vascular+CB1+receptors+mediate+the+vasodilated+state+in+advanced+liver+cirrhosis&amp;amp;author=S+Batkai&amp;amp;author=Z+Jarai&amp;amp;author=JA+Wagner&amp;amp;volume=7&amp;amp;publication_year=2001&amp;amp;pages=827-832&amp;amp;pmid=11433348&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2921</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2922</code><code>]&lt;/span&gt;</code></p><p><code>2923</code><code>&lt;/span&gt;</code></p><p><code>2924</code><code>&lt;/div&gt;</code></p><p><code>2925</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R74"&gt;</code></p><p><code>2926</code><code>74. &lt;span class="citation"&gt;</code></p><p><code>2927</code><code>Batkai S, Osei-Hyiaman D, Pan H, et al.  Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. &lt;span&gt;</code></p><p><code>2928</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2929</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>2930</code><code>2007;&lt;span class="ref-vol"&gt;</code></p><p><code>2931</code><code>21&lt;/span&gt;</code></p><p><code>2932</code><code>:1788–1800.&lt;/span&gt;</code></p><p><code>2933</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>2934</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2228252/"&gt;</code></p><p><code>2935</code><code>PMC free article&lt;/a&gt;</code></p><p><code>2936</code><code>]&lt;/span&gt;</code></p><p><code>2937</code><code> [&lt;a href="/pubmed/17327359" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2938</code><code>PubMed&lt;/a&gt;</code></p><p><code>2939</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2940</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=Cannabinoid-2+receptor+mediates+protection+against+hepatic+ischemia/reperfusion+injury&amp;amp;author=S+Batkai&amp;amp;author=D+Osei-Hyiaman&amp;amp;author=H+Pan&amp;amp;volume=21&amp;amp;publication_year=2007&amp;amp;pages=1788-1800&amp;amp;pmid=17327359&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2941</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2942</code><code>]&lt;/span&gt;</code></p><p><code>2943</code><code>&lt;/span&gt;</code></p><p><code>2944</code><code>&lt;/div&gt;</code></p><p><code>2945</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R75"&gt;</code></p><p><code>2946</code><code>75. &lt;span class="citation"&gt;</code></p><p><code>2947</code><code>Gary-Bobo M, Elachouri G, Gallas JF, et al.  Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. &lt;span&gt;</code></p><p><code>2948</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2949</code><code>Hepatology. &lt;/span&gt;</code></p><p><code>2950</code><code>2007;&lt;span class="ref-vol"&gt;</code></p><p><code>2951</code><code>46&lt;/span&gt;</code></p><p><code>2952</code><code>:122–129.&lt;/span&gt;</code></p><p><code>2953</code><code> [&lt;a href="/pubmed/17526015" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2954</code><code>PubMed&lt;/a&gt;</code></p><p><code>2955</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2956</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;amp;title=Rimonabant+reduces+obesity-associated+hepatic+steatosis+and+features+of+metabolic+syndrome+in+obese+Zucker+fa/fa+rats&amp;amp;author=M+Gary-Bobo&amp;amp;author=G+Elachouri&amp;amp;author=JF+Gallas&amp;amp;volume=46&amp;amp;publication_year=2007&amp;amp;pages=122-129&amp;amp;pmid=17526015&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2957</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2958</code><code>]&lt;/span&gt;</code></p><p><code>2959</code><code>&lt;/span&gt;</code></p><p><code>2960</code><code>&lt;/div&gt;</code></p><p><code>2961</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R76"&gt;</code></p><p><code>2962</code><code>76. &lt;span class="citation"&gt;</code></p><p><code>2963</code><code>Siegmund SV, Qian T, de Minicis S, et al.  The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. &lt;span&gt;</code></p><p><code>2964</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2965</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>2966</code><code>2007;&lt;span class="ref-vol"&gt;</code></p><p><code>2967</code><code>21&lt;/span&gt;</code></p><p><code>2968</code><code>:2798–2806.&lt;/span&gt;</code></p><p><code>2969</code><code> [&lt;a href="/pubmed/17440119" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2970</code><code>PubMed&lt;/a&gt;</code></p><p><code>2971</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2972</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=The+endocannabinoid+2-arachidonoyl+glycerol+induces+death+of+hepatic+stellate+cells+via+mitochondrial+reactive+oxygen+species&amp;amp;author=SV+Siegmund&amp;amp;author=T+Qian&amp;amp;author=S+de+Minicis&amp;amp;volume=21&amp;amp;publication_year=2007&amp;amp;pages=2798-2806&amp;amp;pmid=17440119&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2973</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2974</code><code>]&lt;/span&gt;</code></p><p><code>2975</code><code>&lt;/span&gt;</code></p><p><code>2976</code><code>&lt;/div&gt;</code></p><p><code>2977</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R77"&gt;</code></p><p><code>2978</code><code>77. &lt;span class="citation"&gt;</code></p><p><code>2979</code><code>Hezode C, Roudot-Thoraval F, Nguyen S, et al.  Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. &lt;span&gt;</code></p><p><code>2980</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2981</code><code>Hepatology. &lt;/span&gt;</code></p><p><code>2982</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>2983</code><code>42&lt;/span&gt;</code></p><p><code>2984</code><code>:63–71.&lt;/span&gt;</code></p><p><code>2985</code><code> [&lt;a href="/pubmed/15892090" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>2986</code><code>PubMed&lt;/a&gt;</code></p><p><code>2987</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>2988</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;amp;title=Daily+cannabis+smoking+as+a+risk+factor+for+progression+of+fibrosis+in+chronic+hepatitis+C&amp;amp;author=C+Hezode&amp;amp;author=F+Roudot-Thoraval&amp;amp;author=S+Nguyen&amp;amp;volume=42&amp;amp;publication_year=2005&amp;amp;pages=63-71&amp;amp;pmid=15892090&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>2989</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>2990</code><code>]&lt;/span&gt;</code></p><p><code>2991</code><code>&lt;/span&gt;</code></p><p><code>2992</code><code>&lt;/div&gt;</code></p><p><code>2993</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R78"&gt;</code></p><p><code>2994</code><code>78. &lt;span class="citation"&gt;</code></p><p><code>2995</code><code>Avraham Y, Israeli E, Gabbay E, et al.  Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. &lt;span&gt;</code></p><p><code>2996</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>2997</code><code>Neurobiol Dis. &lt;/span&gt;</code></p><p><code>2998</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>2999</code><code>21&lt;/span&gt;</code></p><p><code>3000</code><code>:237–245.&lt;/span&gt;</code></p><p><code>3001</code><code> [&lt;a href="/pubmed/16102970" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3002</code><code>PubMed&lt;/a&gt;</code></p><p><code>3003</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3004</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurobiol+Dis&amp;amp;title=Endocannabinoids+affect+neurological+and+cognitive+function+in+thioacetamide-induced+hepatic+encephalopathy+in+mice&amp;amp;author=Y+Avraham&amp;amp;author=E+Israeli&amp;amp;author=E+Gabbay&amp;amp;volume=21&amp;amp;publication_year=2006&amp;amp;pages=237-245&amp;amp;pmid=16102970&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3005</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3006</code><code>]&lt;/span&gt;</code></p><p><code>3007</code><code>&lt;/span&gt;</code></p><p><code>3008</code><code>&lt;/div&gt;</code></p><p><code>3009</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R79"&gt;</code></p><p><code>3010</code><code>79. &lt;span class="citation"&gt;</code></p><p><code>3011</code><code>Hegde VL, Hegde S, Cravatt BF, Hofseth LJ, Nagarkatti M, Nagarkatti PS. Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. &lt;span&gt;</code></p><p><code>3012</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3013</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>3014</code><code>2008;&lt;span class="ref-vol"&gt;</code></p><p><code>3015</code><code>74&lt;/span&gt;</code></p><p><code>3016</code><code>:20–33.&lt;/span&gt;</code></p><p><code>3017</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>3018</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2828293/"&gt;</code></p><p><code>3019</code><code>PMC free article&lt;/a&gt;</code></p><p><code>3020</code><code>]&lt;/span&gt;</code></p><p><code>3021</code><code> [&lt;a href="/pubmed/18388242" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3022</code><code>PubMed&lt;/a&gt;</code></p><p><code>3023</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3024</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Attenuation+of+experimental+autoimmune+hepatitis+by+exogenous+and+endogenous+cannabinoids:+involvement+of+regulatory+T+cells&amp;amp;author=VL+Hegde&amp;amp;author=S+Hegde&amp;amp;author=BF+Cravatt&amp;amp;author=LJ+Hofseth&amp;amp;author=M+Nagarkatti&amp;amp;volume=74&amp;amp;publication_year=2008&amp;amp;pages=20-33&amp;amp;pmid=18388242&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3025</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3026</code><code>]&lt;/span&gt;</code></p><p><code>3027</code><code>&lt;/span&gt;</code></p><p><code>3028</code><code>&lt;/div&gt;</code></p><p><code>3029</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R80"&gt;</code></p><p><code>3030</code><code>80. &lt;span class="citation"&gt;</code></p><p><code>3031</code><code>Hurlimann D, Enseleit F, Ruschitzka F. Rheumatoid arthritis, inflammation, and atherosclerosis. &lt;span&gt;</code></p><p><code>3032</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3033</code><code>Herz. &lt;/span&gt;</code></p><p><code>3034</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>3035</code><code>29&lt;/span&gt;</code></p><p><code>3036</code><code>:760–768.&lt;/span&gt;</code></p><p><code>3037</code><code> [&lt;a href="/pubmed/15599672" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3038</code><code>PubMed&lt;/a&gt;</code></p><p><code>3039</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3040</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Herz&amp;amp;title=Rheumatoid+arthritis,+inflammation,+and+atherosclerosis&amp;amp;author=D+Hurlimann&amp;amp;author=F+Enseleit&amp;amp;author=F+Ruschitzka&amp;amp;volume=29&amp;amp;publication_year=2004&amp;amp;pages=760-768&amp;amp;pmid=15599672&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3041</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3042</code><code>]&lt;/span&gt;</code></p><p><code>3043</code><code>&lt;/span&gt;</code></p><p><code>3044</code><code>&lt;/div&gt;</code></p><p><code>3045</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R81"&gt;</code></p><p><code>3046</code><code>81. &lt;span class="citation"&gt;</code></p><p><code>3047</code><code>Pratt AG, Isaacs JD, Mattey DL. Current concepts in the pathogenesis of early rheumatoid arthritis. &lt;span&gt;</code></p><p><code>3048</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3049</code><code>Best Pract Res Clin Rheumatol. &lt;/span&gt;</code></p><p><code>3050</code><code>2009;&lt;span class="ref-vol"&gt;</code></p><p><code>3051</code><code>23&lt;/span&gt;</code></p><p><code>3052</code><code>:37–48.&lt;/span&gt;</code></p><p><code>3053</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>3054</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2652659/"&gt;</code></p><p><code>3055</code><code>PMC free article&lt;/a&gt;</code></p><p><code>3056</code><code>]&lt;/span&gt;</code></p><p><code>3057</code><code> [&lt;a href="/pubmed/19233044" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3058</code><code>PubMed&lt;/a&gt;</code></p><p><code>3059</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3060</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Best+Pract+Res+Clin+Rheumatol&amp;amp;title=Current+concepts+in+the+pathogenesis+of+early+rheumatoid+arthritis&amp;amp;author=AG+Pratt&amp;amp;author=JD+Isaacs&amp;amp;author=DL+Mattey&amp;amp;volume=23&amp;amp;publication_year=2009&amp;amp;pages=37-48&amp;amp;pmid=19233044&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3061</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3062</code><code>]&lt;/span&gt;</code></p><p><code>3063</code><code>&lt;/span&gt;</code></p><p><code>3064</code><code>&lt;/div&gt;</code></p><p><code>3065</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R82"&gt;</code></p><p><code>3066</code><code>82. &lt;span class="citation"&gt;</code></p><p><code>3067</code><code>Zurier RB, Rossetti RG, Burstein SH, Bidinger B. Suppression of human monocyte interleukin-1&amp;#x003b2; production by ajulemic acid, a nonpsychoactive cannabinoid. &lt;span&gt;</code></p><p><code>3068</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3069</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>3070</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>3071</code><code>65&lt;/span&gt;</code></p><p><code>3072</code><code>:649–655.&lt;/span&gt;</code></p><p><code>3073</code><code> [&lt;a href="/pubmed/12566094" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3074</code><code>PubMed&lt;/a&gt;</code></p><p><code>3075</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3076</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=Suppression+of+human+monocyte+interleukin-1&amp;#x003b2;+production+by+ajulemic+acid,+a+nonpsychoactive+cannabinoid&amp;amp;author=RB+Zurier&amp;amp;author=RG+Rossetti&amp;amp;author=SH+Burstein&amp;amp;author=B+Bidinger&amp;amp;volume=65&amp;amp;publication_year=2003&amp;amp;pages=649-655&amp;amp;pmid=12566094&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3077</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3078</code><code>]&lt;/span&gt;</code></p><p><code>3079</code><code>&lt;/span&gt;</code></p><p><code>3080</code><code>&lt;/div&gt;</code></p><p><code>3081</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R83"&gt;</code></p><p><code>3082</code><code>83. &lt;span class="citation"&gt;</code></p><p><code>3083</code><code>George KL, Saltman LH, Stein GS, Lian JB, Zurier RB. Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells. &lt;span&gt;</code></p><p><code>3084</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3085</code><code>J Cell Physiol. &lt;/span&gt;</code></p><p><code>3086</code><code>2008;&lt;span class="ref-vol"&gt;</code></p><p><code>3087</code><code>214&lt;/span&gt;</code></p><p><code>3088</code><code>:714–720.&lt;/span&gt;</code></p><p><code>3089</code><code> [&lt;a href="/pubmed/17786950" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3090</code><code>PubMed&lt;/a&gt;</code></p><p><code>3091</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3092</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Physiol&amp;amp;title=Ajulemic+acid,+a+nonpsychoactive+cannabinoid+acid,+suppresses+osteoclastogenesis+in+mononuclear+precursor+cells+and+induces+apoptosis+in+mature+osteoclast-like+cells&amp;amp;author=KL+George&amp;amp;author=LH+Saltman&amp;amp;author=GS+Stein&amp;amp;author=JB+Lian&amp;amp;author=RB+Zurier&amp;amp;volume=214&amp;amp;publication_year=2008&amp;amp;pages=714-720&amp;amp;pmid=17786950&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3093</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3094</code><code>]&lt;/span&gt;</code></p><p><code>3095</code><code>&lt;/span&gt;</code></p><p><code>3096</code><code>&lt;/div&gt;</code></p><p><code>3097</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R84"&gt;</code></p><p><code>3098</code><code>84. &lt;span class="citation"&gt;</code></p><p><code>3099</code><code>Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? &lt;span&gt;</code></p><p><code>3100</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3101</code><code>Lancet. &lt;/span&gt;</code></p><p><code>3102</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>3103</code><code>357&lt;/span&gt;</code></p><p><code>3104</code><code>:539–545.&lt;/span&gt;</code></p><p><code>3105</code><code> [&lt;a href="/pubmed/11229684" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3106</code><code>PubMed&lt;/a&gt;</code></p><p><code>3107</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3108</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;amp;title=Inflammation+and+cancer:+back+to+Virchow?&amp;amp;author=F+Balkwill&amp;amp;author=A+Mantovani&amp;amp;volume=357&amp;amp;publication_year=2001&amp;amp;pages=539-545&amp;amp;pmid=11229684&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3109</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3110</code><code>]&lt;/span&gt;</code></p><p><code>3111</code><code>&lt;/span&gt;</code></p><p><code>3112</code><code>&lt;/div&gt;</code></p><p><code>3113</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R85"&gt;</code></p><p><code>3114</code><code>85. &lt;span class="citation"&gt;</code></p><p><code>3115</code><code>Malfait AM, Gallily R, Sumariwalla PF, et al.  The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. &lt;span&gt;</code></p><p><code>3116</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3117</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>3118</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>3119</code><code>97&lt;/span&gt;</code></p><p><code>3120</code><code>:9561–9566.&lt;/span&gt;</code></p><p><code>3121</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>3122</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC16904/"&gt;</code></p><p><code>3123</code><code>PMC free article&lt;/a&gt;</code></p><p><code>3124</code><code>]&lt;/span&gt;</code></p><p><code>3125</code><code> [&lt;a href="/pubmed/10920191" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3126</code><code>PubMed&lt;/a&gt;</code></p><p><code>3127</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3128</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=The+nonpsychoactive+cannabis+constituent+cannabidiol+is+an+oral+anti-arthritic+therapeutic+in+murine+collagen-induced+arthritis&amp;amp;author=AM+Malfait&amp;amp;author=R+Gallily&amp;amp;author=PF+Sumariwalla&amp;amp;volume=97&amp;amp;publication_year=2000&amp;amp;pages=9561-9566&amp;amp;pmid=10920191&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3129</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3130</code><code>]&lt;/span&gt;</code></p><p><code>3131</code><code>&lt;/span&gt;</code></p><p><code>3132</code><code>&lt;/div&gt;</code></p><p><code>3133</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R86"&gt;</code></p><p><code>3134</code><code>86. &lt;span class="citation"&gt;</code></p><p><code>3135</code><code>Sumariwalla PF, Gallily R, Tchilibon S, Fride E, Mechoulam R, Feldmann M. A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis. &lt;span&gt;</code></p><p><code>3136</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3137</code><code>Arthritis Rheum. &lt;/span&gt;</code></p><p><code>3138</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>3139</code><code>50&lt;/span&gt;</code></p><p><code>3140</code><code>:985–998.&lt;/span&gt;</code></p><p><code>3141</code><code> [&lt;a href="/pubmed/15022343" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3142</code><code>PubMed&lt;/a&gt;</code></p><p><code>3143</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3144</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;amp;title=A+novel+synthetic,+nonpsychoactive+cannabinoid+acid+(HU-320)+with+antiinflammatory+properties+in+murine+collagen-induced+arthritis&amp;amp;author=PF+Sumariwalla&amp;amp;author=R+Gallily&amp;amp;author=S+Tchilibon&amp;amp;author=E+Fride&amp;amp;author=R+Mechoulam&amp;amp;volume=50&amp;amp;publication_year=2004&amp;amp;pages=985-998&amp;amp;pmid=15022343&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3145</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3146</code><code>]&lt;/span&gt;</code></p><p><code>3147</code><code>&lt;/span&gt;</code></p><p><code>3148</code><code>&lt;/div&gt;</code></p><p><code>3149</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R87"&gt;</code></p><p><code>3150</code><code>87. &lt;span class="citation"&gt;</code></p><p><code>3151</code><code>Mamytbekova A, Rezabek K, Kacerovska H, Grimova J, Svobodova J. Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors. &lt;span&gt;</code></p><p><code>3152</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3153</code><code>Neoplasma. &lt;/span&gt;</code></p><p><code>3154</code><code>1986;&lt;span class="ref-vol"&gt;</code></p><p><code>3155</code><code>33&lt;/span&gt;</code></p><p><code>3156</code><code>:417–421.&lt;/span&gt;</code></p><p><code>3157</code><code> [&lt;a href="/pubmed/3762804" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3158</code><code>PubMed&lt;/a&gt;</code></p><p><code>3159</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3160</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neoplasma&amp;amp;title=Antimetastatic+effect+of+flurbiprofen+and+other+platelet+aggregation+inhibitors&amp;amp;author=A+Mamytbekova&amp;amp;author=K+Rezabek&amp;amp;author=H+Kacerovska&amp;amp;author=J+Grimova&amp;amp;author=J+Svobodova&amp;amp;volume=33&amp;amp;publication_year=1986&amp;amp;pages=417-421&amp;amp;pmid=3762804&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3161</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3162</code><code>]&lt;/span&gt;</code></p><p><code>3163</code><code>&lt;/span&gt;</code></p><p><code>3164</code><code>&lt;/div&gt;</code></p><p><code>3165</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R88"&gt;</code></p><p><code>3166</code><code>88. &lt;span class="citation"&gt;</code></p><p><code>3167</code><code>Sarfaraz S, Adhami VM, Syed DN, Afaq F, Mukhtar H. Cannabinoids for cancer treatment: progress and promise. &lt;span&gt;</code></p><p><code>3168</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3169</code><code>Cancer Res. &lt;/span&gt;</code></p><p><code>3170</code><code>2008;&lt;span class="ref-vol"&gt;</code></p><p><code>3171</code><code>68&lt;/span&gt;</code></p><p><code>3172</code><code>:339–342.&lt;/span&gt;</code></p><p><code>3173</code><code> [&lt;a href="/pubmed/18199524" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3174</code><code>PubMed&lt;/a&gt;</code></p><p><code>3175</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3176</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Cannabinoids+for+cancer+treatment:+progress+and+promise&amp;amp;author=S+Sarfaraz&amp;amp;author=VM+Adhami&amp;amp;author=DN+Syed&amp;amp;author=F+Afaq&amp;amp;author=H+Mukhtar&amp;amp;volume=68&amp;amp;publication_year=2008&amp;amp;pages=339-342&amp;amp;pmid=18199524&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3177</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3178</code><code>]&lt;/span&gt;</code></p><p><code>3179</code><code>&lt;/span&gt;</code></p><p><code>3180</code><code>&lt;/div&gt;</code></p><p><code>3181</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R89"&gt;</code></p><p><code>3182</code><code>89. &lt;span class="citation"&gt;</code></p><p><code>3183</code><code>Carracedo A, Gironella M, Lorente M, et al.  Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. &lt;span&gt;</code></p><p><code>3184</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3185</code><code>Cancer Res. &lt;/span&gt;</code></p><p><code>3186</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>3187</code><code>66&lt;/span&gt;</code></p><p><code>3188</code><code>:6748–6755.&lt;/span&gt;</code></p><p><code>3189</code><code> [&lt;a href="/pubmed/16818650" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3190</code><code>PubMed&lt;/a&gt;</code></p><p><code>3191</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3192</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Cannabinoids+induce+apoptosis+of+pancreatic+tumor+cells+via+endoplasmic+reticulum+stress-related+genes&amp;amp;author=A+Carracedo&amp;amp;author=M+Gironella&amp;amp;author=M+Lorente&amp;amp;volume=66&amp;amp;publication_year=2006&amp;amp;pages=6748-6755&amp;amp;pmid=16818650&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3193</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3194</code><code>]&lt;/span&gt;</code></p><p><code>3195</code><code>&lt;/span&gt;</code></p><p><code>3196</code><code>&lt;/div&gt;</code></p><p><code>3197</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R90"&gt;</code></p><p><code>3198</code><code>90. &lt;span class="citation"&gt;</code></p><p><code>3199</code><code>Casanova ML, Blazquez C, Martinez-Palacio J, et al.  Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. &lt;span&gt;</code></p><p><code>3200</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3201</code><code>J Clin Invest. &lt;/span&gt;</code></p><p><code>3202</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>3203</code><code>111&lt;/span&gt;</code></p><p><code>3204</code><code>:43–50.&lt;/span&gt;</code></p><p><code>3205</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>3206</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC151833/"&gt;</code></p><p><code>3207</code><code>PMC free article&lt;/a&gt;</code></p><p><code>3208</code><code>]&lt;/span&gt;</code></p><p><code>3209</code><code> [&lt;a href="/pubmed/12511587" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3210</code><code>PubMed&lt;/a&gt;</code></p><p><code>3211</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3212</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;amp;title=Inhibition+of+skin+tumor+growth+and+angiogenesis+in+vivo+by+activation+of+cannabinoid+receptors&amp;amp;author=ML+Casanova&amp;amp;author=C+Blazquez&amp;amp;author=J+Martinez-Palacio&amp;amp;volume=111&amp;amp;publication_year=2003&amp;amp;pages=43-50&amp;amp;pmid=12511587&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3213</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3214</code><code>]&lt;/span&gt;</code></p><p><code>3215</code><code>&lt;/span&gt;</code></p><p><code>3216</code><code>&lt;/div&gt;</code></p><p><code>3217</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R91"&gt;</code></p><p><code>3218</code><code>91. &lt;span class="citation"&gt;</code></p><p><code>3219</code><code>Galve-Roperh I, Sanchez C, Cortes ML, et al.  Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. &lt;span&gt;</code></p><p><code>3220</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3221</code><code>Nat Med. &lt;/span&gt;</code></p><p><code>3222</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>3223</code><code>6&lt;/span&gt;</code></p><p><code>3224</code><code>:313–319.&lt;/span&gt;</code></p><p><code>3225</code><code> [&lt;a href="/pubmed/10700234" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3226</code><code>PubMed&lt;/a&gt;</code></p><p><code>3227</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3228</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;amp;title=Anti-tumoral+action+of+cannabinoids:+involvement+of+sustained+ceramide+accumulation+and+extracellular+signal-regulated+kinase+activation&amp;amp;author=I+Galve-Roperh&amp;amp;author=C+Sanchez&amp;amp;author=ML+Cortes&amp;amp;volume=6&amp;amp;publication_year=2000&amp;amp;pages=313-319&amp;amp;pmid=10700234&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3229</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3230</code><code>]&lt;/span&gt;</code></p><p><code>3231</code><code>&lt;/span&gt;</code></p><p><code>3232</code><code>&lt;/div&gt;</code></p><p><code>3233</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R92"&gt;</code></p><p><code>3234</code><code>92. &lt;span class="citation"&gt;</code></p><p><code>3235</code><code>Sanchez C, de Ceballos ML, Gomez del Pulgar T, et al.  Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. &lt;span&gt;</code></p><p><code>3236</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3237</code><code>Cancer Res. &lt;/span&gt;</code></p><p><code>3238</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>3239</code><code>61&lt;/span&gt;</code></p><p><code>3240</code><code>:5784–5789.&lt;/span&gt;</code></p><p><code>3241</code><code> [&lt;a href="/pubmed/11479216" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3242</code><code>PubMed&lt;/a&gt;</code></p><p><code>3243</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3244</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Inhibition+of+glioma+growth+in+vivo+by+selective+activation+of+the+CB(2)+cannabinoid+receptor&amp;amp;author=C+Sanchez&amp;amp;author=ML+de+Ceballos&amp;amp;author=T+Gomez+del+Pulgar&amp;amp;volume=61&amp;amp;publication_year=2001&amp;amp;pages=5784-5789&amp;amp;pmid=11479216&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3245</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3246</code><code>]&lt;/span&gt;</code></p><p><code>3247</code><code>&lt;/span&gt;</code></p><p><code>3248</code><code>&lt;/div&gt;</code></p><p><code>3249</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R93"&gt;</code></p><p><code>3250</code><code>93. &lt;span class="citation"&gt;</code></p><p><code>3251</code><code>Sarfaraz S, Afaq F, Adhami VM, Mukhtar H. Cannabinoid receptor as a novel target for the treatment of prostate cancer. &lt;span&gt;</code></p><p><code>3252</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3253</code><code>Cancer Res. &lt;/span&gt;</code></p><p><code>3254</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>3255</code><code>65&lt;/span&gt;</code></p><p><code>3256</code><code>:1635–1641.&lt;/span&gt;</code></p><p><code>3257</code><code> [&lt;a href="/pubmed/15753356" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3258</code><code>PubMed&lt;/a&gt;</code></p><p><code>3259</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3260</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Cannabinoid+receptor+as+a+novel+target+for+the+treatment+of+prostate+cancer&amp;amp;author=S+Sarfaraz&amp;amp;author=F+Afaq&amp;amp;author=VM+Adhami&amp;amp;author=H+Mukhtar&amp;amp;volume=65&amp;amp;publication_year=2005&amp;amp;pages=1635-1641&amp;amp;pmid=15753356&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3261</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3262</code><code>]&lt;/span&gt;</code></p><p><code>3263</code><code>&lt;/span&gt;</code></p><p><code>3264</code><code>&lt;/div&gt;</code></p><p><code>3265</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R94"&gt;</code></p><p><code>3266</code><code>94. &lt;span class="citation"&gt;</code></p><p><code>3267</code><code>Velasco G, Galve-Roperh I, Sanchez C, Blazquez C, Guzman M. Hypothesis: cannabinoid therapy for the treatment of gliomas? &lt;span&gt;</code></p><p><code>3268</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3269</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>3270</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>3271</code><code>47&lt;/span&gt;</code></p><p><code>3272</code><code>:315–323.&lt;/span&gt;</code></p><p><code>3273</code><code> [&lt;a href="/pubmed/15275820" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3274</code><code>PubMed&lt;/a&gt;</code></p><p><code>3275</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3276</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Hypothesis:+cannabinoid+therapy+for+the+treatment+of+gliomas?&amp;amp;author=G+Velasco&amp;amp;author=I+Galve-Roperh&amp;amp;author=C+Sanchez&amp;amp;author=C+Blazquez&amp;amp;author=M+Guzman&amp;amp;volume=47&amp;amp;publication_year=2004&amp;amp;pages=315-323&amp;amp;pmid=15275820&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3277</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3278</code><code>]&lt;/span&gt;</code></p><p><code>3279</code><code>&lt;/span&gt;</code></p><p><code>3280</code><code>&lt;/div&gt;</code></p><p><code>3281</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R95"&gt;</code></p><p><code>3282</code><code>95. &lt;span class="citation"&gt;</code></p><p><code>3283</code><code>Lombard C, Nagarkatti M, Nagarkatti PS. Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in &amp;#x00394;9-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells. &lt;span&gt;</code></p><p><code>3284</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3285</code><code>Leuk Res. &lt;/span&gt;</code></p><p><code>3286</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>3287</code><code>29&lt;/span&gt;</code></p><p><code>3288</code><code>:915–922.&lt;/span&gt;</code></p><p><code>3289</code><code> [&lt;a href="/pubmed/15978942" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3290</code><code>PubMed&lt;/a&gt;</code></p><p><code>3291</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3292</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Leuk+Res&amp;amp;title=Targeting+cannabinoid+receptors+to+treat+leukemia:+role+of+cross-talk+between+extrinsic+and+intrinsic+pathways+in+&amp;#x00394;9-tetrahydrocannabinol+(THC)-induced+apoptosis+of+Jurkat+cells&amp;amp;author=C+Lombard&amp;amp;author=M+Nagarkatti&amp;amp;author=PS+Nagarkatti&amp;amp;volume=29&amp;amp;publication_year=2005&amp;amp;pages=915-922&amp;amp;pmid=15978942&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3293</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3294</code><code>]&lt;/span&gt;</code></p><p><code>3295</code><code>&lt;/span&gt;</code></p><p><code>3296</code><code>&lt;/div&gt;</code></p><p><code>3297</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R96"&gt;</code></p><p><code>3298</code><code>96. &lt;span class="citation"&gt;</code></p><p><code>3299</code><code>Jia W, Hegde VL, Singh NP, et al.  &amp;#x00394;9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria. &lt;span&gt;</code></p><p><code>3300</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3301</code><code>Mol Cancer Res. &lt;/span&gt;</code></p><p><code>3302</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>3303</code><code>4&lt;/span&gt;</code></p><p><code>3304</code><code>:549–562.&lt;/span&gt;</code></p><p><code>3305</code><code> [&lt;a href="/pubmed/16908594" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3306</code><code>PubMed&lt;/a&gt;</code></p><p><code>3307</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3308</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cancer+Res&amp;amp;title=&amp;#x00394;9-tetrahydrocannabinol-induced+apoptosis+in+Jurkat+leukemia+T+cells+is+regulated+by+translocation+of+Bad+to+mitochondria&amp;amp;author=W+Jia&amp;amp;author=VL+Hegde&amp;amp;author=NP+Singh&amp;amp;volume=4&amp;amp;publication_year=2006&amp;amp;pages=549-562&amp;amp;pmid=16908594&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3309</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3310</code><code>]&lt;/span&gt;</code></p><p><code>3311</code><code>&lt;/span&gt;</code></p><p><code>3312</code><code>&lt;/div&gt;</code></p><p><code>3313</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R97"&gt;</code></p><p><code>3314</code><code>97. &lt;span class="citation"&gt;</code></p><p><code>3315</code><code>McKallip RJ, Lombard C, Fisher M, et al.  Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. &lt;span&gt;</code></p><p><code>3316</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3317</code><code>Blood. &lt;/span&gt;</code></p><p><code>3318</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>3319</code><code>100&lt;/span&gt;</code></p><p><code>3320</code><code>:627–634.&lt;/span&gt;</code></p><p><code>3321</code><code> [&lt;a href="/pubmed/12091357" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3322</code><code>PubMed&lt;/a&gt;</code></p><p><code>3323</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3324</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;amp;title=Targeting+CB2+cannabinoid+receptors+as+a+novel+therapy+to+treat+malignant+lymphoblastic+disease&amp;amp;author=RJ+McKallip&amp;amp;author=C+Lombard&amp;amp;author=M+Fisher&amp;amp;volume=100&amp;amp;publication_year=2002&amp;amp;pages=627-634&amp;amp;pmid=12091357&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3325</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3326</code><code>]&lt;/span&gt;</code></p><p><code>3327</code><code>&lt;/span&gt;</code></p><p><code>3328</code><code>&lt;/div&gt;</code></p><p><code>3329</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R98"&gt;</code></p><p><code>3330</code><code>98. &lt;span class="citation"&gt;</code></p><p><code>3331</code><code>Ligresti A, Bisogno T, Matias I, et al.  Possible endocannabinoid control of colorectal cancer growth. &lt;span&gt;</code></p><p><code>3332</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3333</code><code>Gastroenterology. &lt;/span&gt;</code></p><p><code>3334</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>3335</code><code>125&lt;/span&gt;</code></p><p><code>3336</code><code>:677–687.&lt;/span&gt;</code></p><p><code>3337</code><code> [&lt;a href="/pubmed/12949714" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3338</code><code>PubMed&lt;/a&gt;</code></p><p><code>3339</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3340</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;amp;title=Possible+endocannabinoid+control+of+colorectal+cancer+growth&amp;amp;author=A+Ligresti&amp;amp;author=T+Bisogno&amp;amp;author=I+Matias&amp;amp;volume=125&amp;amp;publication_year=2003&amp;amp;pages=677-687&amp;amp;pmid=12949714&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3341</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3342</code><code>]&lt;/span&gt;</code></p><p><code>3343</code><code>&lt;/span&gt;</code></p><p><code>3344</code><code>&lt;/div&gt;</code></p><p><code>3345</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R99"&gt;</code></p><p><code>3346</code><code>99. &lt;span class="citation"&gt;</code></p><p><code>3347</code><code>Cianchi F, Papucci L, Schiavone N, et al.  Cannabinoid receptor activation induces apoptosis through tumor necrosis factor &amp;#x003b1;-mediated ceramide de novo synthesis in colon cancer cells. &lt;span&gt;</code></p><p><code>3348</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3349</code><code>Clin Cancer Res. &lt;/span&gt;</code></p><p><code>3350</code><code>2008;&lt;span class="ref-vol"&gt;</code></p><p><code>3351</code><code>14&lt;/span&gt;</code></p><p><code>3352</code><code>:7691–7700.&lt;/span&gt;</code></p><p><code>3353</code><code> [&lt;a href="/pubmed/19047095" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3354</code><code>PubMed&lt;/a&gt;</code></p><p><code>3355</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3356</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;amp;title=Cannabinoid+receptor+activation+induces+apoptosis+through+tumor+necrosis+factor+&amp;#x003b1;-mediated+ceramide+de+novo+synthesis+in+colon+cancer+cells&amp;amp;author=F+Cianchi&amp;amp;author=L+Papucci&amp;amp;author=N+Schiavone&amp;amp;volume=14&amp;amp;publication_year=2008&amp;amp;pages=7691-7700&amp;amp;pmid=19047095&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3357</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3358</code><code>]&lt;/span&gt;</code></p><p><code>3359</code><code>&lt;/span&gt;</code></p><p><code>3360</code><code>&lt;/div&gt;</code></p><p><code>3361</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R100"&gt;</code></p><p><code>3362</code><code>100. &lt;span class="citation"&gt;</code></p><p><code>3363</code><code>Bifulco M, Laezza C, Valenti M, et al.  A new strategy to block tumor growth by inhibiting endocannabinoid inactivation. &lt;span&gt;</code></p><p><code>3364</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3365</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>3366</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>3367</code><code>18&lt;/span&gt;</code></p><p><code>3368</code><code>:1606–1608.&lt;/span&gt;</code></p><p><code>3369</code><code> [&lt;a href="/pubmed/15289448" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3370</code><code>PubMed&lt;/a&gt;</code></p><p><code>3371</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3372</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=A+new+strategy+to+block+tumor+growth+by+inhibiting+endocannabinoid+inactivation&amp;amp;author=M+Bifulco&amp;amp;author=C+Laezza&amp;amp;author=M+Valenti&amp;amp;volume=18&amp;amp;publication_year=2004&amp;amp;pages=1606-1608&amp;amp;pmid=15289448&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3373</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3374</code><code>]&lt;/span&gt;</code></p><p><code>3375</code><code>&lt;/span&gt;</code></p><p><code>3376</code><code>&lt;/div&gt;</code></p><p><code>3377</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R101"&gt;</code></p><p><code>3378</code><code>101. &lt;span class="citation"&gt;</code></p><p><code>3379</code><code>De Lago E, Gustafsson SB, Fernandez-Ruiz J, et al.  Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations. &lt;span&gt;</code></p><p><code>3380</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3381</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>3382</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>3383</code><code>99&lt;/span&gt;</code></p><p><code>3384</code><code>:677–688.&lt;/span&gt;</code></p><p><code>3385</code><code> [&lt;a href="/pubmed/16899063" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3386</code><code>PubMed&lt;/a&gt;</code></p><p><code>3387</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3388</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Acyl-based+anandamide+uptake+inhibitors+cause+rapid+toxicity+to+C6+glioma+cells+at+pharmacologically+relevant+concentrations&amp;amp;author=E+De+Lago&amp;amp;author=SB+Gustafsson&amp;amp;author=J+Fernandez-Ruiz&amp;amp;volume=99&amp;amp;publication_year=2006&amp;amp;pages=677-688&amp;amp;pmid=16899063&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3389</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3390</code><code>]&lt;/span&gt;</code></p><p><code>3391</code><code>&lt;/span&gt;</code></p><p><code>3392</code><code>&lt;/div&gt;</code></p><p><code>3393</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R102"&gt;</code></p><p><code>3394</code><code>102. &lt;span class="citation"&gt;</code></p><p><code>3395</code><code>Endsley MP, Aggarwal N, Isbell MA, et al.  Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: location, hydrolysis and 12-lipoxygenase metabolism. &lt;span&gt;</code></p><p><code>3396</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3397</code><code>Int J Cancer. &lt;/span&gt;</code></p><p><code>3398</code><code>2007;&lt;span class="ref-vol"&gt;</code></p><p><code>3399</code><code>121&lt;/span&gt;</code></p><p><code>3400</code><code>:984–991.&lt;/span&gt;</code></p><p><code>3401</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>3402</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2565646/"&gt;</code></p><p><code>3403</code><code>PMC free article&lt;/a&gt;</code></p><p><code>3404</code><code>]&lt;/span&gt;</code></p><p><code>3405</code><code> [&lt;a href="/pubmed/17443494" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3406</code><code>PubMed&lt;/a&gt;</code></p><p><code>3407</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3408</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer&amp;amp;title=Diverse+roles+of+2-arachidonoylglycerol+in+invasion+of+prostate+carcinoma+cells:+location,+hydrolysis+and+12-lipoxygenase+metabolism&amp;amp;author=MP+Endsley&amp;amp;author=N+Aggarwal&amp;amp;author=MA+Isbell&amp;amp;volume=121&amp;amp;publication_year=2007&amp;amp;pages=984-991&amp;amp;pmid=17443494&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3409</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3410</code><code>]&lt;/span&gt;</code></p><p><code>3411</code><code>&lt;/span&gt;</code></p><p><code>3412</code><code>&lt;/div&gt;</code></p><p><code>3413</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R103"&gt;</code></p><p><code>3414</code><code>103. &lt;span class="citation"&gt;</code></p><p><code>3415</code><code>Nithipatikom K, Endsley MP, Isbell MA, Wheelock CE, Hammock BD, Campbell WB. A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells. &lt;span&gt;</code></p><p><code>3416</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3417</code><code>Biochem Biophys Res Commun. &lt;/span&gt;</code></p><p><code>3418</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>3419</code><code>332&lt;/span&gt;</code></p><p><code>3420</code><code>:1028–1033.&lt;/span&gt;</code></p><p><code>3421</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>3422</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1450257/"&gt;</code></p><p><code>3423</code><code>PMC free article&lt;/a&gt;</code></p><p><code>3424</code><code>]&lt;/span&gt;</code></p><p><code>3425</code><code> [&lt;a href="/pubmed/15919052" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3426</code><code>PubMed&lt;/a&gt;</code></p><p><code>3427</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3428</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;amp;title=A+new+class+of+inhibitors+of+2-arachidonoylglycerol+hydrolysis+and+invasion+of+prostate+cancer+cells&amp;amp;author=K+Nithipatikom&amp;amp;author=MP+Endsley&amp;amp;author=MA+Isbell&amp;amp;author=CE+Wheelock&amp;amp;author=BD+Hammock&amp;amp;volume=332&amp;amp;publication_year=2005&amp;amp;pages=1028-1033&amp;amp;pmid=15919052&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3429</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3430</code><code>]&lt;/span&gt;</code></p><p><code>3431</code><code>&lt;/span&gt;</code></p><p><code>3432</code><code>&lt;/div&gt;</code></p><p><code>3433</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R104"&gt;</code></p><p><code>3434</code><code>104. &lt;span class="citation"&gt;</code></p><p><code>3435</code><code>Contassot E, Tenan M, Schnuriger V, Pelte MF, Dietrich PY. Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1. &lt;span&gt;</code></p><p><code>3436</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3437</code><code>Gynecol Oncol. &lt;/span&gt;</code></p><p><code>3438</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>3439</code><code>93&lt;/span&gt;</code></p><p><code>3440</code><code>:182–188.&lt;/span&gt;</code></p><p><code>3441</code><code> [&lt;a href="/pubmed/15047233" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3442</code><code>PubMed&lt;/a&gt;</code></p><p><code>3443</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3444</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gynecol+Oncol&amp;amp;title=Arachidonyl+ethanolamide+induces+apoptosis+of+uterine+cervix+cancer+cells+via+aberrantly+expressed+vanilloid+receptor-1&amp;amp;author=E+Contassot&amp;amp;author=M+Tenan&amp;amp;author=V+Schnuriger&amp;amp;author=MF+Pelte&amp;amp;author=PY+Dietrich&amp;amp;volume=93&amp;amp;publication_year=2004&amp;amp;pages=182-188&amp;amp;pmid=15047233&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3445</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3446</code><code>]&lt;/span&gt;</code></p><p><code>3447</code><code>&lt;/span&gt;</code></p><p><code>3448</code><code>&lt;/div&gt;</code></p><p><code>3449</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R105"&gt;</code></p><p><code>3450</code><code>105. &lt;span class="citation"&gt;</code></p><p><code>3451</code><code>Contassot E, Wilmotte R, Tenan M, et al.  Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1. &lt;span&gt;</code></p><p><code>3452</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3453</code><code>J Neuropathol Exp Neurol. &lt;/span&gt;</code></p><p><code>3454</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>3455</code><code>63&lt;/span&gt;</code></p><p><code>3456</code><code>:956–963.&lt;/span&gt;</code></p><p><code>3457</code><code> [&lt;a href="/pubmed/15453094" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3458</code><code>PubMed&lt;/a&gt;</code></p><p><code>3459</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3460</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neuropathol+Exp+Neurol&amp;amp;title=Arachidonylethanolamide+induces+apoptosis+of+human+glioma+cells+through+vanilloid+receptor-1&amp;amp;author=E+Contassot&amp;amp;author=R+Wilmotte&amp;amp;author=M+Tenan&amp;amp;volume=63&amp;amp;publication_year=2004&amp;amp;pages=956-963&amp;amp;pmid=15453094&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3461</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3462</code><code>]&lt;/span&gt;</code></p><p><code>3463</code><code>&lt;/span&gt;</code></p><p><code>3464</code><code>&lt;/div&gt;</code></p><p><code>3465</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R106"&gt;</code></p><p><code>3466</code><code>106. &lt;span class="citation"&gt;</code></p><p><code>3467</code><code>DeMorrow S, Glaser S, Francis H, et al.  Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts. &lt;span&gt;</code></p><p><code>3468</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3469</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>3470</code><code>2007;&lt;span class="ref-vol"&gt;</code></p><p><code>3471</code><code>282&lt;/span&gt;</code></p><p><code>3472</code><code>:13098–13113.&lt;/span&gt;</code></p><p><code>3473</code><code> [&lt;a href="/pubmed/17329257" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3474</code><code>PubMed&lt;/a&gt;</code></p><p><code>3475</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3476</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Opposing+actions+of+endocannabinoids+on+cholangiocarcinoma+growth:+recruitment+of+Fas+and+Fas+ligand+to+lipid+rafts&amp;amp;author=S+DeMorrow&amp;amp;author=S+Glaser&amp;amp;author=H+Francis&amp;amp;volume=282&amp;amp;publication_year=2007&amp;amp;pages=13098-13113&amp;amp;pmid=17329257&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3477</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3478</code><code>]&lt;/span&gt;</code></p><p><code>3479</code><code>&lt;/span&gt;</code></p><p><code>3480</code><code>&lt;/div&gt;</code></p><p><code>3481</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R107"&gt;</code></p><p><code>3482</code><code>107. &lt;span class="citation"&gt;</code></p><p><code>3483</code><code>Bifulco M, Laezza C, Portella G, et al.  Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. &lt;span&gt;</code></p><p><code>3484</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3485</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>3486</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>3487</code><code>15&lt;/span&gt;</code></p><p><code>3488</code><code>:2745–2747.&lt;/span&gt;</code></p><p><code>3489</code><code> [&lt;a href="/pubmed/11687506" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3490</code><code>PubMed&lt;/a&gt;</code></p><p><code>3491</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3492</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=Control+by+the+endogenous+cannabinoid+system+of+ras+oncogene-dependent+tumor+growth&amp;amp;author=M+Bifulco&amp;amp;author=C+Laezza&amp;amp;author=G+Portella&amp;amp;volume=15&amp;amp;publication_year=2001&amp;amp;pages=2745-2747&amp;amp;pmid=11687506&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3493</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3494</code><code>]&lt;/span&gt;</code></p><p><code>3495</code><code>&lt;/span&gt;</code></p><p><code>3496</code><code>&lt;/div&gt;</code></p><p><code>3497</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R108"&gt;</code></p><p><code>3498</code><code>108. &lt;span class="citation"&gt;</code></p><p><code>3499</code><code>Caffarel MM, Sarrio D, Palacios J, Guzman M, Sanchez C. &amp;#x00394;9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. &lt;span&gt;</code></p><p><code>3500</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3501</code><code>Cancer Res. &lt;/span&gt;</code></p><p><code>3502</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>3503</code><code>66&lt;/span&gt;</code></p><p><code>3504</code><code>:6615–6621.&lt;/span&gt;</code></p><p><code>3505</code><code> [&lt;a href="/pubmed/16818634" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3506</code><code>PubMed&lt;/a&gt;</code></p><p><code>3507</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3508</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=&amp;#x00394;9-tetrahydrocannabinol+inhibits+cell+cycle+progression+in+human+breast+cancer+cells+through+Cdc2+regulation&amp;amp;author=MM+Caffarel&amp;amp;author=D+Sarrio&amp;amp;author=J+Palacios&amp;amp;author=M+Guzman&amp;amp;author=C+Sanchez&amp;amp;volume=66&amp;amp;publication_year=2006&amp;amp;pages=6615-6621&amp;amp;pmid=16818634&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3509</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3510</code><code>]&lt;/span&gt;</code></p><p><code>3511</code><code>&lt;/span&gt;</code></p><p><code>3512</code><code>&lt;/div&gt;</code></p><p><code>3513</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R109"&gt;</code></p><p><code>3514</code><code>109. &lt;span class="citation"&gt;</code></p><p><code>3515</code><code>Ek S, Hogerkorp CM, Dictor M, Ehinger M, Borrebaeck CA. Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells. &lt;span&gt;</code></p><p><code>3516</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3517</code><code>Cancer Res. &lt;/span&gt;</code></p><p><code>3518</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>3519</code><code>62&lt;/span&gt;</code></p><p><code>3520</code><code>:4398–4405.&lt;/span&gt;</code></p><p><code>3521</code><code> [&lt;a href="/pubmed/12154046" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3522</code><code>PubMed&lt;/a&gt;</code></p><p><code>3523</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3524</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Mantle+cell+lymphomas+express+a+distinct+genetic+signature+affecting+lymphocyte+trafficking+and+growth+regulation+as+compared+with+subpopulations+of+normal+human+B+cells&amp;amp;author=S+Ek&amp;amp;author=CM+Hogerkorp&amp;amp;author=M+Dictor&amp;amp;author=M+Ehinger&amp;amp;author=CA+Borrebaeck&amp;amp;volume=62&amp;amp;publication_year=2002&amp;amp;pages=4398-4405&amp;amp;pmid=12154046&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3525</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3526</code><code>]&lt;/span&gt;</code></p><p><code>3527</code><code>&lt;/span&gt;</code></p><p><code>3528</code><code>&lt;/div&gt;</code></p><p><code>3529</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R110"&gt;</code></p><p><code>3530</code><code>110. &lt;span class="citation"&gt;</code></p><p><code>3531</code><code>Islam TC, Asplund AC, Lindvall JM, et al.  High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of cyclin D1 in mantle cell lymphoma. &lt;span&gt;</code></p><p><code>3532</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3533</code><code>Leukemia. &lt;/span&gt;</code></p><p><code>3534</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>3535</code><code>17&lt;/span&gt;</code></p><p><code>3536</code><code>:1880–1890.&lt;/span&gt;</code></p><p><code>3537</code><code> [&lt;a href="/pubmed/12970790" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3538</code><code>PubMed&lt;/a&gt;</code></p><p><code>3539</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3540</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;amp;title=High+level+of+cannabinoid+receptor+1,+absence+of+regulator+of+G+protein+signalling+13+and+differential+expression+of+cyclin+D1+in+mantle+cell+lymphoma&amp;amp;author=TC+Islam&amp;amp;author=AC+Asplund&amp;amp;author=JM+Lindvall&amp;amp;volume=17&amp;amp;publication_year=2003&amp;amp;pages=1880-1890&amp;amp;pmid=12970790&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3541</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3542</code><code>]&lt;/span&gt;</code></p><p><code>3543</code><code>&lt;/span&gt;</code></p><p><code>3544</code><code>&lt;/div&gt;</code></p><p><code>3545</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R111"&gt;</code></p><p><code>3546</code><code>111. &lt;span class="citation"&gt;</code></p><p><code>3547</code><code>Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. &lt;span&gt;</code></p><p><code>3548</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3549</code><code>Annu Rev Immunol. &lt;/span&gt;</code></p><p><code>3550</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>3551</code><code>17&lt;/span&gt;</code></p><p><code>3552</code><code>:255–281.&lt;/span&gt;</code></p><p><code>3553</code><code> [&lt;a href="/pubmed/10358759" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3554</code><code>PubMed&lt;/a&gt;</code></p><p><code>3555</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3556</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Immunol&amp;amp;title=Immunologic+basis+of+antigen-induced+airway+hyperresponsiveness&amp;amp;author=M+Wills-Karp&amp;amp;volume=17&amp;amp;publication_year=1999&amp;amp;pages=255-281&amp;amp;pmid=10358759&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3557</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3558</code><code>]&lt;/span&gt;</code></p><p><code>3559</code><code>&lt;/span&gt;</code></p><p><code>3560</code><code>&lt;/div&gt;</code></p><p><code>3561</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R112"&gt;</code></p><p><code>3562</code><code>112. &lt;span class="citation"&gt;</code></p><p><code>3563</code><code>Anderson GP, Coyle AJ. TH2 and &amp;#x02018;TH2-like&amp;#x02019; cells in allergy and asthma: pharmacological perspectives. &lt;span&gt;</code></p><p><code>3564</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3565</code><code>Trends Pharmacol Sci. &lt;/span&gt;</code></p><p><code>3566</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>3567</code><code>15&lt;/span&gt;</code></p><p><code>3568</code><code>:324–332.&lt;/span&gt;</code></p><p><code>3569</code><code> [&lt;a href="/pubmed/7992386" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3570</code><code>PubMed&lt;/a&gt;</code></p><p><code>3571</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3572</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Trends+Pharmacol+Sci&amp;amp;title=TH2+and+&amp;#x02018;TH2-like&amp;#x02019;+cells+in+allergy+and+asthma:+pharmacological+perspectives&amp;amp;author=GP+Anderson&amp;amp;author=AJ+Coyle&amp;amp;volume=15&amp;amp;publication_year=1994&amp;amp;pages=324-332&amp;amp;pmid=7992386&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3573</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3574</code><code>]&lt;/span&gt;</code></p><p><code>3575</code><code>&lt;/span&gt;</code></p><p><code>3576</code><code>&lt;/div&gt;</code></p><p><code>3577</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R113"&gt;</code></p><p><code>3578</code><code>113. &lt;span class="citation"&gt;</code></p><p><code>3579</code><code>Jan TR, Farraj AK, Harkema JR, Kaminski NE. Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice. &lt;span&gt;</code></p><p><code>3580</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3581</code><code>Toxicol Appl Pharmacol. &lt;/span&gt;</code></p><p><code>3582</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>3583</code><code>188&lt;/span&gt;</code></p><p><code>3584</code><code>:24–35.&lt;/span&gt;</code></p><p><code>3585</code><code> [&lt;a href="/pubmed/12668119" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3586</code><code>PubMed&lt;/a&gt;</code></p><p><code>3587</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3588</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Toxicol+Appl+Pharmacol&amp;amp;title=Attenuation+of+the+ovalbumin-induced+allergic+airway+response+by+cannabinoid+treatment+in+A/J+mice&amp;amp;author=TR+Jan&amp;amp;author=AK+Farraj&amp;amp;author=JR+Harkema&amp;amp;author=NE+Kaminski&amp;amp;volume=188&amp;amp;publication_year=2003&amp;amp;pages=24-35&amp;amp;pmid=12668119&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3589</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3590</code><code>]&lt;/span&gt;</code></p><p><code>3591</code><code>&lt;/span&gt;</code></p><p><code>3592</code><code>&lt;/div&gt;</code></p><p><code>3593</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R114"&gt;</code></p><p><code>3594</code><code>114. &lt;span class="citation"&gt;</code></p><p><code>3595</code><code>Tashkin DP, Reiss S, Shapiro BJ, Calvarese B, Olsen JL, Lodge JW. Bronchial effects of aerosolized &amp;#x00394;9-tetrahydrocannabinol in healthy and asthmatic subjects. &lt;span&gt;</code></p><p><code>3596</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3597</code><code>Am Rev Respir Dis. &lt;/span&gt;</code></p><p><code>3598</code><code>1977;&lt;span class="ref-vol"&gt;</code></p><p><code>3599</code><code>115&lt;/span&gt;</code></p><p><code>3600</code><code>:57–65.&lt;/span&gt;</code></p><p><code>3601</code><code> [&lt;a href="/pubmed/319717" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3602</code><code>PubMed&lt;/a&gt;</code></p><p><code>3603</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3604</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+Rev+Respir+Dis&amp;amp;title=Bronchial+effects+of+aerosolized+&amp;#x00394;9-tetrahydrocannabinol+in+healthy+and+asthmatic+subjects&amp;amp;author=DP+Tashkin&amp;amp;author=S+Reiss&amp;amp;author=BJ+Shapiro&amp;amp;author=B+Calvarese&amp;amp;author=JL+Olsen&amp;amp;volume=115&amp;amp;publication_year=1977&amp;amp;pages=57-65&amp;amp;pmid=319717&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3605</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3606</code><code>]&lt;/span&gt;</code></p><p><code>3607</code><code>&lt;/span&gt;</code></p><p><code>3608</code><code>&lt;/div&gt;</code></p><p><code>3609</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R115"&gt;</code></p><p><code>3610</code><code>115. &lt;span class="citation"&gt;</code></p><p><code>3611</code><code>Abboud RT, Sanders HD. Effect of oral administration of &amp;#x00394;-tetrahydrocannabinol on airway mechanics in normal and asthmatic subjects. &lt;span&gt;</code></p><p><code>3612</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3613</code><code>Chest. &lt;/span&gt;</code></p><p><code>3614</code><code>1976;&lt;span class="ref-vol"&gt;</code></p><p><code>3615</code><code>70&lt;/span&gt;</code></p><p><code>3616</code><code>:480–485.&lt;/span&gt;</code></p><p><code>3617</code><code> [&lt;a href="/pubmed/789025" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3618</code><code>PubMed&lt;/a&gt;</code></p><p><code>3619</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3620</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;amp;title=Effect+of+oral+administration+of+&amp;#x00394;-tetrahydrocannabinol+on+airway+mechanics+in+normal+and+asthmatic+subjects&amp;amp;author=RT+Abboud&amp;amp;author=HD+Sanders&amp;amp;volume=70&amp;amp;publication_year=1976&amp;amp;pages=480-485&amp;amp;pmid=789025&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3621</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3622</code><code>]&lt;/span&gt;</code></p><p><code>3623</code><code>&lt;/span&gt;</code></p><p><code>3624</code><code>&lt;/div&gt;</code></p><p><code>3625</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R116"&gt;</code></p><p><code>3626</code><code>116. &lt;span class="citation"&gt;</code></p><p><code>3627</code><code>Hartley JP, Nogrady SG, Seaton A. Bronchodilator effect of &amp;#x00394;1-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>3628</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3629</code><code>Br J Clin Pharmacol. &lt;/span&gt;</code></p><p><code>3630</code><code>1978;&lt;span class="ref-vol"&gt;</code></p><p><code>3631</code><code>5&lt;/span&gt;</code></p><p><code>3632</code><code>:523–525.&lt;/span&gt;</code></p><p><code>3633</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>3634</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1429361/"&gt;</code></p><p><code>3635</code><code>PMC free article&lt;/a&gt;</code></p><p><code>3636</code><code>]&lt;/span&gt;</code></p><p><code>3637</code><code> [&lt;a href="/pubmed/656294" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3638</code><code>PubMed&lt;/a&gt;</code></p><p><code>3639</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3640</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Clin+Pharmacol&amp;amp;title=Bronchodilator+effect+of+&amp;#x00394;1-tetrahydrocannabinol&amp;amp;author=JP+Hartley&amp;amp;author=SG+Nogrady&amp;amp;author=A+Seaton&amp;amp;volume=5&amp;amp;publication_year=1978&amp;amp;pages=523-525&amp;amp;pmid=656294&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3641</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3642</code><code>]&lt;/span&gt;</code></p><p><code>3643</code><code>&lt;/span&gt;</code></p><p><code>3644</code><code>&lt;/div&gt;</code></p><p><code>3645</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R117"&gt;</code></p><p><code>3646</code><code>117. &lt;span class="citation"&gt;</code></p><p><code>3647</code><code>Calignano A, Katona I, Desarnaud F, et al.  Bidirectional control of airway responsiveness by endogenous cannabinoids. &lt;span&gt;</code></p><p><code>3648</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3649</code><code>Nature. &lt;/span&gt;</code></p><p><code>3650</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>3651</code><code>408&lt;/span&gt;</code></p><p><code>3652</code><code>:96–101.&lt;/span&gt;</code></p><p><code>3653</code><code> [&lt;a href="/pubmed/11081515" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3654</code><code>PubMed&lt;/a&gt;</code></p><p><code>3655</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3656</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;amp;title=Bidirectional+control+of+airway+responsiveness+by+endogenous+cannabinoids&amp;amp;author=A+Calignano&amp;amp;author=I+Katona&amp;amp;author=F+Desarnaud&amp;amp;volume=408&amp;amp;publication_year=2000&amp;amp;pages=96-101&amp;amp;pmid=11081515&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3657</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3658</code><code>]&lt;/span&gt;</code></p><p><code>3659</code><code>&lt;/span&gt;</code></p><p><code>3660</code><code>&lt;/div&gt;</code></p><p><code>3661</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R118"&gt;</code></p><p><code>3662</code><code>118. &lt;span class="citation"&gt;</code></p><p><code>3663</code><code>Rajesh M, Mukhopadhyay P, Batkai S, et al.  Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. &lt;span&gt;</code></p><p><code>3664</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3665</code><code>Am J Physiol Heart Circ Physiol. &lt;/span&gt;</code></p><p><code>3666</code><code>2007;&lt;span class="ref-vol"&gt;</code></p><p><code>3667</code><code>293&lt;/span&gt;</code></p><p><code>3668</code><code>:H610–H619.&lt;/span&gt;</code></p><p><code>3669</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>3670</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2228254/"&gt;</code></p><p><code>3671</code><code>PMC free article&lt;/a&gt;</code></p><p><code>3672</code><code>]&lt;/span&gt;</code></p><p><code>3673</code><code> [&lt;a href="/pubmed/17384130" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3674</code><code>PubMed&lt;/a&gt;</code></p><p><code>3675</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3676</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Heart+Circ+Physiol&amp;amp;title=Cannabidiol+attenuates+high+glucose-induced+endothelial+cell+inflammatory+response+and+barrier+disruption&amp;amp;author=M+Rajesh&amp;amp;author=P+Mukhopadhyay&amp;amp;author=S+Batkai&amp;amp;volume=293&amp;amp;publication_year=2007&amp;amp;pages=H610-H619&amp;amp;pmid=17384130&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3677</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3678</code><code>]&lt;/span&gt;</code></p><p><code>3679</code><code>&lt;/span&gt;</code></p><p><code>3680</code><code>&lt;/div&gt;</code></p><p><code>3681</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R119"&gt;</code></p><p><code>3682</code><code>119. &lt;span class="citation"&gt;</code></p><p><code>3683</code><code>Rajesh M, Mukhopadhyay P, Hasko G, Huffman JW, Mackie K, Pacher P. CB2 cannabinoid receptor agonists attenuate TNF-&amp;#x003b1;-induced human vascular smooth muscle cell proliferation and migration. &lt;span&gt;</code></p><p><code>3684</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3685</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>3686</code><code>2008;&lt;span class="ref-vol"&gt;</code></p><p><code>3687</code><code>153&lt;/span&gt;</code></p><p><code>3688</code><code>:347–357.&lt;/span&gt;</code></p><p><code>3689</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>3690</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2219520/"&gt;</code></p><p><code>3691</code><code>PMC free article&lt;/a&gt;</code></p><p><code>3692</code><code>]&lt;/span&gt;</code></p><p><code>3693</code><code> [&lt;a href="/pubmed/17994109" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3694</code><code>PubMed&lt;/a&gt;</code></p><p><code>3695</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3696</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=CB2+cannabinoid+receptor+agonists+attenuate+TNF-&amp;#x003b1;-induced+human+vascular+smooth+muscle+cell+proliferation+and+migration&amp;amp;author=M+Rajesh&amp;amp;author=P+Mukhopadhyay&amp;amp;author=G+Hasko&amp;amp;author=JW+Huffman&amp;amp;author=K+Mackie&amp;amp;volume=153&amp;amp;publication_year=2008&amp;amp;pages=347-357&amp;amp;pmid=17994109&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3697</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3698</code><code>]&lt;/span&gt;</code></p><p><code>3699</code><code>&lt;/span&gt;</code></p><p><code>3700</code><code>&lt;/div&gt;</code></p><p><code>3701</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R120"&gt;</code></p><p><code>3702</code><code>120. &lt;span class="citation"&gt;</code></p><p><code>3703</code><code>de Kozak Y, Sakai J, Thillaye B, Faure JP. S antigen-induced experimental autoimmune uveo-retinitis in rats. &lt;span&gt;</code></p><p><code>3704</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3705</code><code>Curr Eye Res. &lt;/span&gt;</code></p><p><code>3706</code><code>1981;&lt;span class="ref-vol"&gt;</code></p><p><code>3707</code><code>1&lt;/span&gt;</code></p><p><code>3708</code><code>:327–337.&lt;/span&gt;</code></p><p><code>3709</code><code> [&lt;a href="/pubmed/6975701" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3710</code><code>PubMed&lt;/a&gt;</code></p><p><code>3711</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3712</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Eye+Res&amp;amp;title=S+antigen-induced+experimental+autoimmune+uveo-retinitis+in+rats&amp;amp;author=Y+de+Kozak&amp;amp;author=J+Sakai&amp;amp;author=B+Thillaye&amp;amp;author=JP+Faure&amp;amp;volume=1&amp;amp;publication_year=1981&amp;amp;pages=327-337&amp;amp;pmid=6975701&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3713</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3714</code><code>]&lt;/span&gt;</code></p><p><code>3715</code><code>&lt;/span&gt;</code></p><p><code>3716</code><code>&lt;/div&gt;</code></p><p><code>3717</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R121"&gt;</code></p><p><code>3718</code><code>121. &lt;span class="citation"&gt;</code></p><p><code>3719</code><code>Xu H, Cheng CL, Chen M, et al.  Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis. &lt;span&gt;</code></p><p><code>3720</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3721</code><code>J Leukoc Biol. &lt;/span&gt;</code></p><p><code>3722</code><code>2007;&lt;span class="ref-vol"&gt;</code></p><p><code>3723</code><code>82&lt;/span&gt;</code></p><p><code>3724</code><code>:532–541.&lt;/span&gt;</code></p><p><code>3725</code><code> [&lt;a href="/pubmed/17537989" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3726</code><code>PubMed&lt;/a&gt;</code></p><p><code>3727</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3728</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Leukoc+Biol&amp;amp;title=Anti-inflammatory+property+of+the+cannabinoid+receptor-2-selective+agonist+JWH-133+in+a+rodent+model+of+autoimmune+uveoretinitis&amp;amp;author=H+Xu&amp;amp;author=CL+Cheng&amp;amp;author=M+Chen&amp;amp;volume=82&amp;amp;publication_year=2007&amp;amp;pages=532-541&amp;amp;pmid=17537989&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3729</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3730</code><code>]&lt;/span&gt;</code></p><p><code>3731</code><code>&lt;/span&gt;</code></p><p><code>3732</code><code>&lt;/div&gt;</code></p><p><code>3733</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R122"&gt;</code></p><p><code>3734</code><code>122. &lt;span class="citation"&gt;</code></p><p><code>3735</code><code>Correa F, Mestre L, Docagne F, Guaza C. Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling. &lt;span&gt;</code></p><p><code>3736</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3737</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>3738</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>3739</code><code>145&lt;/span&gt;</code></p><p><code>3740</code><code>:441–448.&lt;/span&gt;</code></p><p><code>3741</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>3742</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1576166/"&gt;</code></p><p><code>3743</code><code>PMC free article&lt;/a&gt;</code></p><p><code>3744</code><code>]&lt;/span&gt;</code></p><p><code>3745</code><code> [&lt;a href="/pubmed/15821753" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3746</code><code>PubMed&lt;/a&gt;</code></p><p><code>3747</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3748</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Activation+of+cannabinoid+CB2+receptor+negatively+regulates+IL-12p40+production+in+murine+macrophages:+role+of+IL-10+and+ERK1/2+kinase+signaling&amp;amp;author=F+Correa&amp;amp;author=L+Mestre&amp;amp;author=F+Docagne&amp;amp;author=C+Guaza&amp;amp;volume=145&amp;amp;publication_year=2005&amp;amp;pages=441-448&amp;amp;pmid=15821753&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3749</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3750</code><code>]&lt;/span&gt;</code></p><p><code>3751</code><code>&lt;/span&gt;</code></p><p><code>3752</code><code>&lt;/div&gt;</code></p><p><code>3753</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R123"&gt;</code></p><p><code>3754</code><code>123. &lt;span class="citation"&gt;</code></p><p><code>3755</code><code>Broderick CA, Smith AJ, Balaggan KS, et al.  Local administration of an adeno-associated viral vector expressing IL-10 reduces monocyte infiltration and subsequent photoreceptor damage during experimental autoimmune uveitis. &lt;span&gt;</code></p><p><code>3756</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3757</code><code>Mol Ther. &lt;/span&gt;</code></p><p><code>3758</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>3759</code><code>12&lt;/span&gt;</code></p><p><code>3760</code><code>:369–373.&lt;/span&gt;</code></p><p><code>3761</code><code> [&lt;a href="/pubmed/16043105" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3762</code><code>PubMed&lt;/a&gt;</code></p><p><code>3763</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3764</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;amp;title=Local+administration+of+an+adeno-associated+viral+vector+expressing+IL-10+reduces+monocyte+infiltration+and+subsequent+photoreceptor+damage+during+experimental+autoimmune+uveitis&amp;amp;author=CA+Broderick&amp;amp;author=AJ+Smith&amp;amp;author=KS+Balaggan&amp;amp;volume=12&amp;amp;publication_year=2005&amp;amp;pages=369-373&amp;amp;pmid=16043105&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3765</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3766</code><code>]&lt;/span&gt;</code></p><p><code>3767</code><code>&lt;/span&gt;</code></p><p><code>3768</code><code>&lt;/div&gt;</code></p><p><code>3769</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R124"&gt;</code></p><p><code>3770</code><code>124. &lt;span class="citation"&gt;</code></p><p><code>3771</code><code>De Kozak Y, Thillaye-Goldenberg B, Naud MC, Da Costa AV, Auriault C, Verwaerde C. Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene. &lt;span&gt;</code></p><p><code>3772</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3773</code><code>Clin Exp Immunol. &lt;/span&gt;</code></p><p><code>3774</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>3775</code><code>130&lt;/span&gt;</code></p><p><code>3776</code><code>:212–223.&lt;/span&gt;</code></p><p><code>3777</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>3778</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1906512/"&gt;</code></p><p><code>3779</code><code>PMC free article&lt;/a&gt;</code></p><p><code>3780</code><code>]&lt;/span&gt;</code></p><p><code>3781</code><code> [&lt;a href="/pubmed/12390308" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3782</code><code>PubMed&lt;/a&gt;</code></p><p><code>3783</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3784</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Immunol&amp;amp;title=Inhibition+of+experimental+autoimmune+uveoretinitis+by+systemic+and+subconjunctival+adenovirus-mediated+transfer+of+the+viral+IL-10+gene&amp;amp;author=Y+De+Kozak&amp;amp;author=B+Thillaye-Goldenberg&amp;amp;author=MC+Naud&amp;amp;author=AV+Da+Costa&amp;amp;author=C+Auriault&amp;amp;volume=130&amp;amp;publication_year=2002&amp;amp;pages=212-223&amp;amp;pmid=12390308&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3785</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3786</code><code>]&lt;/span&gt;</code></p><p><code>3787</code><code>&lt;/span&gt;</code></p><p><code>3788</code><code>&lt;/div&gt;</code></p><p><code>3789</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R125"&gt;</code></p><p><code>3790</code><code>125. &lt;span class="citation"&gt;</code></p><p><code>3791</code><code>Mandrup-Poulsen T. &amp;#x003b2; cell death and protection. &lt;span&gt;</code></p><p><code>3792</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3793</code><code>Ann NY Acad Sci. &lt;/span&gt;</code></p><p><code>3794</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>3795</code><code>1005&lt;/span&gt;</code></p><p><code>3796</code><code>:32–42.&lt;/span&gt;</code></p><p><code>3797</code><code> [&lt;a href="/pubmed/14679038" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3798</code><code>PubMed&lt;/a&gt;</code></p><p><code>3799</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3800</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Ann+NY+Acad+Sci&amp;amp;title=&amp;#x003b2;+cell+death+and+protection&amp;amp;author=T+Mandrup-Poulsen&amp;amp;volume=1005&amp;amp;publication_year=2003&amp;amp;pages=32-42&amp;amp;pmid=14679038&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3801</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3802</code><code>]&lt;/span&gt;</code></p><p><code>3803</code><code>&lt;/span&gt;</code></p><p><code>3804</code><code>&lt;/div&gt;</code></p><p><code>3805</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R126"&gt;</code></p><p><code>3806</code><code>126. &lt;span class="citation"&gt;</code></p><p><code>3807</code><code>Li X, Kaminski NE, Fischer LJ. Examination of the immunosuppressive effect of &amp;#x00394;9-tetrahydrocannabinol in streptozotocin-induced autoimmune diabetes. &lt;span&gt;</code></p><p><code>3808</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3809</code><code>Int Immunopharmacol. &lt;/span&gt;</code></p><p><code>3810</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>3811</code><code>1&lt;/span&gt;</code></p><p><code>3812</code><code>:699–712.&lt;/span&gt;</code></p><p><code>3813</code><code> [&lt;a href="/pubmed/11357882" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3814</code><code>PubMed&lt;/a&gt;</code></p><p><code>3815</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3816</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+Immunopharmacol&amp;amp;title=Examination+of+the+immunosuppressive+effect+of+&amp;#x00394;9-tetrahydrocannabinol+in+streptozotocin-induced+autoimmune+diabetes&amp;amp;author=X+Li&amp;amp;author=NE+Kaminski&amp;amp;author=LJ+Fischer&amp;amp;volume=1&amp;amp;publication_year=2001&amp;amp;pages=699-712&amp;amp;pmid=11357882&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3817</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3818</code><code>]&lt;/span&gt;</code></p><p><code>3819</code><code>&lt;/span&gt;</code></p><p><code>3820</code><code>&lt;/div&gt;</code></p><p><code>3821</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R127"&gt;</code></p><p><code>3822</code><code>127. &lt;span class="citation"&gt;</code></p><p><code>3823</code><code>Weiss L, Zeira M, Reich S, et al.  Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. &lt;span&gt;</code></p><p><code>3824</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3825</code><code>Autoimmunity. &lt;/span&gt;</code></p><p><code>3826</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>3827</code><code>39&lt;/span&gt;</code></p><p><code>3828</code><code>:143–151.&lt;/span&gt;</code></p><p><code>3829</code><code> [&lt;a href="/pubmed/16698671" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3830</code><code>PubMed&lt;/a&gt;</code></p><p><code>3831</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3832</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Autoimmunity&amp;amp;title=Cannabidiol+lowers+incidence+of+diabetes+in+non-obese+diabetic+mice&amp;amp;author=L+Weiss&amp;amp;author=M+Zeira&amp;amp;author=S+Reich&amp;amp;volume=39&amp;amp;publication_year=2006&amp;amp;pages=143-151&amp;amp;pmid=16698671&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3833</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3834</code><code>]&lt;/span&gt;</code></p><p><code>3835</code><code>&lt;/span&gt;</code></p><p><code>3836</code><code>&lt;/div&gt;</code></p><p><code>3837</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R128"&gt;</code></p><p><code>3838</code><code>128. &lt;span class="citation"&gt;</code></p><p><code>3839</code><code>Weiss L, Zeira M, Reich S, et al.  Cannabidiol arrests onset of autoimmune diabetes in NOD mice. &lt;span&gt;</code></p><p><code>3840</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3841</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>3842</code><code>2008;&lt;span class="ref-vol"&gt;</code></p><p><code>3843</code><code>54&lt;/span&gt;</code></p><p><code>3844</code><code>:244–249.&lt;/span&gt;</code></p><p><code>3845</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>3846</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2270485/"&gt;</code></p><p><code>3847</code><code>PMC free article&lt;/a&gt;</code></p><p><code>3848</code><code>]&lt;/span&gt;</code></p><p><code>3849</code><code> [&lt;a href="/pubmed/17714746" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3850</code><code>PubMed&lt;/a&gt;</code></p><p><code>3851</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3852</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Cannabidiol+arrests+onset+of+autoimmune+diabetes+in+NOD+mice&amp;amp;author=L+Weiss&amp;amp;author=M+Zeira&amp;amp;author=S+Reich&amp;amp;volume=54&amp;amp;publication_year=2008&amp;amp;pages=244-249&amp;amp;pmid=17714746&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3853</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3854</code><code>]&lt;/span&gt;</code></p><p><code>3855</code><code>&lt;/span&gt;</code></p><p><code>3856</code><code>&lt;/div&gt;</code></p><p><code>3857</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R129"&gt;</code></p><p><code>3858</code><code>129. &lt;span class="citation"&gt;</code></p><p><code>3859</code><code>El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI. Neuroprotective and blood&amp;#x02013;retinal barrier-preserving effects of cannabidiol in experimental diabetes. &lt;span&gt;</code></p><p><code>3860</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3861</code><code>Am J Pathol. &lt;/span&gt;</code></p><p><code>3862</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>3863</code><code>168&lt;/span&gt;</code></p><p><code>3864</code><code>:235–244.&lt;/span&gt;</code></p><p><code>3865</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>3866</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1592672/"&gt;</code></p><p><code>3867</code><code>PMC free article&lt;/a&gt;</code></p><p><code>3868</code><code>]&lt;/span&gt;</code></p><p><code>3869</code><code> [&lt;a href="/pubmed/16400026" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3870</code><code>PubMed&lt;/a&gt;</code></p><p><code>3871</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3872</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Pathol&amp;amp;title=Neuroprotective+and+blood&amp;#x02013;retinal+barrier-preserving+effects+of+cannabidiol+in+experimental+diabetes&amp;amp;author=AB+El-Remessy&amp;amp;author=M+Al-Shabrawey&amp;amp;author=Y+Khalifa&amp;amp;author=NT+Tsai&amp;amp;author=RB+Caldwell&amp;amp;volume=168&amp;amp;publication_year=2006&amp;amp;pages=235-244&amp;amp;pmid=16400026&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3873</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3874</code><code>]&lt;/span&gt;</code></p><p><code>3875</code><code>&lt;/span&gt;</code></p><p><code>3876</code><code>&lt;/div&gt;</code></p><p><code>3877</code><code>&lt;div class="ref-cit-blk half_rhythm" id="R130"&gt;</code></p><p><code>3878</code><code>130. &lt;span class="citation"&gt;</code></p><p><code>3879</code><code>Dogrul A, Gul H, Yildiz O, Bilgin F, Guzeldemir ME. Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect. &lt;span&gt;</code></p><p><code>3880</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>3881</code><code>Neurosci Lett. &lt;/span&gt;</code></p><p><code>3882</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>3883</code><code>368&lt;/span&gt;</code></p><p><code>3884</code><code>:82–86.&lt;/span&gt;</code></p><p><code>3885</code><code> [&lt;a href="/pubmed/15342139" ref="reftype=pubmed&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>3886</code><code>PubMed&lt;/a&gt;</code></p><p><code>3887</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>3888</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;amp;title=Cannabinoids+blocks+tactile+allodynia+in+diabetic+mice+without+attenuation+of+its+antinociceptive+effect&amp;amp;author=A+Dogrul&amp;amp;author=H+Gul&amp;amp;author=O+Yildiz&amp;amp;author=F+Bilgin&amp;amp;author=ME+Guzeldemir&amp;amp;volume=368&amp;amp;publication_year=2004&amp;amp;pages=82-86&amp;amp;pmid=15342139&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2828614&amp;amp;issue-id=185260&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>3889</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3890</code><code>]&lt;/span&gt;</code></p><p><code>3891</code><code>&lt;/span&gt;</code></p><p><code>3892</code><code>&lt;/div&gt;</code></p><p><code>3893</code><code>&lt;/div&gt;</code></p><p><code>3894</code><code>&lt;/div&gt;</code></p><p><code>3895</code><code>&lt;/div&gt;</code></p><p><code>3896</code><code>&lt;!--post-content--&gt;</code></p><p><code>3897</code><code>&lt;/div&gt;</code></p><p><code>3898</code><code>          </code></p><p><code>3899</code><code>            </code></p><p><code>3900</code><code>            </code></p><p><code>3901</code><code>        </code></p><p><code>3902</code><code>            </code></p><p><code>3903</code><code>        &lt;/div&gt;</code></p><p><code>3904</code><code>          </code></p><p><code>3905</code><code>        &lt;!-- Book content --&gt;</code></p><p><code>3906</code><code>          </code></p><p><code>3907</code><code>    &lt;/div&gt;</code></p><p><code>3908</code><code>          </code></p><p><code>3909</code><code>    </code></p><p><code>3910</code><code>    &lt;div id="rightcolumn" class="four_col col last"&gt;</code></p><p><code>3911</code><code>          </code></p><p><code>3912</code><code>        &lt;!-- Custom content above discovery portlets --&gt;</code></p><p><code>3913</code><code>          </code></p><p><code>3914</code><code>        &lt;div class="col6"&gt;</code></p><p><code>3915</code><code>          </code></p><p><code>3916</code><code>            </code></p><p><code>3917</code><code>        &lt;/div&gt;</code></p><p><code>3918</code><code>          </code></p><p><code>3919</code><code>        </code></p><p><code>3920</code><code>        &lt;div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"&gt;</code></p><p><code>3921</code><code>&lt;div class="format-menu"&gt;</code></p><p><code>3922</code><code>&lt;h2&gt;</code></p><p><code>3923</code><code>Formats:&lt;/h2&gt;</code></p><p><code>3924</code><code>&lt;ul&gt;</code></p><p><code>3925</code><code>&lt;li class="selected"&gt;</code></p><p><code>3926</code><code>Article&lt;/li&gt;</code></p><p><code>3927</code><code> | &lt;li&gt;</code></p><p><code>3928</code><code>&lt;a href="/pmc/articles/PMC2828614/?report=reader"&gt;</code></p><p><code>3929</code><code>PubReader&lt;/a&gt;</code></p><p><code>3930</code><code>&lt;/li&gt;</code></p><p><code>3931</code><code> | &lt;li&gt;</code></p><p><code>3932</code><code>&lt;a href="/pmc/articles/PMC2828614/pdf/nihms155268.pdf"&gt;</code></p><p><code>3933</code><code>PDF (849K)&lt;/a&gt;</code></p><p><code>3934</code><code>&lt;/li&gt;</code></p><p><code>3935</code><code> | &lt;li&gt;</code></p><p><code>3936</code><code>&lt;a href="#" data-citationid="PMC2828614" class="citationexporter ctxp"&gt;</code></p><p><code>3937</code><code>Cite&lt;/a&gt;</code></p><p><code>3938</code><code>&lt;/li&gt;</code></p><p><code>3939</code><code>&lt;/ul&gt;</code></p><p><code>3940</code><code>&lt;/div&gt;</code></p><p><code>3941</code><code>&lt;/div&gt;</code></p><p><code>3942</code><code>&lt;div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"&gt;</code></p><p><code>3943</code><code>&lt;h2&gt;</code></p><p><code>3944</code><code>Share&lt;/h2&gt;</code></p><p><code>3945</code><code>&lt;ul&gt;</code></p><p><code>3946</code><code>&lt;li class="facebook"&gt;</code></p><p><code>3947</code><code>&lt;a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2828614%2F"&gt;</code></p><p><code>3948</code><code>&lt;img src="//static.pubmed.gov/portal/portal3rc.fcgi/4201310/img/4047626" alt="Share on Facebook" /&gt;</code></p><p><code>3949</code><code>          </code></p><p><code>3950</code><code>                             Facebook</code></p><p><code>3951</code><code>                        &lt;/a&gt;</code></p><p><code>3952</code><code>&lt;/li&gt;</code></p><p><code>3953</code><code>&lt;li class="twitter"&gt;</code></p><p><code>3954</code><code>&lt;a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2828614%2F&amp;amp;text=Cannabinoids%20as%20novel%20anti-inflammatory%20drugs"&gt;</code></p><p><code>3955</code><code>&lt;img src="//static.pubmed.gov/portal/portal3rc.fcgi/4201310/img/4047627" alt="Share on Twitter" /&gt;</code></p><p><code>3956</code><code>          </code></p><p><code>3957</code><code>                             Twitter</code></p><p><code>3958</code><code>                        &lt;/a&gt;</code></p><p><code>3959</code><code>&lt;/li&gt;</code></p><p><code>3960</code><code>&lt;li class="gplus"&gt;</code></p><p><code>3961</code><code>&lt;a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2828614%2F"&gt;</code></p><p><code>3962</code><code>&lt;img src="//static.pubmed.gov/portal/portal3rc.fcgi/4201310/img/4047628" alt="Share on Google Plus" /&gt;</code></p><p><code>3963</code><code>          </code></p><p><code>3964</code><code>                             Google+</code></p><p><code>3965</code><code>                        &lt;/a&gt;</code></p><p><code>3966</code><code>&lt;/li&gt;</code></p><p><code>3967</code><code>&lt;/ul&gt;</code></p><p><code>3968</code><code>&lt;/div&gt;</code></p><p><code>3969</code><code>          </code></p><p><code>3970</code><code>        </code></p><p><code>3971</code><code>        &lt;div id="ajax-portlets" data-pmid="20191092" data-aiid="2828614" data-aid="2828614" data-iid="185260" data-domainid="319" data-domain="nihpa" data-accid="PMC2828614" data-md5="2d5168bf2f4e3c60617fe94e9a9adfa1"&gt;</code></p><p><code>3972</code><code>&lt;/div&gt;</code></p><p><code>3973</code><code>          </code></p><p><code>3974</code><code>                </code></p><p><code>3975</code><code>        &lt;!-- Custom content below discovery portlets --&gt;</code></p><p><code>3976</code><code>          </code></p><p><code>3977</code><code>        &lt;div class="col7"&gt;</code></p><p><code>3978</code><code>          </code></p><p><code>3979</code><code>            </code></p><p><code>3980</code><code>        &lt;/div&gt;</code></p><p><code>3981</code><code>          </code></p><p><code>3982</code><code>    &lt;/div&gt;</code></p><p><code>3983</code><code>          </code></p><p><code>3984</code><code>&lt;/div&gt;</code></p><p><code>3985</code><code>          </code></p><p><code>3986</code><code>          </code></p><p><code>3987</code><code>&lt;!-- Custom content after all --&gt;</code></p><p><code>3988</code><code>          </code></p><p><code>3989</code><code>&lt;div class="col8"&gt;</code></p><p><code>3990</code><code>          </code></p><p><code>3991</code><code>    </code></p><p><code>3992</code><code>&lt;/div&gt;</code></p><p><code>3993</code><code>          </code></p><p><code>3994</code><code>&lt;div class="col9"&gt;</code></p><p><code>3995</code><code>          </code></p><p><code>3996</code><code>    </code></p><p><code>3997</code><code>&lt;/div&gt;</code></p><p><code>3998</code><code>          </code></p><p><code>3999</code><code>          </code></p><p><code>4000</code><code>&lt;script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"&gt;</code></p><p><code>4001</code><code>&lt;/script&gt;</code></p><p><code>4002</code><code>          </code></p><p><code>4003</code><code>&lt;script&gt;</code></p><p><code>4004</code><code>          </code></p><p><code>4005</code><code>    (function($){</code></p><p><code>4006</code><code>        $('.skiplink').each(function(i, item){</code></p><p><code>4007</code><code>            var href = $($(item).attr('href'));</code></p><p><code>4008</code><code>            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus</code></p><p><code>4009</code><code>            $(item).on('click', function(event){</code></p><p><code>4010</code><code>                event.preventDefault();</code></p><p><code>4011</code><code>                $.scrollTo(href, 0, {</code></p><p><code>4012</code><code>                    onAfter: function(){</code></p><p><code>4013</code><code>                        href.focus();</code></p><p><code>4014</code><code>                    }</code></p><p><code>4015</code><code>                });</code></p><p><code>4016</code><code>            });</code></p><p><code>4017</code><code>        });</code></p><p><code>4018</code><code>    })(jQuery);</code></p><p><code>4019</code><code>&lt;/script&gt;</code></p><p><code>4020</code><code>          </code></p><p><code>4021</code><code>          </code></p><p><code>4022</code><code>          </code></p><p><code>4023</code><code>          </code></p><p><code>4024</code><code>&lt;div id="body-link-poppers"&gt;</code></p><p><code>4025</code><code>&lt;/div&gt;</code></p><p><code>4026</code><code>          </code></p><p><code>4027</code><code>                        &lt;/div&gt;</code></p><p><code>4028</code><code>          </code></p><p><code>4029</code><code>                        &lt;div class="bottom"&gt;</code></p><p><code>4030</code><code>          </code></p><p><code>4031</code><code>                            </code></p><p><code>4032</code><code>                            &lt;div id="NCBIFooter_dynamic"&gt;</code></p><p><code>4033</code><code>          </code></p><p><code>4034</code><code>    &lt;a id="help-desk-link" class="help_desk" href="" target="_blank"&gt;</code></p><p><code>4035</code><code>Support Center&lt;/a&gt;</code></p><p><code>4036</code><code>          </code></p><p><code>4037</code><code>    &lt;a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2021-10-26T14:06:02-04:00&amp;amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.52&amp;amp;Host=ptpmc101&amp;amp;ncbi_phid=8A1AC59A17840EA10000000001100110&amp;amp;ncbi_session=8A1AED4817306781_0453SID&amp;amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2828614%2F&amp;amp;Db=pmc&amp;amp;folderID=132&amp;amp;Ncbi_App=pmc&amp;amp;Page=literature&amp;amp;style=classic&amp;amp;deptID=28049" target="_blank"&gt;</code></p><p><code>4038</code><code>Support Center&lt;/a&gt;</code></p><p><code>4039</code><code>          </code></p><p><code>4040</code><code>    </code></p><p><code>4041</code><code>&lt;/div&gt;</code></p><p><code>4042</code><code>          </code></p><p><code>4043</code><code>          </code></p><p><code>4044</code><code>                            &lt;div class="footer" id="footer"&gt;</code></p><p><code>4045</code><code>          </code></p><p><code>4046</code><code>    </code></p><p><code>4047</code><code>    &lt;div class="subfooter"&gt;</code></p><p><code>4048</code><code> &lt;/div&gt;</code></p><p><code>4049</code><code>&lt;script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"&gt;</code></p><p><code>4050</code><code> &lt;/script&gt;</code></p><p><code>4051</code><code>          </code></p><p><code>4052</code><code>    &lt;div id="external-disclaimer" class="offscreen_noflow"&gt;</code></p><p><code>4053</code><code>          </code></p><p><code>4054</code><code>        External link. Please review our &lt;a href="https://www.nlm.nih.gov/privacy.html"&gt;</code></p><p><code>4055</code><code>privacy policy&lt;/a&gt;</code></p><p><code>4056</code><code>.</code></p><p><code>4057</code><code>    &lt;/div&gt;</code></p><p><code>4058</code><code>    </code></p><p><code>4059</code><code>    &lt;div id="ncbifooter" class="contact_info"&gt;</code></p><p><code>4060</code><code>      </code></p><p><code>4061</code><code>        &lt;div id="footer-contents-right"&gt;</code></p><p><code>4062</code><code>          </code></p><p><code>4063</code><code>            &lt;div id="nlm_thumb_logo"&gt;</code></p><p><code>4064</code><code>          </code></p><p><code>4065</code><code>                &lt;a href="https://www.nlm.nih.gov" title="NLM"&gt;</code></p><p><code>4066</code><code>NLM&lt;/a&gt;</code></p><p><code>4067</code><code>          </code></p><p><code>4068</code><code>            &lt;/div&gt;</code></p><p><code>4069</code><code>          </code></p><p><code>4070</code><code>            &lt;div id="nih_thumb_logo"&gt;</code></p><p><code>4071</code><code>          </code></p><p><code>4072</code><code>                &lt;a href="https://www.nih.gov" title="NIH"&gt;</code></p><p><code>4073</code><code>NIH&lt;/a&gt;</code></p><p><code>4074</code><code>          </code></p><p><code>4075</code><code>            &lt;/div&gt;</code></p><p><code>4076</code><code>          </code></p><p><code>4077</code><code>            &lt;div id="hhs_thumb_logo"&gt;</code></p><p><code>4078</code><code>          </code></p><p><code>4079</code><code>                &lt;a href="https://www.hhs.gov" title="DHHS"&gt;</code></p><p><code>4080</code><code>DHHS&lt;/a&gt;</code></p><p><code>4081</code><code>          </code></p><p><code>4082</code><code>            &lt;/div&gt;</code></p><p><code>4083</code><code>          </code></p><p><code>4084</code><code>            &lt;div id="usagov_thumb_logo"&gt;</code></p><p><code>4085</code><code>          </code></p><p><code>4086</code><code>                &lt;a href="https://www.usa.gov" title="USA.gov"&gt;</code></p><p><code>4087</code><code>USA.gov&lt;/a&gt;</code></p><p><code>4088</code><code>          </code></p><p><code>4089</code><code>            &lt;/div&gt;</code></p><p><code>4090</code><code>         </code></p><p><code>4091</code><code>        &lt;/div&gt;</code></p><p><code>4092</code><code>          </code></p><p><code>4093</code><code>        </code></p><p><code>4094</code><code>        &lt;div id="footer-contents-left"&gt;</code></p><p><code>4095</code><code>          </code></p><p><code>4096</code><code>            &lt;p class="address vcard"&gt;</code></p><p><code>4097</code><code>          </code></p><p><code>4098</code><code>                &lt;span class="url"&gt;</code></p><p><code>4099</code><code>          </code></p><p><code>4100</code><code>                    &lt;a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov"&gt;</code></p><p><code>4101</code><code>National Center for</code></p><p><code>4102</code><code>                        Biotechnology Information&lt;/a&gt;</code></p><p><code>4103</code><code>,</code></p><p><code>4104</code><code>                &lt;/span&gt;</code></p><p><code>4105</code><code> &lt;span class="org url newdomain"&gt;</code></p><p><code>4106</code><code>&lt;a href="https://www.nlm.nih.gov/"&gt;</code></p><p><code>4107</code><code>U.S. National Library of Medicine&lt;/a&gt;</code></p><p><code>4108</code><code>&lt;/span&gt;</code></p><p><code>4109</code><code>          </code></p><p><code>4110</code><code>                &lt;span class="adr"&gt;</code></p><p><code>4111</code><code>          </code></p><p><code>4112</code><code>                    &lt;span class="street-address"&gt;</code></p><p><code>4113</code><code>8600 Rockville Pike&lt;/span&gt;</code></p><p><code>4114</code><code>, &lt;span class="locality"&gt;</code></p><p><code>4115</code><code>Bethesda&lt;/span&gt;</code></p><p><code>4116</code><code>          </code></p><p><code>4117</code><code>                    &lt;span class="region"&gt;</code></p><p><code>4118</code><code>MD&lt;/span&gt;</code></p><p><code>4119</code><code>, &lt;span class="postal-code"&gt;</code></p><p><code>4120</code><code>20894&lt;/span&gt;</code></p><p><code>4121</code><code>          </code></p><p><code>4122</code><code>                    &lt;span class="country-name"&gt;</code></p><p><code>4123</code><code>USA&lt;/span&gt;</code></p><p><code>4124</code><code>          </code></p><p><code>4125</code><code>                &lt;/span&gt;</code></p><p><code>4126</code><code>          </code></p><p><code>4127</code><code>            &lt;/p&gt;</code></p><p><code>4128</code><code>          </code></p><p><code>4129</code><code>            </code></p><p><code>4130</code><code>            &lt;a href="/home/about/policies.shtml"&gt;</code></p><p><code>4131</code><code>Policies and Guidelines&lt;/a&gt;</code></p><p><code>4132</code><code> | &lt;a href="/home/about/contact.shtml"&gt;</code></p><p><code>4133</code><code>Contact&lt;/a&gt;</code></p><p><code>4134</code><code>          </code></p><p><code>4135</code><code>        &lt;/div&gt;</code></p><p><code>4136</code><code>          </code></p><p><code>4137</code><code>    &lt;/div&gt;</code></p><p><code>4138</code><code>          </code></p><p><code>4139</code><code>    &lt;script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"&gt;</code></p><p><code>4140</code><code> &lt;/script&gt;</code></p><p><code>4141</code><code>    </code></p><p><code>4142</code><code>    &lt;script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"&gt;</code></p><p><code>4143</code><code> &lt;/script&gt;</code></p><p><code>4144</code><code>          </code></p><p><code>4145</code><code>&lt;/div&gt;</code></p><p><code>4146</code><code>          </code></p><p><code>4147</code><code>                        &lt;/div&gt;</code></p><p><code>4148</code><code>          </code></p><p><code>4149</code><code>                    &lt;/div&gt;</code></p><p><code>4150</code><code>          </code></p><p><code>4151</code><code>                    &lt;!--/.page--&gt;</code></p><p><code>4152</code><code>          </code></p><p><code>4153</code><code>                &lt;/div&gt;</code></p><p><code>4154</code><code>          </code></p><p><code>4155</code><code>                &lt;!--/.wrap--&gt;</code></p><p><code>4156</code><code>          </code></p><p><code>4157</code><code>            &lt;/div&gt;</code></p><p><code>4158</code><code>&lt;!-- /.twelve_col --&gt;</code></p><p><code>4159</code><code>          </code></p><p><code>4160</code><code>        &lt;/div&gt;</code></p><p><code>4161</code><code>          </code></p><p><code>4162</code><code>        &lt;!-- /.grid --&gt;</code></p><p><code>4163</code><code>          </code></p><p><code>4164</code><code>          </code></p><p><code>4165</code><code>        &lt;span class="PAFAppResources"&gt;</code></p><p><code>4166</code><code>&lt;/span&gt;</code></p><p><code>4167</code><code>          </code></p><p><code>4168</code><code>        </code></p><p><code>4169</code><code>        &lt;!-- BESelector tab --&gt;</code></p><p><code>4170</code><code>          </code></p><p><code>4171</code><code>        </code></p><p><code>4172</code><code>        </code></p><p><code>4173</code><code>        </code></p><p><code>4174</code><code>        &lt;noscript&gt;</code></p><p><code>4175</code><code>&lt;img alt="statistics" src="/stat?jsdisabled=true&amp;amp;ncbi_db=pmc&amp;amp;ncbi_pdid=article&amp;amp;ncbi_acc=&amp;amp;ncbi_domain=nihpa&amp;amp;ncbi_report=record&amp;amp;ncbi_type=fulltext&amp;amp;ncbi_objectid=&amp;amp;ncbi_pcid=/articles/PMC2828614/&amp;amp;ncbi_app=pmc" /&gt;</code></p><p><code>4176</code><code>&lt;/noscript&gt;</code></p><p><code>4177</code><code>          </code></p><p><code>4178</code><code>        </code></p><p><code>4179</code><code>        </code></p><p><code>4180</code><code>        &lt;!-- usually for JS scripts at page bottom --&gt;</code></p><p><code>4181</code><code>          </code></p><p><code>4182</code><code>        &lt;!--&lt;component id="PageFixtures" label="styles"&gt;</code></p><p><code>4183</code><code>&lt;/component&gt;</code></p><p><code>4184</code><code>--&gt;</code></p><p><code>4185</code><code>          </code></p><p><code>4186</code><code>    </code></p><p><code>4187</code><code>          </code></p><p><code>4188</code><code>&lt;!-- 8A1AED4817306781_0453SID /projects/PMC/PMCViewer@4.52 ptpmc101 v4.1.r635708 Mon, Aug 09 2021 01:08:56 --&gt;</code></p><p><code>4189</code><code>          </code></p><p><code>4190</code><code>&lt;span id="portal-csrf-token" style="display:none" data-token="8A1AED4817306781_0453SID"&gt;</code></p><p><code>4191</code><code>&lt;/span&gt;</code></p><p><code>4192</code><code>          </code></p><p><code>4193</code><code>          </code></p><p><code>4194</code><code>&lt;script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4201310/js/3879255/4121861/3818874/3821238/4117325/4200673/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"&gt;</code></p><p><code>4195</code><code>&lt;/script&gt;</code></p><p><code>4196</code><code>&lt;/body&gt;</code></p><p><code>4197</code><code>          </code></p><p><code>4198</code><code>&lt;/html&gt;</code></p><div></div></main><iframe hidden="hidden" title="Hidden frame for spell checking" src="about:blank" id="iframeSpelling"></iframe></body></html>